Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024980	s-igg4	g/l (g/l)	5173	8187	0.00%
3024980	s-igg4	— (—)	1881	2565	100.00%	Distribution not available
3024980	s-immunoglobuliinig,alaluokka4	g/l (g/l)	31	33	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic sinusitis

956

2484

3.97

321.34

1.6

1.5

0.74

0.75

g/l

0.14

748

1847

Used for control exclusion in common control thyroid runs

1876

3339

2.90

317.81

1.8

1.4

0.77

0.79

g/l

0.27

1424

2514

Other systemic involvement of connective tissue

682

1391

5.13

314.46

2.0

1.5

0.73

0.72

g/l

0.09

517

1034

Noninfective enteritis and colitis

1055

2986

3.64

312.64

2.0

1.5

0.72

0.77

g/l

0.63

844

2242

Chronic lower respiratory diseases

2152

4519

2.62

310.50

1.5

1.6

0.76

0.74

g/l

0.30

1647

3386

Pneumonias (Asthma/COPD co-morbidities)

1826

4710

2.74

307.67

1.5

1.6

0.72

0.77

g/l

0.74

1369

3554

Immunodeficiency with predominantly antibody defects

287

121

33.42

307.65

2.1

1.8

0.28

0.83

g/l

3.38

232

L04AX Other immunosuppressants

1289

3488

3.82

307.65

1.9

1.5

0.72

0.76

g/l

0.43

982

2637

IBD (strict) with PSC

226

119.19

307.65

3.3

1.3

0.85

0.54

g/l

2.16

213

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1715

3284

3.34

307.65

1.5

1.6

0.72

0.80

g/l

1.24

1287

2453

Colitis, primary sclerosing, strict definition

225

86.12

307.65

3.1

1.3

0.85

0.64

g/l

1.17

211

Diseases of liver

968

1869

5.45

307.65

1.7

1.6

0.76

0.81

g/l

0.70

762

1401

ILD medications: prednisolone, methylprednisolone, prednisone

2844

3094

5.37

307.65

1.8

1.3

0.76

0.75

g/l

0.15

2168

2294

1111

2615

4.37

307.65

1.6

0.70

0.74

g/l

0.49

854

1982

Autoimmune diseases excluding thyroid diseases

2158

3620

3.38

307.65

1.8

1.5

0.73

0.79

g/l

1.17

1682

2696

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1311

3282

3.81

307.65

1.7

1.5

0.84

0.77

g/l

0.87

983

2452

Inflammatory bowel disease treatment related agents

3036

3364

5.30

307.65

1.9

1.3

0.75

g/l

0.02

2334

2482

Reimbursement for rheumatic diseases

1365

3509

4.02

307.65

2.0

1.5

0.72

0.75

g/l

0.44

1080

2629

Asthma (only as main-diagnosis), excluding more controls

1539

1948

4.83

307.65

1.6

0.73

0.75

g/l

0.25

1152

1456

Any gastric operation

1592

1801

4.53

307.65

1.7

1.3

0.73

0.75

g/l

0.21

1199

1455

Ulcerative colitis (strict) with PSC

189

127.27

307.65

3.2

1.3

0.87

0.58

g/l

1.43

178

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1949

4475

3.20

307.65

1.7

1.5

0.72

0.76

g/l

0.78

1467

3391

Chronic pancreatitis

477

493

10.60

307.65

2.5

1.3

1.03

0.88

g/l

0.84

315

393

Cholangitis (primary sclerosing, PSC), with reimbursement 202

325

69.57

307.65

3.3

1.5

0.80

0.66

g/l

0.41

297

Asthma (only as main-diagnosis)

1549

2038

4.71

307.65

1.6

1.5

0.73

0.75

g/l

0.37

1160

1520

Disorders of gallbladder, biliary tract and pancreas

2304

3660

4.18

307.65

1.9

1.4

0.76

g/l

0.08

1684

2818

Asthma, unspecified (mode), excluding more controls

1000

1720

4.68

307.65

1.6

1.5

0.81

0.73

g/l

0.91

728

1286

Influenza and pneumonia

1946

4686

2.78

307.65

1.6

0.72

0.76

g/l

0.68

1464

3538

1715

3284

3.34

307.65

1.5

1.6

0.72

0.80

g/l

1.24

1287

2453

Asthma (diagnoses ohter than nonallergic)

1709

4839

3.09

307.65

1.6

1.5

0.77

0.74

g/l

0.42

1298

3657

Autoimmune diseases

1988

3637

2.84

307.65

1.8

1.5

0.76

0.79

g/l

0.47

1532

2708

Cholangitis (primary sclerosing, PSC)

525

196

34.08

307.65

2.8

1.4

0.80

0.95

g/l

0.73

446

158

Certain disorders involving the immune mechanism

679

1115

6.54

307.65

2.0

1.5

0.60

0.81

g/l

3.81

509

851

Asthma, hospital admission 2, infections

1364

3407

4.07

307.65

1.6

0.70

0.76

g/l

1.02

1046

2579

Asthma-related infections

1364

3407

4.07

307.65

1.6

0.70

0.76

g/l

1.02

1046

2579

Fever of other and unknown origin

1241

2721

4.36

307.65

1.6

1.5

0.65

0.79

g/l

4.59

929

2061

Asthma, hospital admissions , main diagnosis only

1598

4916

2.97

307.65

1.6

1.5

0.75

0.74

g/l

0.08

1205

3719

Systemic connective tissue disorders

960

1886

5.34

307.65

1.9

1.4

0.72

0.73

g/l

0.08

732

1402

5-aminosalicylic acid

565

920

6.43

307.65

2.3

1.3

0.80

0.73

g/l

0.66

462

681

Asthma, hospital admissions 3, pneumonia

829

1781

4.83

307.65

1.6

1.5

0.68

0.77

g/l

1.14

632

1339

Asthma (mode)

1622

2053

4.45

307.65

1.6

1.5

0.75

g/l

0.01

1236

1532

Acute pancreatitis (for exclusion)

940

1001

10.41

307.65

1.9

1.5

0.71

0.85

g/l

1.85

608

781

Other diseases of biliary tract

369

272

15.13

307.65

3.0

1.5

0.97

0.85

g/l

0.48

286

213

Oral corticosteroids

2797

3222

5.44

307.65

1.8

1.3

0.75

g/l

0.00

2120

2373

Abnormal findings on diagnostic imaging of lung

957

2315

4.16

307.65

1.6

1.5

0.83

0.81

g/l

0.21

722

1734

Asthma-related pneumonia or sepsis

829

1781

4.83

307.65

1.6

1.5

0.68

0.77

g/l

1.14

632

1339

Other systemic involvement of connective tissue (FG)

663

1196

5.76

307.65

2.0

1.4

0.74

0.73

g/l

0.06

503

891

Asthma, excluding more controls

1655

1948

4.65

307.65

1.6

0.76

0.75

g/l

0.15

1253

1456

Asthma-related pneumonia

825

1775

4.82

307.65

1.6

1.5

0.69

0.78

g/l

1.12

628

1337

Autoimmune diseases related-to ILD

1877

4566

3.72

307.65

1.8

1.5

0.70

0.77

g/l

1.71

1451

3412

Azathioprine

526

616

9.15

307.65

2.4

1.3

0.74

0.73

g/l

0.04

415

462

ILD medications: immunosuppressive drugs

1597

2729

5.83

307.65

1.9

1.3

0.71

0.74

g/l

0.45

1219

2035

GASTRO-related operations

1592

1801

4.53

307.65

1.7

1.3

0.73

0.75

g/l

0.21

1199

1455

Second line medication for Crohn's disease

1344

3562

3.91

307.65

2.0

1.5

0.72

0.76

g/l

0.47

1023

2700

Immunodeficiencies

374

237

19.59

307.65

2.0

1.6

0.41

0.87

g/l

4.60

293

181

Colitis, primary sclerosing

285

84.57

307.65

3.1

1.6

0.87

0.77

g/l

0.21

264

First line medication for Crohn's disease

2767

3024

5.14

307.65

1.9

1.3

0.77

0.75

g/l

0.24

2121

2243

Autoimmune diseases excluding thyroid diseases, strict definition

2072

3508

3.36

307.65

1.8

1.4

0.74

0.80

g/l

0.95

1621

2624

Asthma, unspecified (mode)

1004

1792

4.55

307.65

1.6

1.5

0.81

0.74

g/l

0.73

732

1337

ILD medications: azathioprine

526

608

9.27

307.65

2.4

1.4

0.74

g/l

0.00

415

459

Acute pancreatitis

940

829

12.59

307.65

1.9

1.4

0.71

0.85

g/l

1.67

608

647

ILD medications

2880

3160

5.16

307.65

1.8

1.3

0.76

g/l

0.02

2199

2347

Asthma

1681

2038

4.54

307.65

1.6

1.5

0.76

0.75

g/l

0.04

1277

1520

All pneumoniae

1832

4731

2.72

305.45

1.5

1.6

0.72

0.77

g/l

0.81

1372

3568

Pneumonia, organism unspecified

1650

4274

2.85

302.57

1.6

0.71

0.77

g/l

0.91

1241

3212

General symptoms and signs

1944

3590

2.76

301.27

1.6

1.5

0.74

0.77

g/l

0.44

1484

2707

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

366

243

11.81

295.59

1.7

1.4

0.97

0.94

g/l

0.08

266

174

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1776

4699

2.71

294.06

1.6

0.71

0.77

g/l

0.85

1331

3543

Examination and observation for other reasons

1178

2059

3.56

291.94

1.7

1.5

0.69

0.85

g/l

3.33

1028

1424

Gastrointestinal diseases

1029

1289

4.07

283.12

1.7

1.4

0.69

0.80

g/l

2.03

783

989

Asthma, including avohilmo

2031

4763

2.52

277.34

1.6

0.77

0.74

g/l

0.44

1542

3580

Undetermined asthma, excluding more controls

350

415

8.89

273.72

1.7

1.5

0.83

0.74

g/l

0.56

256

317

Bronchiectasis

289

268

11.82

273.10

1.5

0.67

0.87

g/l

1.45

219

199

Undetermined asthma

350

425

8.68

268.50

1.7

1.4

0.83

0.74

g/l

0.57

256

324

Excluding asthma or asthma-COPD overlap

1316

2060

3.25

267.59

1.6

0.76

g/l

0.01

988

1536

Inflammatory bowel disease

781

2010

4.03

267.12

2.1

1.5

0.75

0.76

g/l

0.06

640

1505

Other pulmonary diagnosis

1313

2060

3.24

266.05

1.6

0.75

0.76

g/l

0.07

989

1536

ILD differential diagnosis

1306

2053

3.24

263.81

1.6

1.5

0.76

0.75

g/l

0.04

981

1532

COPD differential diagnosis

1305

2055

3.23

262.93

1.6

1.5

0.76

0.75

g/l

0.04

981

1533

Ulcerative colitis

648

1476

4.58

261.25

2.2

1.5

0.79

0.77

g/l

0.09

540

1112

COPD/asthma related infections

1727

3287

2.67

252.81

1.5

1.6

0.69

0.80

g/l

2.44

1315

2455

COPD/asthma/ILD related infections

1727

3287

2.67

252.81

1.5

1.6

0.69

0.80

g/l

2.44

1315

2455

IBD patients in KELA-register

625

1427

4.58

251.35

2.2

1.5

0.77

g/l

0.01

509

1085

Abnormalities of breathing

1544

3442

2.71

245.01

1.5

1.6

0.68

0.79

g/l

2.43

1168

2594

Asthma/COPD (KELA code 203)

1604

4497

2.55

238.24

1.6

0.77

0.74

g/l

0.45

1229

3369

Inflammatory bowel disease, strict (require KELA)

625

1488

4.39

238.14

2.2

1.5

0.77

0.76

g/l

0.10

509

1134

Any reimbursement code in KELA

1035

1502

3.51

235.33

1.7

1.4

0.71

0.77

g/l

0.84

790

1133

Mucosal proctocolitis

414

706

6.24

233.64

2.5

1.5

0.83

0.81

g/l

0.13

350

536

Other diseases of pancreas

255

250

11.11

231.74

2.1

1.4

0.93

0.87

g/l

0.17

170

198

1810

3970

2.44

226.18

1.6

0.68

0.79

g/l

3.69

1395

2961

Other respiratory diseases principally affecting the interstitium

419

746

5.90

225.23

1.7

1.5

0.98

0.87

g/l

0.57

304

565

Pain in joint

1000

2073

3.25

224.30

1.4

1.6

0.61

0.88

g/l

10.05

775

1546

Abnormal findings on examination of blood, without diagnosis

864

2474

3.36

223.18

1.8

1.6

0.84

g/l

0.01

666

1844

Ulcerative colitis, NAS

425

783

5.75

220.82

2.3

1.6

0.80

0.78

g/l

0.09

354

595

ILD, hospital admission 2, with pulmonary infections

263

292

9.61

217.36

1.7

0.88

0.94

g/l

0.20

192

230

Budesonide

335

494

7.12

217.10

1.9

1.3

0.69

0.72

g/l

0.17

266

367

Other interstitial pulmonary diseases

369

617

6.31

212.00

1.6

0.89

0.91

g/l

0.06

266

465

Bacterial infection, other or unspecified

883

2538

3.21

211.05

1.5

1.6

0.69

0.83

g/l

2.23

666

1900

Other and unspecified immunodeficiencies with predominantly antibody defects

145

34.35

211.03

2.2

1.5

0.27

0.72

g/l

3.95

118

Acute sinusitis

982

3123

3.00

210.40

1.6

0.64

0.77

g/l

3.82

766

2343

Other bacterial diseases

1535

4385

2.46

209.78

1.5

1.6

0.72

0.79

g/l

1.08

1154

3302

ILD, hospital admissions

367

619

6.26

209.06

1.6

0.89

0.91

g/l

0.06

264

468

Other inflammatory liver diseases

251

278

9.90

208.95

1.9

1.6

0.77

0.82

g/l

0.17

186

205

Interstitial lung disease

369

626

6.22

208.90

1.6

0.89

0.91

g/l

0.05

266

471

Interstitial lung disease endpoints

369

626

6.22

208.90

1.6

0.89

0.91

g/l

0.05

266

471

Symptoms and signs involving the digestive system and abdomen

1605

3252

2.51

208.38

1.7

1.5

0.77

0.81

g/l

0.40

1202

2460

Tramadol

1303

3177

2.68

207.59

1.5

1.6

0.67

0.81

g/l

4.09

1004

2383

Abdominal and pelvic pain

1597

3251

2.50

206.97

1.7

1.5

0.75

0.81

g/l

0.83

1191

2459

Other diseases of liver

461

965

5.02

206.82

1.7

1.6

0.71

0.79

g/l

0.80

367

726

Anaemias

535

755

4.85

202.17

1.8

1.6

0.73

0.80

g/l

0.49

407

602

Cough

740

2112

3.44

201.01

1.5

1.6

0.69

0.83

g/l

1.91

573

1605

Asthma and opportunity respiratory infection

200

171

13.17

200.27

1.5

0.69

0.80

g/l

0.49

145

133

Ulcerative colitis (strict definition, require KELA)

471

1033

4.79

199.70

2.3

1.6

0.79

0.78

g/l

0.04

387

785

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

461

997

4.86

198.92

2.3

1.6

0.79

0.78

g/l

0.10

381

755

Cholelithiasis, broad definition with cholecystitis

1256

3309

2.64

198.32

1.7

1.4

0.69

0.75

g/l

1.13

915

2548

Symptoms and signs involving the circulatory and respiratory systems

1644

3468

2.41

196.67

1.5

1.6

0.72

0.79

g/l

1.44

1229

2610

ILD, hospital admissions 1, main diag only

333

543

6.49

196.40

1.7

1.6

0.90

0.87

g/l

0.14

240

416

Diseases of oesophagus, stomach and duodenum

1697

4543

2.30

194.24

1.6

0.70

0.78

g/l

1.89

1301

3403

Fibrosis and cirrhosis of liver

247

297

9.04

192.55

1.7

0.78

0.83

g/l

0.19

206

222

ILD, hospital admissions 3, with pneumonia sepsis

228

254

9.60

188.09

1.6

1.7

0.85

0.95

g/l

0.34

164

198

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

484

1139

4.45

187.54

2.3

1.5

0.79

0.78

g/l

0.07

397

857

Allergic asthma (mode), excluding more controls

447

965

4.66

186.22

1.6

0.73

0.75

g/l

0.11

366

733

Allergic asthma (mode)

447

975

4.62

183.90

1.6

0.73

0.76

g/l

0.16

366

739

Chronic rhinitis, nasopharyngitis and pharyngitis

618

1777

3.58

179.32

1.7

1.6

0.70

0.74

g/l

0.39

505

1327

Bronchitis

1655

4947

2.22

178.48

1.5

1.6

0.68

0.78

g/l

2.51

1259

3716

Certain infectious and parasitic diseases

1551

3342

2.35

176.85

1.5

1.6

0.70

0.79

g/l

1.82

1162

2502

Cholelithiasis

1177

3266

2.56

176.58

1.6

1.4

0.66

0.75

g/l

2.17

854

2516

Finngen Rheumatological endpoints

1545

3856

2.32

176.37

1.6

1.5

0.71

0.77

g/l

0.98

1179

2885

Bacterial pneumonia (organism specified)

740

2164

3.18

175.15

1.5

1.6

0.66

0.82

g/l

2.74

536

1636

Non-allergic asthma (mode), excluding more controls

353

674

5.34

172.56

1.6

1.5

0.73

0.78

g/l

0.24

269

516

Acute upper respiratory infections

1592

4525

2.23

171.58

1.5

1.6

0.67

0.78

g/l

3.02

1232

3387

Chronic hepatitis, not elsewhere classified

164

132

14.14

170.78

2.0

1.7

0.69

0.86

g/l

0.53

124

Septicaemia

662

1957

3.33

170.75

1.6

0.76

0.84

g/l

0.57

495

1480

Bacterial pneumoniae

674

1839

3.32

169.42

1.5

1.6

0.67

0.83

g/l

2.28

492

1381

Enlarged lymph nodes

367

749

5.10

169.21

2.0

1.4

1.11

0.77

g/l

2.45

285

576

Non-allergic asthma (mode)

353

690

5.22

168.07

1.6

1.5

0.73

0.78

g/l

0.26

269

524

Medical observation and evaluation for suspected diseases and conditions

1084

2065

2.73

166.71

1.7

1.5

0.80

0.85

g/l

0.46

860

1429

Dyspnoea

1362

4584

2.31

166.44

1.5

1.6

0.67

0.77

g/l

2.28

1026

3470

Other necrotizing vasculopathies

222

280

8.56

166.24

1.7

1.5

0.68

0.78

g/l

0.56

163

219

Other specified/unspecified systemic involvement of connective tissue

212

265

8.72

160.27

2.9

1.5

0.94

0.70

g/l

1.32

172

197

Opioids

1523

3597

2.25

159.48

1.6

0.68

0.79

g/l

2.82

1141

2712

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

556

675

4.19

159.25

1.7

1.5

0.74

0.85

g/l

0.92

421

501

Bacterial pneumonia, not elsewhere classified

637

1744

3.31

159.19

1.5

1.6

0.69

0.82

g/l

1.71

464

1306

Other diseases of intestines

1649

4518

2.15

158.82

1.6

0.71

0.77

g/l

1.11

1265

3404

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

220

290

8.09

158.30

1.7

1.6

0.84

0.79

g/l

0.21

154

218

Other septicaemia

585

1719

3.42

158.29

1.6

0.74

0.84

g/l

1.14

439

1304

Explicit Sepsis

690

2184

3.10

157.83

1.6

0.75

0.80

g/l

0.40

516

1654

Other necrotizing vasculopathies (FG)

190

211

9.72

157.46

1.7

1.6

0.70

0.76

g/l

0.29

139

169

Headache

978

3197

2.60

157.06

1.6

1.5

0.61

0.76

g/l

5.13

748

2420

L04AA Selective immunosuppressants

490

1345

3.79

153.25

1.7

1.5

0.60

0.75

g/l

2.46

376

1023

Nonhereditary hypogammaglobulinemia

107

31.46

153.17

2.3

2.0

0.21

0.81

g/l

1.61

Obesity related asthma

590

1865

3.25

147.22

1.5

0.65

0.78

g/l

2.10

421

1389

Bacterial Sepsis

678

2037

3.02

146.36

1.5

1.6

0.70

0.84

g/l

1.49

499

1532

Pain in throat and chest

1232

3274

2.33

145.67

1.6

0.70

0.79

g/l

2.14

943

2460

Other acute lower respiratory infections

878

3282

2.60

145.18

1.6

0.70

0.81

g/l

1.68

671

2468

Polyarthropathies

1075

2969

2.45

144.81

1.5

1.6

0.69

0.81

g/l

2.31

821

2245

Codeine

1394

3515

2.21

141.22

1.5

1.6

0.66

0.79

g/l

4.58

1033

2649

Other diseases of upper respiratory tract

1595

4025

2.09

139.43

1.6

0.77

0.78

g/l

0.17

1234

2987

Other diseases of pleura

674

2069

2.95

139.00

1.6

0.80

0.85

g/l

0.40

498

1548

Acute upper respiratory infections of multiple and unspecified sites

1134

3725

2.31

138.69

1.5

1.6

0.66

0.79

g/l

2.81

862

2799

Other specific joint derangements/joint disorders

1149

3387

2.31

135.98

1.4

1.6

0.61

0.80

g/l

7.49

880

2571

Diseases of the respiratory system

900

1689

2.70

135.58

1.6

1.5

0.74

0.76

g/l

0.14

674

1254

Crohn disease

327

744

4.60

132.49

2.1

1.5

0.70

0.78

g/l

0.47

268

567

Kela reimbursement Agammaglobulinemia (D80-84)

34.73

131.48

2.1

1.6

0.20

0.67

g/l

3.40

Other noninfective gastroenteritis and colitis

466

1365

3.51

131.47

1.8

1.5

0.68

0.78

g/l

1.31

369

1039

Implicit bacterial Sepsis

574

1730

3.11

130.92

1.5

1.6

0.69

0.85

g/l

2.44

420

1308

Acute bronchitis

664

2348

2.83

130.01

1.6

0.67

0.78

g/l

1.25

507

1764

Malaise and fatigue

687

2064

2.82

129.48

1.5

0.70

0.79

g/l

0.96

530

1565

Infections, IBD-co-morbidities

304

439

5.18

128.58

1.6

0.67

0.84

g/l

0.99

217

334

Mixed connective tissue disease

203

315

6.93

126.35

2.2

1.6

0.81

0.74

g/l

0.30

162

234

Other soft tissue disorders, not elsewhere classified

1347

3991

2.11

126.26

1.5

1.6

0.67

0.79

g/l

3.15

1030

2985

Suggestive for eosinophilic asthma

231

408

5.97

125.67

2.0

1.6

1.16

0.79

g/l

2.51

182

308

Ulcerative colitis (strict definition, all Crohn cases excluded)

345

852

4.22

125.47

2.3

1.6

0.80

0.77

g/l

0.25

281

649

Sicca syndrome [Sjögren]

231

412

5.94

124.55

1.6

1.5

0.62

0.66

g/l

0.18

162

311

Asthma and allergy, excluding more controls

265

526

5.13

123.66

1.8

1.7

0.73

0.78

g/l

0.29

223

410

Asthma and allergy

265

526

5.13

123.65

1.8

1.7

0.73

0.80

g/l

0.38

223

407

Primary biliary cholangitis (PBC)

107

16.79

122.57

2.0

1.9

0.56

0.96

g/l

1.04

Early onset COPD, excluding more controls

300

688

4.46

119.35

1.7

1.5

0.69

0.82

g/l

1.12

226

518

Pain (limb, back, neck, head abdominally)

1026

2193

2.37

119.33

1.6

0.71

0.89

g/l

4.22

780

1634

Implicit Sepsis

1015

3558

2.25

117.29

1.5

1.6

0.72

0.79

g/l

1.04

742

2678

Eosinophilic disease (BM)

22.76

117.05

2.0

1.3

1.70

0.65

g/l

2.86

Diseases of salivary glands

370

1040

3.67

111.53

1.9

1.6

0.80

0.79

g/l

0.04

275

770

Sulfasalazine

409

1229

3.39

110.65

1.6

1.3

0.60

0.74

g/l

1.92

304

912

Other special examinations and investigations of persons without complaint or reported diagnosis

953

2065

2.36

110.44

1.6

1.5

0.75

0.85

g/l

1.44

721

1429

Nausea and vomiting

401

1176

3.43

109.40

1.6

1.5

0.70

0.77

g/l

0.53

311

906

Codeine or tramadol medication

1599

4715

1.90

109.12

1.5

1.6

0.67

0.77

g/l

3.02

1186

3550

Gastro-oesophageal reflux disease

950

3851

2.22

108.90

1.5

1.6

0.63

0.79

g/l

5.91

699

2894

Other ulcerative colitis

179

286

6.69

108.23

2.5

1.6

0.88

0.87

g/l

0.02

150

215

Diseases of the digestive system

662

2618

2.57

107.97

1.8

1.6

0.79

0.80

g/l

0.09

494

1950

Other disorders of white blood cells

164

240

7.34

107.86

1.7

1.30

0.87

g/l

1.37

113

183

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

750

3082

2.42

107.57

1.6

0.67

0.79

g/l

2.46

554

2277

Dermatitis

879

3962

2.25

107.16

1.7

1.6

0.77

0.75

g/l

0.17

654

3023

Other diseases of blood and blood-forming organs, wide

411

1276

3.32

106.11

1.6

0.85

0.75

g/l

0.54

293

968

Unspecified jaundice

134

158

9.01

105.74

2.1

1.5

0.80

0.97

g/l

0.58

130

Diseases of the skin and subcutaneous tissue

1451

3760

1.95

105.23

1.6

0.74

0.78

g/l

0.59

1085

2819

Hernia of abdominal wall, postoperative

230

476

4.94

103.93

1.7

1.3

0.62

0.80

g/l

1.88

166

389

Parasetamol

1157

2824

2.11

103.81

1.5

1.6

0.67

0.84

g/l

4.94

871

2122

Other and unspecified dermatitis

750

3224

2.37

102.46

1.7

1.5

0.76

0.75

g/l

0.05

559

2461

Other immunodeficiencies

19.38

101.30

2.3

2.1

0.73

0.84

g/l

0.15

Cholecystectomy

961

4051

2.13

99.30

1.6

1.5

0.67

0.75

g/l

1.74

691

3086

Low back pain

1019

3791

2.09

98.84

1.6

0.67

0.79

g/l

2.68

767

2849

Oedema, not elsewhere classified

420

1369

3.11

98.34

1.7

1.4

0.65

0.78

g/l

1.85

322

1034

Ethmoidectomy

293

770

3.96

97.95

1.9

1.6

1.02

0.78

g/l

1.33

215

586

Abnormal serum enzyme levels

455

1549

2.97

97.43

1.8

1.6

0.75

0.93

g/l

2.60

373

1164

Exclusions for E4_PCOS_BROAD

352

1054

3.45

96.42

1.6

1.7

0.67

0.78

g/l

1.00

203

828

Intestinal infectious diseases

1292

5335

1.90

96.22

1.7

1.5

0.72

0.76

g/l

0.57

977

4024

Heart failure, not strict

994

3284

2.11

96.20

1.5

1.6

0.72

0.81

g/l

1.06

740

2455

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

279

719

4.03

95.75

1.7

1.6

0.87

g/l

0.00

220

549

Cardiovascular diseases

962

2431

2.18

95.06

1.6

0.71

0.74

g/l

0.22

710

1898

FESS (DNB20)

283

742

3.97

94.95

1.9

1.7

1.05

0.76

g/l

1.68

206

562

Other Crohn's disease

189

362

5.51

94.36

2.1

1.5

0.62

0.82

g/l

1.21

152

275

Dermatitis and eczema

1477

5354

1.83

93.28

1.6

0.73

0.76

g/l

0.30

1110

4035

Eosinophilia

14.47

92.80

2.0

1.7

1.70

0.80

g/l

1.85

Pain in limb

1057

3814

2.03

92.74

1.5

1.6

0.70

0.80

g/l

1.97

817

2858

Irritable bowel syndrome

452

1602

2.88

92.32

1.5

1.6

0.58

0.73

g/l

2.80

340

1194

Nonalcoholic fatty liver disease

228

522

4.59

92.02

1.4

1.7

0.71

0.79

g/l

0.54

190

396

Endocrine, nutritional and metabolic diseases

1207

3151

1.97

89.84

1.6

0.71

0.78

g/l

1.09

885

2446

Viral Sepsis

319

940

3.49

89.48

1.6

0.59

0.80

g/l

3.24

238

724

Dorsalgia

1356

3949

1.88

89.38

1.6

0.68

0.79

g/l

2.84

1017

2965

Implicit viral Sepsis

318

937

3.49

89.20

1.6

0.59

0.81

g/l

3.25

237

721

Cardiovascular diseases (excluding rheumatic etc)

994

2786

2.08

89.11

1.6

0.76

0.72

g/l

0.42

725

2160

Diagnoses used for exclusion with ILD

408

1399

2.99

88.63

1.6

0.86

0.80

g/l

0.37

294

1075

Intestinal malabsorption

138

209

7.09

87.98

2.3

1.6

0.97

0.81

g/l

0.43

165

Pain, not elsewhere classified

391

1319

3.02

87.25

1.7

1.5

0.68

0.75

g/l

0.62

314

997

Primary_lymphoid and hematopoietic malignant neoplasms

369

1206

3.13

87.19

1.5

1.6

0.58

0.87

g/l

4.41

269

911

Aplastic and other anaemias

572

2215

2.49

86.73

1.5

1.6

0.76

0.83

g/l

0.50

403

1673

Vasomotor and allergic rhinitis

563

2275

2.48

85.32

1.7

1.6

0.76

0.75

g/l

0.03

458

1703

Disorders of other endocrine glands

647

2778

2.33

85.23

1.5

1.6

0.68

0.74

g/l

0.54

415

2134

L04AD Calcineurin inhibitors

253

663

3.99

85.16

1.7

1.6

0.65

0.79

g/l

1.22

192

509

Diarrhoea and gastroenteritis of presumed infectious origin

974

4503

1.99

84.68

1.7

1.6

0.74

0.77

g/l

0.30

742

3395

Adrenocortical insufficiency

119

162

7.98

83.80

1.7

0.55

0.83

g/l

1.19

124

Primary_lymphoid and hematopoietic malignant neoplasms

369

1238

3.05

83.42

1.5

1.6

0.58

0.84

g/l

3.94

269

939

Other heart diseases

738

2191

2.26

83.03

1.5

1.6

0.74

0.75

g/l

0.05

556

1693

Oxycodone

458

1664

2.71

82.90

1.6

0.64

0.90

g/l

5.12

336

1243

Condition for Implicit Sepsis (Organ dysfunction codes)

1095

4184

1.92

82.70

1.5

1.6

0.72

0.78

g/l

0.98

795

3176

Neoplasms

1116

3091

1.95

82.62

1.7

1.6

0.73

0.77

g/l

0.52

836

2357

Vocal cord dysfunction

216

468

4.39

82.47

1.7

1.3

0.63

0.81

g/l

1.37

153

352

Other arthritis (FG)

450

1693

2.71

81.93

1.5

0.68

0.81

g/l

1.25

343

1261

Crohn's disease NAS

169

333

5.35

81.76

2.0

1.6

0.65

0.82

g/l

0.91

145

253

Other disorders of adrenal gland

135

217

6.68

81.32

1.7

0.55

0.79

g/l

1.29

165

Persons encountering health services in other circumstances, wide

1596

4813

1.74

80.79

1.6

0.79

0.75

g/l

0.41

1233

3602

Haemorrhage from respiratory passages

427

1448

2.78

80.75

1.7

1.5

0.76

0.90

g/l

1.62

313

1087

Dental caries

418

1513

2.79

80.47

1.6

0.60

0.86

g/l

6.38

321

1137

Disorders of lacrimal system

587

2523

2.37

80.46

1.7

1.5

0.66

0.73

g/l

0.72

437

1905

General examination and investigation of persons without complaint and reported diagnosis

831

2065

2.16

80.29

1.6

1.5

0.67

0.85

g/l

4.16

689

1429

Ulcerative ileocolitis

131

208

6.76

79.87

2.8

1.7

0.88

0.93

g/l

0.13

106

159

Noninfectious colitis NAS

253

692

3.77

79.68

2.0

1.5

0.67

0.80

g/l

1.07

208

523

Other anaemias

522

2063

2.48

78.99

1.5

1.6

0.78

0.83

g/l

0.32

368

1554

Other and unspecified anaemias

516

2045

2.48

78.11

1.5

1.6

0.76

0.83

g/l

0.52

363

1543

Cirrhosis of liver, NAS

126

198

6.78

77.46

1.5

1.7

0.99

0.90

g/l

0.23

104

147

Hypothyroidism (congenital or acquired)

408

794

3.00

77.31

1.6

0.63

0.78

g/l

1.95

295

624

Pleural effusion

229

598

3.94

76.95

1.8

1.6

0.96

0.89

g/l

0.21

172

452

Arthropathies

1254

3497

1.84

76.84

1.5

1.6

0.70

0.81

g/l

2.29

958

2653

Functional dyspepsia

390

1414

2.81

76.40

1.7

1.5

0.75

0.74

g/l

0.03

299

1048

Complications of surgical and medical care, not elsewhere classified

1258

5083

1.79

76.23

1.5

1.6

0.69

0.76

g/l

1.05

950

3824

Other disorders involving the immune mechanism, not elsewhere classified

107

144

8.10

76.17

3.1

1.8

0.96

0.89

g/l

0.13

114

Other joint disorders

1199

3479

1.85

75.72

1.5

1.6

0.70

0.80

g/l

2.14

909

2636

Drug-induced adrenocortical insufficiency

12.16

75.64

2.0

0.44

0.83

g/l

1.02

Disorders of thyroid, IBD co-morbidities

257

503

3.79

75.14

1.5

1.6

0.78

0.80

g/l

0.08

192

380

Other dorsopathies, not elsewhere classified

1338

3987

1.79

75.02

1.6

0.71

0.79

g/l

1.53

1006

2999

Neurological diseases, wide definition

462

836

2.81

75.01

1.6

0.73

0.80

g/l

0.40

343

646

Soft tissue disorders

1381

4092

1.77

74.61

1.5

1.6

0.69

0.80

g/l

2.88

1043

3064

Lower back pain or/and sciatica

1324

5278

1.76

74.47

1.5

1.6

0.65

0.77

g/l

3.62

991

3969

Persons encountering health services for examination and investigation

853

2065

2.09

74.47

1.7

1.5

0.77

0.85

g/l

0.97

667

1429

Hypothyroidism and >3 levothyroxin purchases

400

788

2.96

74.45

1.5

1.6

0.62

0.78

g/l

2.16

287

620

Hypothyroidism, levothyroxine purchases

400

788

2.96

74.45

1.5

1.6

0.62

0.78

g/l

2.16

287

620

Other specified/unspecified arthritis

400

1490

2.74

74.37

1.4

1.6

0.72

0.84

g/l

1.07

302

1125

Other functional intestinal disorders

581

2437

2.30

74.37

1.5

1.6

0.64

0.78

g/l

2.68

428

1844

Other heart diseases, wide

1258

4391

1.79

74.32

1.5

1.6

0.74

g/l

0.03

934

3350

Nasal polyp

303

971

3.20

74.20

1.9

1.6

1.14

0.80

g/l

2.22

252

721

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

157

316

5.18

73.94

1.5

1.8

0.49

0.94

g/l

4.64

110

241

Hypertensive diseases (excluding secondary)

777

2145

2.13

73.94

1.6

0.67

0.73

g/l

0.65

561

1655

Disorders of eyelid, lacrimal system and orbit

1072

4580

1.85

73.90

1.7

1.5

0.70

0.75

g/l

0.55

811

3461

Benign neoplasm of colon, rectum, anus and anal canal

714

2396

2.16

73.57

1.7

1.6

0.69

0.82

g/l

2.33

556

1798

Other disorders of lacrimal gland

491

2031

2.46

73.51

1.7

1.5

0.64

0.73

g/l

0.96

359

1522

Rheumatoid arthritis

450

1608

2.59

73.46

1.6

0.67

0.82

g/l

1.93

339

1217

Wegener granulomatosis

12.58

72.51

1.9

1.7

0.67

0.74

g/l

0.11

Covid-19 confirmed case

430

1685

2.60

72.27

1.8

1.6

0.67

0.78

g/l

1.38

314

1259

Neurological diseases

1219

3398

1.82

72.14

1.5

1.6

0.70

0.80

g/l

2.05

894

2618

Osteoporosis

328

1060

3.01

71.99

1.7

1.5

0.65

0.75

g/l

0.65

239

775

Benign neoplasm of colon, rectum, anus and anal canal

736

3255

2.07

71.20

1.7

1.5

0.69

0.82

g/l

2.31

573

2420

Other diseases of pericardium

108

158

7.24

70.93

1.6

1.7

0.77

0.87

g/l

0.30

123

Biological medication for rheuma

308

1033

3.07

70.04

1.5

1.6

0.53

0.76

g/l

4.38

227

777

Metabolic disorders

1216

4284

1.78

70.01

1.6

0.77

g/l

0.00

912

3221

Dentinal caries

363

1322

2.79

69.87

1.6

0.60

0.88

g/l

6.29

278

989

Episodal and paroxysmal disorders

1470

4454

1.70

69.86

1.5

1.6

0.71

0.78

g/l

1.44

1069

3405

Respiratory disorders in diseases classified elsewhere

13.08

69.80

2.1

1.7

0.76

0.77

g/l

0.01

Persons encountering health services for specific procedures and health care

1406

5158

1.70

69.40

1.5

1.6

0.68

0.77

g/l

2.42

1070

3875

Symptoms and signs involving the skin and subcutaneous tissue

888

4691

1.91

69.30

1.8

1.5

0.78

0.73

g/l

0.57

705

3532

All influenza

358

1307

2.79

69.23

1.5

1.6

0.65

0.84

g/l

2.57

274

1006

Benign neoplasms

1070

3296

1.85

68.86

1.6

0.75

0.77

g/l

0.16

797

2492

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

131

8.05

68.84

3.3

1.9

0.94

0.90

g/l

0.09

102

Idiopathic pulmonary fibrosis

131

239

5.70

68.79

1.6

1.5

1.00

0.91

g/l

0.25

184

Spondylopathies

989

3207

1.89

68.76

1.5

1.6

0.65

0.81

g/l

4.45

715

2393

Provisional assignment of new diseases of uncertain etiology

636

3017

2.14

68.49

1.8

1.5

0.69

0.74

g/l

0.60

497

2289

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1420

4805

1.70

68.29

1.6

0.77

0.75

g/l

0.21

1125

3594

Codes for special purposes

636

3023

2.13

68.13

1.8

1.5

0.69

0.74

g/l

0.60

497

2294

Dorsopathies

1356

4030

1.73

68.00

1.5

1.6

0.70

0.79

g/l

2.01

1016

3037

Renal failure

520

2069

2.33

67.98

1.5

1.6

0.71

0.86

g/l

2.10

367

1567

Benign neoplasm of other and ill-defined parts of digestive system

275

878

3.22

67.92

1.9

1.6

0.70

0.77

g/l

0.42

214

657

Total colectomy operation

116

192

6.44

67.84

2.4

1.7

1.00

0.90

g/l

0.21

149

Total colectomy

116

192

6.44

67.84

2.4

1.7

1.00

0.90

g/l

0.21

149

Diseases of the musculoskeletal system and connective tissue

747

1783

2.12

67.83

1.6

0.71

0.81

g/l

1.40

562

1360

Cholecystitis

195

498

4.01

67.57

2.0

1.4

0.90

0.83

g/l

0.22

146

381

Other headache syndromes

589

2729

2.19

67.38

1.5

1.6

0.64

0.72

g/l

1.77

441

2087

Benign neoplasm: Colon

616

2180

2.20

67.37

1.7

1.6

0.69

0.83

g/l

2.16

477

1642

Anxiety disorders, excluding more controls

1113

4142

1.80

67.34

1.6

0.67

0.78

g/l

2.48

860

3115

Diseases of the eye and adnexa

1151

3222

1.80

66.06

1.6

1.5

0.71

0.79

g/l

1.51

865

2434

Methotrexate

203

544

3.82

65.70

1.5

1.3

0.60

0.68

g/l

0.49

144

409

Temporomandibular joint disorders

238

709

3.43

65.61

1.6

0.54

0.85

g/l

5.31

167

548

Benign neoplasm: Colon

623

2916

2.12

65.53

1.7

1.5

0.69

0.82

g/l

1.93

483

2170

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

146

306

4.95

65.52

1.8

0.77

0.96

g/l

0.81

107

234

Pneumonia due to other infectious organisms, not elsewhere classified

115

8.28

65.36

1.4

1.6

0.51

0.81

g/l

1.18

Viral pneumonia

208

570

3.75

65.34

1.4

1.7

0.60

0.82

g/l

2.60

154

443

Renal tubulo-interstitial diseases

1066

4614

1.79

65.13

1.6

0.67

0.77

g/l

2.23

793

3480

Symptoms and signs concerning food and fluid intake

174

421

4.26

64.95

1.8

1.5

0.89

0.77

g/l

0.42

128

331

Nutritional anaemias

599

2754

2.14

64.77

1.7

1.5

0.70

0.78

g/l

0.91

469

2072

Dialysis, with operation codes

228

669

3.52

64.74

1.4

1.7

0.60

0.88

g/l

3.21

172

522

Diverticular disease of intestine

830

2854

1.95

64.61

1.6

0.74

0.81

g/l

0.77

652

2121

COPD (mode)

308

829

2.99

64.29

1.5

0.81

g/l

0.02

238

615

Crohn's disease of large intestine

135

272

5.23

63.79

2.2

1.6

0.81

0.85

g/l

0.09

112

211

Benign neoplasm of other and ill-defined parts of digestive system

275

913

3.09

63.57

1.9

1.6

0.70

0.77

g/l

0.44

214

684

Hypopituitarism

172

422

4.28

63.57

1.5

1.7

0.73

0.85

g/l

0.57

341

Collagenous colitis

169

410

4.28

63.19

1.7

1.6

0.66

0.83

g/l

1.07

124

315

Sleep disorders (combined)

1257

4876

1.70

63.06

1.4

1.6

0.75

0.76

g/l

0.04

902

3716

Abnormal results of function studies

170

415

4.26

63.05

1.9

1.6

0.77

0.81

g/l

0.17

129

318

Benign neoplasms

1271

4180

1.71

62.58

1.6

1.5

0.78

0.77

g/l

0.05

946

3147

Polymyalgia rheumatica

176

442

4.09

62.52

1.5

0.72

0.80

g/l

0.46

138

330

Osteopathies and chondropathies

701

3370

2.00

62.39

1.6

0.69

0.78

g/l

0.97

522

2549

Abnormal findings on diagnostic imaging of other body structures

208

590

3.63

62.16

1.9

1.5

0.86

0.72

g/l

0.53

155

441

Complications of medical and surgical care

896

4677

1.84

62.12

1.5

1.6

0.69

0.75

g/l

0.85

669

3526

Other respiratory disorders and diseases

277

935

3.03

62.04

1.5

1.6

0.64

0.89

g/l

3.12

204

708

Other diseases of the respiratory system

277

935

3.03

62.04

1.5

1.6

0.64

0.89

g/l

3.12

204

708

Chronic hepatitis NAS

12.60

60.97

2.0

1.7

0.69

0.84

g/l

0.26

Anxiety disorders

1178

4924

1.71

60.85

1.6

0.67

0.76

g/l

2.31

907

3693

Complications of procedures, not elsewhere classified

989

4848

1.78

60.77

1.5

1.6

0.70

0.76

g/l

0.67

755

3646

Coagulation defects, purpura and other haemorrhagic conditions

306

1105

2.84

60.72

1.8

1.6

0.71

0.78

g/l

0.40

239

838

Sarcoidosis

236

737

3.30

60.65

1.6

0.78

0.81

g/l

0.14

166

569

Neurotic, stress-related and somatoform disorders

1166

4887

1.71

60.35

1.6

0.67

0.76

g/l

2.13

900

3669

Alcohol-induced chronic pancreatitis

147

333

4.63

60.27

1.5

1.7

0.85

0.87

g/l

0.07

258

COPD

487

1777

2.29

60.02

1.5

1.6

0.76

0.83

g/l

0.53

372

1305

Dysphagia

295

1050

2.86

59.90

1.5

0.77

0.85

g/l

0.49

210

793

Fibromyalgia

168

422

4.12

59.89

1.5

1.6

0.58

0.70

g/l

0.89

129

317

Nephropathy related operations

217

649

3.45

59.86

1.5

1.7

0.62

0.87

g/l

2.51

161

500

SLE (Finngen)

124

7.52

59.84

1.7

1.8

0.53

0.87

g/l

1.35

Constipation

1060

4383

1.75

59.23

1.5

1.6

0.64

0.79

g/l

4.65

772

3345

Ulcerative enterocolitis

146

6.88

58.57

2.5

1.6

0.92

0.90

g/l

0.04

108

Other chronic obstructive pulmonary disease

465

1701

2.30

58.18

1.5

1.6

0.76

0.83

g/l

0.58

354

1251

Iron deficiency anaemia

513

2363

2.18

58.09

1.6

1.5

0.68

0.78

g/l

0.94

400

1766

Antihypertensive medication - note that there are other indications

871

2560

1.88

58.08

1.5

1.6

0.69

0.76

g/l

1.18

633

1977

Spondyloarthritis

261

888

3.00

57.63

1.5

0.59

0.84

g/l

3.45

190

675

Other intervertebral disc disorders

1016

3543

1.77

57.55

1.5

1.6

0.70

0.80

g/l

1.77

746

2649

ILD-related respiratory insufficiency

106

8.07

57.53

1.4

1.6

0.67

0.93

g/l

0.62

Hypertension, essential

1004

3246

1.78

57.06

1.6

0.70

0.77

g/l

1.10

737

2466

Mycoses

378

1563

2.47

56.84

1.6

0.73

0.78

g/l

0.27

277

1194

Other antidepressants

1310

4151

1.66

56.74

1.5

1.6

0.68

0.81

g/l

3.50

966

3135

Purpura and other haemorrhagic conditions

228

727

3.23

56.62

1.9

1.6

0.74

0.79

g/l

0.21

179

562

Chronic kidney disease

346

1367

2.56

56.59

1.6

0.73

0.87

g/l

1.24

246

1043

Seropositive rheumatoid arthritis

325

1249

2.64

56.58

1.6

1.4

0.74

0.75

g/l

0.04

243

924

Fungal Sepsis

139

6.87

56.28

1.5

1.7

0.60

0.87

g/l

0.80

107

Depression medications

425

862

2.51

56.18

1.5

1.6

0.66

0.79

g/l

1.51

317

679

Other and unspecified iron deficiency

412

1780

2.35

55.95

1.5

0.66

0.76

g/l

0.89

320

1337

Migraine

653

2836

1.98

55.86

1.5

1.6

0.60

0.69

g/l

1.57

496

2196

Abnormalities of heart beat

409

1751

2.34

55.38

1.4

1.6

0.69

0.81

g/l

1.55

300

1320

Hypertensive diseases

1038

3390

1.75

55.33

1.6

0.69

0.77

g/l

1.18

758

2578

9.63

55.27

1.6

1.3

0.85

0.78

g/l

0.16

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

168

6.13

55.17

1.5

1.8

0.57

1.07

g/l

2.66

131

Tumor necrosis factor alpha inhibitors

263

928

2.91

54.70

1.5

1.6

0.54

0.77

g/l

3.54

191

700

Hypertension

1035

3388

1.74

54.69

1.6

0.69

0.77

g/l

1.31

755

2576

Alcohol-induced acute pancreatitis

101

182

5.93

54.24

1.4

1.7

0.72

0.88

g/l

0.61

140

Other disorders of fluid, electrolyte and acid-base balance

364

1453

2.45

54.09

1.4

1.6

0.72

0.83

g/l

0.79

266

1082

6-mercaptopurine

117

7.34

53.90

2.6

1.4

0.72

0.70

g/l

0.06

Chronic laryngitis and laryngotracheitis

208

646

3.30

53.86

1.5

1.6

0.70

0.78

g/l

0.43

161

480

Rheumatoid arthritis, including avohilmo

495

2345

2.14

53.70

1.6

1.5

0.66

0.75

g/l

1.24

371

1750

Implicit fungal Sepsis

127

7.03

53.63

1.5

1.6

0.63

0.80

g/l

0.43

Cardiac arrhythmias

820

2980

1.84

53.23

1.5

1.6

0.75

0.74

g/l

0.08

600

2275

Mood disorders, excluding more controls

1179

4356

1.66

53.00

1.5

1.6

0.68

0.78

g/l

2.21

896

3271

Transplanted organ and tissue status

185

541

3.54

52.97

1.9

1.7

0.59

0.85

g/l

2.46

140

431

Other gastritis (incl. Duodenitis)

294

1117

2.68

52.76

1.8

1.6

0.65

0.87

g/l

3.34

230

830

Diaphragmatic hernia

442

2025

2.21

52.22

1.6

1.5

0.69

0.78

g/l

1.11

354

1517

Depression

1203

5120

1.63

51.69

1.5

1.6

0.67

0.76

g/l

2.09

913

3838

Acute renal failure

264

963

2.80

51.37

1.4

1.6

0.67

0.91

g/l

2.67

177

735

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

607

1931

2.02

51.34

1.7

1.6

0.77

0.73

g/l

0.39

448

1489

Mood disorders

1279

5269

1.61

51.31

1.5

1.6

0.67

0.77

g/l

2.32

970

3959

Mood [affective] disorders

1275

5263

1.61

51.04

1.5

1.6

0.68

0.77

g/l

2.29

968

3953

COPD, hospital admission 2, with asthma infections

365

1313

2.41

50.77

1.5

1.6

0.70

0.89

g/l

2.51

276

984

Unspecified acute lower respiratory infection

235

814

2.96

50.47

1.6

1.7

0.65

0.82

g/l

1.58

177

622

Hepatic failure, not elsewhere classified

130

6.67

49.99

1.7

1.8

0.87

0.92

g/l

0.10

Rheumatism, unspecified

214

709

3.09

49.74

1.8

1.5

0.65

0.75

g/l

0.72

160

523

Pneumocystosis

9.83

49.36

1.5

1.8

0.38

0.83

g/l

1.43

Adalimumab

180

542

3.44

49.30

1.6

1.7

0.53

0.78

g/l

2.75

137

416

Drug-induced osteoporosis with pathological fracture

11.29

49.24

2.2

2.3

0.76

1.04

g/l

0.38

Giant cell arteritis

143

6.26

48.83

1.4

1.7

0.79

0.82

g/l

0.06

107

Crohn disease (strict definition, require KELA)

143

372

4.01

48.83

2.0

1.7

0.68

0.79

g/l

0.36

113

290

Pulmonary eosinophilia, not elsewhere classified

13.40

48.75

2.0

1.9

1.73

0.92

g/l

0.86

Sleep apnoea

1103

4592

1.64

48.69

1.4

1.6

0.76

0.77

g/l

0.10

788

3495

Depression or dysthymia

904

2910

1.75

48.67

1.5

1.6

0.71

0.83

g/l

2.10

665

2198

Systemic lupus erythematosus

154

6.04

48.62

1.7

1.5

0.53

0.75

g/l

1.09

120

Bleeding

955

4123

1.70

48.60

1.7

1.6

0.76

0.80

g/l

0.40

727

3088

Myalgia

312

1272

2.49

48.42

1.5

1.6

0.58

0.76

g/l

3.01

236

953

Crohn disease (strict definition, require KELA, min 2 HDR)

141

367

4.01

48.12

2.0

1.7

0.68

0.78

g/l

0.31

111

285

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

147

394

3.88

48.08

2.0

1.7

0.69

0.80

g/l

0.36

117

305

Allergic rhinitis

460

2194

2.11

47.82

1.6

0.74

0.72

g/l

0.21

382

1661

Glomerular diseases

266

1016

2.68

47.43

1.8

1.6

0.63

0.84

g/l

1.98

194

782

Chronic gastritis

315

1302

2.45

47.36

1.4

1.6

0.66

0.82

g/l

1.95

264

963

Urticaria and erythema

498

2479

2.04

47.36

1.6

0.70

g/l

0.02

390

1886

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

444

2123

2.12

47.15

1.7

1.5

0.72

g/l

0.02

293

1611

COPD, hospital admissions 3, with asthma pneumonia sepsis

299

1013

2.55

47.02

1.5

1.6

0.69

0.88

g/l

2.00

231

757

Childhood asthma (age<16), excluding more controls

192

472

3.28

46.81

1.5

1.8

0.71

0.80

g/l

0.49

147

360

Osteoporosis with pathological fracture (FG)

199

5.14

46.71

1.8

1.5

0.80

0.68

g/l

0.24

155

Childhood asthma (age<16)

192

473

3.27

46.69

1.5

1.8

0.71

0.80

g/l

0.50

147

360

Infections of the skin and subcutaneous tissue

728

4100

1.79

46.51

1.6

0.77

0.80

g/l

0.21

573

3080

Continuous positive airway pressure

252

802

2.76

46.38

1.5

1.6

0.66

0.91

g/l

2.90

219

607

Care involving use of rehabilitation procedures

774

4224

1.76

46.36

1.5

1.6

0.66

0.79

g/l

2.69

581

3178

Diseases of pulp and periapical tissues

448

2162

2.10

46.34

1.5

1.6

0.67

0.83

g/l

2.23

344

1614

Viral infections characterized by skin and mucous membrane lesions

536

2756

1.97

46.34

1.6

0.65

0.78

g/l

1.23

403

2082

Crohn's disease of small intestine

137

359

3.96

46.24

1.9

1.6

0.72

0.81

g/l

0.22

113

276

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1153

4932

1.60

45.96

1.6

0.74

0.75

g/l

0.11

845

3771

Pulmonary heart disease, diseases of pulmonary circulation

369

1656

2.26

45.91

1.6

0.78

0.82

g/l

0.20

291

1237

Pericarditis

132

6.28

45.68

1.3

1.8

0.65

0.90

g/l

0.94

103

Spondylopathies (FG)

217

761

2.92

45.59

1.6

0.56

0.77

g/l

2.36

159

571

Biological medicines for asthma

9.29

45.51

1.5

1.9

1.34

0.82

g/l

1.12

Simple and mucopurulent chronic bronchitis

139

6.06

45.46

1.3

1.6

0.49

0.91

g/l

2.45

105

Anxiety (asthma-related co-morbidities)

783

3550

1.76

45.43

1.5

1.6

0.67

0.73

g/l

0.98

622

2695

Explicit bacterial Sepsis

154

442

3.57

45.27

1.6

1.7

0.82

0.87

g/l

0.10

110

353

Infection due to other mycobacteria

11.33

45.23

1.3

0.64

0.63

g/l

0.03

Other bacterial intestinal infections

238

880

2.76

45.19

1.6

0.62

0.78

g/l

1.09

178

661

Early onset COPD

300

1244

2.46

44.97

1.7

1.6

0.69

0.87

g/l

1.74

226

925

Sleep apnoea, including avohilmo

1150

4710

1.60

44.96

1.4

1.6

0.76

g/l

0.06

818

3582

Diseases of arteries, arterioles and capillaries (FINNGEN)

306

862

2.52

44.80

1.7

1.6

0.85

0.86

g/l

0.06

228

649

Disorders of conjunctiva

995

5142

1.63

44.65

1.7

1.5

0.65

0.75

g/l

2.29

782

3874

Oesophageal varices

168

5.51

44.28

2.3

1.6

0.81

0.87

g/l

0.15

133

Syncope and collapse

448

1935

2.07

44.01

1.6

1.5

0.72

0.80

g/l

0.71

328

1458

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

101

218

4.79

43.88

2.1

1.7

0.77

0.99

g/l

0.86

171

Benign neoplasm: Colon, unspecified

279

1129

2.50

43.55

1.7

0.72

0.88

g/l

1.17

210

842

Sciatica+with lumbago

589

3020

1.87

43.50

1.4

1.6

0.60

0.81

g/l

6.03

442

2266

Heart failure and antihypertensive medication

320

878

2.44

43.38

1.4

1.6

0.79

0.92

g/l

0.61

235

661

Diseases of oral cavity, salivary glands and jaws

1079

3437

1.62

42.86

1.6

0.71

0.80

g/l

1.76

828

2570

Lumbar disc prolapse

736

3364

1.75

42.74

1.5

1.6

0.68

0.81

g/l

2.34

539

2514

Hypothyroidism, strict autoimmune

733

2758

1.77

42.71

1.5

1.4

0.66

0.77

g/l

2.04

536

2081

All anxiety disorders

791

3741

1.72

42.69

1.5

1.6

0.66

0.72

g/l

0.93

630

2836

Chronic periapical parodontitis

275

1123

2.49

42.63

1.6

0.65

0.88

g/l

3.43

202

828

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

691

3942

1.76

42.33

1.5

1.6

0.70

0.76

g/l

0.61

522

2970

Other pleural conditions

131

353

3.80

42.30

1.7

1.6

0.86

0.90

g/l

0.12

279

Recurrent or chronic depression

546

2065

1.93

42.23

1.5

1.6

0.69

0.78

g/l

1.07

418

1580

Protozoal diseases

127

6.23

41.89

1.5

1.8

0.39

0.77

g/l

1.96

Heart failure,strict

536

2018

1.94

41.82

1.4

1.6

0.78

0.88

g/l

0.76

390

1492

Streptococcal septicaemia

126

334

3.88

41.74

1.7

0.83

0.89

g/l

0.10

272

Atrial fibrillation and flutter

400

1214

2.18

41.70

1.5

1.6

0.75

0.81

g/l

0.41

305

924

Pulmonary embolism

335

1510

2.25

41.32

1.6

0.80

0.81

g/l

0.05

261

1120

Ulcerative rectosigmoiditis

147

436

3.48

41.24

1.9

1.5

0.76

0.81

g/l

0.14

109

326

Voice disturbances

341

1554

2.23

41.05

1.5

0.60

0.73

g/l

1.76

258

1167

Factors influencing health status and contact with health services

383

857

2.26

40.90

1.6

1.7

0.76

1.02

g/l

2.88

299

619

Pulmonary heart disease

335

1520

2.23

40.67

1.6

0.80

0.81

g/l

0.05

261

1130

Other chronic obstructive pulmonary disease, including avohilmo

560

2512

1.87

40.66

1.5

1.6

0.76

0.85

g/l

0.87

428

1866

Other disorders of skin and subcutaneous tissue

761

4133

1.70

40.61

1.6

0.70

0.78

g/l

0.78

568

3124

Other diseases of the digestive system

352

1632

2.18

40.48

1.6

0.76

0.85

g/l

0.66

270

1231

Benign neoplasm: Colon, unspecified

279

1181

2.40

39.97

1.7

1.5

0.72

0.85

g/l

0.90

210

894

GI-bleeding

348

1616

2.18

39.85

1.6

0.76

0.85

g/l

0.70

265

1222

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

8.72

39.82

2.3

1.3

0.96

0.74

g/l

0.50

Conjunctivitis

899

4873

1.62

39.44

1.7

1.5

0.66

0.73

g/l

1.39

719

3659

Polyneuropathies and other disorders of the peripheral nervous system

269

1128

2.43

39.42

1.6

0.62

0.88

g/l

4.05

213

849

Dentofacial anomalies [including malocclusion]

362

1701

2.13

39.09

1.5

1.6

0.55

0.74

g/l

4.49

259

1299

COPD, hospital admissions

466

2032

1.96

39.01

1.5

1.6

0.76

0.89

g/l

1.38

354

1498

Atypical mycobacterium lung infection

13.42

38.93

1.2

1.4

0.79

0.63

g/l

0.42

Follow-up examination after treatment for conditions other than malignant neoplasms

480

1607

1.97

38.92

1.5

0.69

0.80

g/l

1.18

382

1125

Ascites

104

253

4.23

38.81

1.7

1.4

0.92

0.82

g/l

0.24

197

Respiratory insufficiency

183

4.84

38.73

1.4

0.61

0.87

g/l

1.22

142

Chronic diseases of tonsils and adenoids

899

3505

1.63

38.72

1.5

1.6

0.61

0.77

g/l

4.68

702

2601

Other general symptoms and signs

206

4.62

38.55

2.0

1.4

0.61

0.72

g/l

0.56

160

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

181

632

2.93

38.45

1.5

1.6

0.60

0.84

g/l

1.61

130

478

Hypothyroidism, drug reimbursement

193

475

2.95

38.43

1.8

1.5

0.64

0.76

g/l

0.81

146

380

Erysipelas

561

2829

1.82

38.25

1.6

0.78

0.83

g/l

0.28

429

2116

Symptoms and signs involving speech and voice

393

1946

2.05

38.08

1.6

1.5

0.63

0.76

g/l

1.55

301

1456

Other and unspecified polyneuropathies, also in other diseases

237

954

2.53

38.00

1.6

0.61

0.89

g/l

3.79

186

717

Other diseases of hard tissues of teeth

748

3322

1.69

37.90

1.5

1.6

0.68

0.80

g/l

2.61

559

2480

Hypermobility syndrome

105

263

4.14

37.81

1.6

1.5

0.45

0.58

g/l

1.21

201

Bacterial intestinal infections, IBD co-morbidities

230

916

2.56

37.69

1.6

0.62

0.79

g/l

1.20

173

692

COPD, early/later onset

466

2051

1.94

37.68

1.5

1.6

0.76

0.88

g/l

1.28

354

1514

Glomerulonephritis

159

526

3.11

37.28

2.0

1.7

0.70

0.80

g/l

0.40

109

408

Symptoms and signs involving the nervous and musculoskeletal systems

656

3840

1.72

37.22

1.6

0.66

0.77

g/l

1.98

493

2915

Panniculitis, unspecified

13.63

37.17

1.6

3.0

0.60

1.27

g/l

0.61

Seropositive rheumatoid arthritis, wide

325

1515

2.18

37.00

1.6

1.5

0.74

0.75

g/l

0.04

243

1126

Thrombocytopenia, unspecified

115

312

3.81

36.97

2.0

1.6

0.66

0.88

g/l

1.01

237

Non-invasive ventilation

255

1004

2.42

36.86

1.5

1.6

0.72

0.86

g/l

0.68

756

Any mental disorder

1329

4480

1.49

36.86

1.5

1.6

0.73

0.78

g/l

0.92

1013

3368

Other symptoms and signs involving the digestive system and abdomen

191

701

2.77

36.85

1.6

1.5

0.67

0.73

g/l

0.24

130

542

SLE, strict definition

174

4.97

36.65

1.6

0.54

0.83

g/l

1.44

134

SLE, ICD10

174

4.97

36.65

1.6

0.54

0.83

g/l

1.44

134

UC patients in KELA-register (code 208), prior to 1994

211

4.50

36.36

2.3

1.6

0.72

0.91

g/l

0.60

164

Other specified/unspecified necrotizing vasculopathies

9.43

36.32

2.0

1.9

0.58

0.82

g/l

0.42

Psychiatric diseases

1312

4428

1.49

36.21

1.5

1.6

0.71

0.79

g/l

1.48

995

3332

Disorders of orbit

208

4.51

36.10

2.2

1.6

0.77

0.80

g/l

0.10

165

Other diseases of intestine

159

535

3.04

36.10

1.5

1.6

0.75

0.81

g/l

0.26

117

397

Nonsuppurative otitis media

325

1309

2.18

36.02

1.7

1.6

0.73

0.74

g/l

0.06

242

1017

Deposits [accretions] on teeth

127

360

3.52

35.97

1.8

1.6

0.70

0.87

g/l

0.94

290

Gout

267

1051

2.34

35.85

1.4

1.7

0.68

0.99

g/l

3.18

195

790

Nerve, nerve root and plexus disorders

1198

5043

1.50

35.66

1.5

1.6

0.69

0.76

g/l

1.36

886

3795

DVT of lower extremities and pulmonary embolism

438

2297

1.92

35.53

1.6

0.76

0.80

g/l

0.28

336

1725

Urticaria

393

1999

1.99

35.36

1.6

0.70

g/l

0.01

310

1512

Aspergillosis

11.51

35.32

1.5

2.0

0.64

1.00

g/l

0.57

Persons encountering health services in other circumstances

452

2409

1.89

35.19

1.5

1.6

0.70

0.73

g/l

0.29

301

1803

Exposure to unspecified factor

1114

5766

1.51

35.19

1.5

1.6

0.74

0.76

g/l

0.16

799

4390

Other disorders of teeth and supporting structures

260

1130

2.34

35.14

1.7

1.6

0.70

0.87

g/l

1.34

200

823

Insulin, combination of fast acting with intermediate-acting or long-acting

676

3727

1.69

35.04

1.8

1.6

0.85

0.79

g/l

0.42

485

2817

Migraine with aura

309

1444

2.17

34.96

1.4

1.6

0.60

0.69

g/l

0.68

241

1118

Inflammatory diseases of the central nervous system

136

427

3.28

34.88

1.6

1.7

0.59

0.82

g/l

1.81

106

323

Other reaction to severe stress, and adjustment disorders

471

2554

1.86

34.86

1.7

1.6

0.67

0.71

g/l

0.43

355

1934

Other/unspecified dorsalgia

422

2198

1.93

34.75

1.4

1.6

0.71

0.81

g/l

0.93

313

1645

Visual disturbances and blindness

572

3291

1.76

34.67

1.8

1.6

0.80

0.76

g/l

0.22

439

2470

Paralytic ileus and intestinal obstruction

269

1194

2.28

34.50

1.5

1.6

0.67

0.86

g/l

1.42

195

887

Venous thromboembolism

565

3145

1.76

34.46

1.6

0.76

0.81

g/l

0.41

429

2344

Other diseases of lip and oral mucosa

204

802

2.59

34.41

1.6

0.74

0.80

g/l

0.22

150

601

Spondylosis

558

2720

1.77

34.37

1.5

1.6

0.69

0.83

g/l

2.15

398

2033

Heart failure, strict

561

2278

1.79

34.33

1.4

1.6

0.81

0.87

g/l

0.37

408

1696

Cystitis

955

3757

1.56

34.11

1.5

0.63

0.73

g/l

2.51

735

2870

Candidiasis

192

738

2.66

34.00

1.6

0.76

0.75

g/l

0.03

138

564

Disturbances of skin sensation

355

1770

2.03

33.85

1.4

1.5

0.63

0.72

g/l

1.33

276

1317

Diseases of the ear and mastoid process

1388

4856

1.45

33.80

1.5

1.6

0.74

0.76

g/l

0.19

1027

3697

Thyroiditis, ILD-related definition

159

556

2.92

33.74

1.6

1.5

0.63

0.76

g/l

0.95

121

417

Multiple myeloma, excluding all cancers (controls excluding all cancers)

162

4.87

33.64

1.5

2.0

0.34

1.06

g/l

5.09

125

Drug-induced cataract

104

6.14

33.63

1.8

0.48

0.91

g/l

1.52

Migraine without aura

273

1237

2.24

33.44

1.4

1.6

0.57

0.69

g/l

1.93

206

973

Other/unspecified seropositive rheumatoid arthritis

313

1499

2.12

33.29

1.6

1.5

0.74

g/l

0.00

236

1114

Weight loss

139

455

3.13

33.23

1.7

1.5

0.95

0.78

g/l

0.52

351

Later onset COPD, excluding more controls

156

410

3.00

33.03

1.3

1.4

0.87

0.83

g/l

0.13

122

309

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

626

3742

1.69

32.92

1.5

1.6

0.68

0.77

g/l

1.13

469

2818

Abnormal weight loss

129

407

3.26

32.84

1.7

1.5

1.00

0.78

g/l

0.67

311

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

309

1481

2.12

32.81

1.6

1.5

0.73

0.74

g/l

0.01

234

1101

All-cause Heart Failure

545

2234

1.77

32.47

1.4

1.6

0.81

0.87

g/l

0.37

399

1659

Multiple myeloma and malignant plasma cell neoplasms

163

4.77

32.44

1.5

1.9

0.34

1.06

g/l

5.11

126

Insulin medication

676

3518

1.66

32.43

1.8

1.6

0.85

0.79

g/l

0.42

485

2639

Psoriatic and enteropathic arthropathies

166

611

2.77

32.03

1.5

1.6

0.61

0.77

g/l

1.34

129

454

Symptoms and signs involving cognition, perception, emotional state and behaviour

1078

5096

1.49

31.79

1.4

1.6

0.71

0.76

g/l

0.79

800

3846

Gastroduodenal ulcer

256

1150

2.25

31.74

1.4

1.6

0.76

0.92

g/l

1.29

190

847

Other disorders of urethra and urinary system

753

3526

1.61

31.74

1.4

1.5

0.67

0.74

g/l

1.02

542

2687

Pneumonia derived septicemia

132

5.22

31.54

1.8

1.9

0.53

0.84

g/l

1.30

107

Atrial fibrillation and flutter with reimbursement

295

871

2.20

31.51

1.5

1.6

0.72

0.87

g/l

1.29

224

662

Hypokalaemia

148

517

2.92

31.49

1.4

1.6

0.83

0.81

g/l

0.06

112

384

Visual disturbances

534

3100

1.74

31.44

1.8

1.6

0.81

0.76

g/l

0.32

408

2316

Diseases of arteries, arterioles and capillaries

662

2998

1.66

31.37

1.5

1.6

0.74

0.85

g/l

1.03

496

2226

Diseases of middle ear and mastoid

691

3490

1.63

31.29

1.6

0.78

0.74

g/l

0.32

510

2633

Temporal arteritis

122

5.38

31.21

1.4

1.6

0.79

g/l

0.01

Gingivitis and periodontal diseases

1003

3412

1.53

31.12

1.5

1.6

0.71

0.81

g/l

2.07

775

2546

Other and unspecified disorders of white blood cells

173

4.58

31.11

1.4

1.7

0.71

0.86

g/l

0.40

131

Secondary hypertension

111

326

3.45

31.09

1.3

1.6

0.91

0.82

g/l

0.21

248

Multiple myeloma and malignant plasma cell neoplasms

169

4.60

31.05

1.5

1.7

0.34

0.88

g/l

3.68

126

Other specified/unspecified inflammatory spondylopathies

233

3.99

31.02

1.7

1.8

0.46

0.81

g/l

2.76

176

Enterocolitis due to Clostridium difficile

128

416

3.14

30.92

1.6

0.50

0.89

g/l

4.28

320

Disorders of sclera, cornea, iris and ciliary body

620

3762

1.66

30.91

1.7

1.6

0.72

0.77

g/l

0.42

468

2839

Cervical disc disorders

397

2128

1.88

30.54

1.6

0.65

0.86

g/l

4.33

290

1585

Migraine with aura and triptan purchases

217

929

2.38

30.52

1.5

1.6

0.63

0.69

g/l

0.28

170

704

Hypo-osmolality and hyponatraemia

189

757

2.53

30.47

1.4

1.6

0.62

0.82

g/l

1.68

133

570

Missing teeth due to accident, extraction or parodontitis

157

577

2.78

30.42

1.6

0.67

0.85

g/l

1.48

119

434

Other complications of surgical and medical care, not elsewhere classified

138

474

2.98

30.34

1.4

1.6

0.56

0.80

g/l

2.89

106

365

COPD related to multimorbidity

367

1604

1.95

30.19

1.5

1.6

0.78

0.87

g/l

0.68

276

1187

Other nutritional deficiencies

729

4524

1.59

30.03

1.4

1.6

0.67

0.74

g/l

1.13

559

3436

Polypectomy (DHB20)

111

338

3.38

30.02

2.3

1.7

1.04

0.88

g/l

0.76

261

Other diseases of urinary system

1143

4405

1.47

29.96

1.5

1.6

0.68

0.76

g/l

1.88

847

3350

Other anxiety disorders

549

2877

1.71

29.73

1.5

1.6

0.67

0.71

g/l

0.39

445

2172

Herpesviral [herpes simplex] infections

168

647

2.65

29.73

1.6

1.7

0.79

0.76

g/l

0.08

127

497

Polyarteritis nodosa and related conditions

7.73

29.69

1.7

1.8

1.00

0.81

g/l

0.21

Use of hypnotics and sedatives

1206

4845

1.45

29.54

1.5

1.6

0.71

0.77

g/l

1.13

924

3630

Colectomy operation

199

834

2.43

29.37

2.0

1.6

0.93

0.83

g/l

0.38

155

627

Direct fill therapy

202

855

2.41

29.23

1.5

1.7

0.55

0.80

g/l

4.05

148

662

Alcohol use disorder, Swedish definition

616

3508

1.64

29.09

1.5

1.6

0.73

0.83

g/l

1.46

431

2645

Intracranial trauma

642

2946

1.64

29.08

1.5

1.6

0.74

0.80

g/l

0.55

479

2266

Giant cell arteritis with polymyalgia rheumatica

130

5.05

29.06

1.4

1.6

0.79

0.80

g/l

0.02

Other symptoms and signs involving the circulatory and respiratory systems

267

3.65

29.02

1.5

1.7

0.64

0.86

g/l

1.14

209

648

3697

1.62

29.01

1.5

1.6

0.74

0.82

g/l

1.20

456

2785

Postviral fatigue syndrome

10.26

28.83

2.0

1.6

0.48

0.47

g/l

0.02

182

739

2.51

28.81

1.7

1.6

0.64

0.72

g/l

0.34

120

554

Pain in thoracic spine

191

793

2.45

28.77

1.4

1.6

0.64

0.78

g/l

0.72

156

600

Special screening examination for infectious and parasitic diseases

287

1029

2.10

28.72

1.5

0.66

0.77

g/l

1.34

231

721

Benign neoplasm: Pancreas

5.88

28.65

1.8

2.1

0.46

1.12

g/l

2.41

L04AC Interleukin inhibitors

280

3.60

28.63

1.5

1.8

0.54

0.78

g/l

1.59

217

COPD, hospital admissions 1, only main diagnosis

334

1459

1.97

28.57

1.4

1.6

0.70

0.89

g/l

2.28

252

1088

Malignant neoplasm of pancreas

215

3.97

28.54

1.5

1.6

0.88

0.92

g/l

0.09

167

Other CVD (FINNGEN)

126

323

3.12

28.53

1.6

1.5

0.62

0.88

g/l

1.82

244

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

629

3844

1.62

28.41

1.7

1.5

0.66

0.70

g/l

0.41

513

2923

Idiopathic thrombocytopenic purpura

137

4.90

28.34

1.9

1.7

0.87

0.83

g/l

0.06

106

Other overlap syndromes

7.40

28.28

1.7

1.4

0.80

0.55

g/l

0.52

Concussion

550

2854

1.68

28.08

1.5

1.7

0.72

0.80

g/l

0.82

407

2201

Other (seronegative) rheumatoid arthritis, wide

226

1023

2.24

27.88

1.5

1.6

0.57

0.76

g/l

2.26

178

765

Glomerular disorders in diseases classified elsewhere

154

587

2.68

27.84

1.4

1.7

0.54

0.85

g/l

3.58

114

451

All influenza (not pneumonia)

190

799

2.42

27.83

1.4

1.6

0.71

0.84

g/l

0.81

140

616

Acute tubulo-interstitial nephritis

633

3501

1.61

27.77

1.5

0.63

0.77

g/l

3.23

490

2652

Polyarthrosis

209

880

2.31

27.45

1.8

1.6

0.65

0.79

g/l

1.23

147

667

Cerebrovascular diseases (FINNGEN)

351

1313

1.93

27.45

1.5

1.6

0.84

0.80

g/l

0.17

276

999

Deviated nasal septum

353

1886

1.89

27.44

1.5

1.6

0.75

0.83

g/l

0.77

256

1380

Viral pneumonia (unknown virus, not influenza)

106

332

3.28

27.41

1.4

1.8

0.54

0.84

g/l

2.69

259

Benzodiazepine use

1098

5451

1.44

27.37

1.5

1.6

0.69

0.76

g/l

1.22

807

4118

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

110

5.30

27.33

1.3

1.6

0.86

1.03

g/l

0.27

Cutaneous abscess, furuncle and carbuncle

315

1629

1.96

27.18

1.5

1.6

0.73

0.77

g/l

0.13

242

1241

Systemic sclerosis (FG)

5.97

27.04

1.4

1.7

0.50

0.72

g/l

0.59

Shoulder lesions

806

3228

1.54

26.95

1.5

1.6

0.68

0.82

g/l

2.40

625

2392

Gout, FINNGEN

267

1306

2.07

26.90

1.4

1.7

0.68

0.95

g/l

2.97

195

987

Other symptoms and signs involving the nervous and musculoskeletal systems

470

2753

1.72

26.88

1.7

1.5

0.63

0.76

g/l

1.76

349

2087

Disorders of oesophagus in diseases classified elsewhere

6.91

26.65

1.7

1.2

0.73

0.78

g/l

0.11

Non-follicular lymphoma, hilmo, excluding all cancers

121

416

2.97

26.62

1.5

1.7

0.49

0.91

g/l

4.83

320

674

3862

1.57

26.62

1.5

1.6

0.74

0.81

g/l

1.15

474

2910

Agranulocytosis

148

566

2.67

26.61

1.5

1.6

0.55

0.80

g/l

2.60

108

428

Symptoms and signs involving the urinary system

802

4101

1.52

26.57

1.6

0.81

0.77

g/l

0.33

597

3073

Pain and other conditions associated with female genital organs and menstrual cycle

250

1148

2.11

26.52

1.4

1.5

0.69

0.62

g/l

0.38

185

866

Crohn disease (strict definition, all UC cases excluded)

270

3.52

26.46

1.7

1.6

0.62

0.77

g/l

0.64

206

Coeliac disease

165

667

2.52

26.44

2.0

1.6

0.66

0.73

g/l

0.40

120

502

Insulin, fast-acting

411

2332

1.78

26.29

1.8

1.6

0.80

g/l

0.01

296

1784

Systemic lupus erythematosus, unspecified

150

4.54

26.28

1.4

1.7

0.52

0.76

g/l

1.03

114

Adenocarcinoma and ductal carcinoma of pancreas

114

5.11

26.25

1.3

1.6

0.86

0.90

g/l

0.06

Disorders of skin appendages

553

3405

1.64

26.08

1.5

1.6

0.60

0.76

g/l

5.08

422

2561

Non-follicular lymphoma

121

421

2.94

26.07

1.5

1.7

0.49

0.89

g/l

4.44

320

Insulin, intermediate and long-acting

573

3489

1.62

26.07

1.8

1.6

0.83

0.80

g/l

0.21

420

2636

Congenital malformations of the respiratory system

5.65

26.04

1.7

1.8

0.68

0.77

g/l

0.17

COPD-related respiratory insufficiency

123

432

2.90

25.97

1.4

1.6

0.61

0.94

g/l

2.72

329

Allergic conjunctivitis

649

4091

1.57

25.90

1.7

1.5

0.65

0.69

g/l

0.54

531

3097

Chronic periodontitis

177

746

2.41

25.86

1.5

1.6

0.57

0.89

g/l

4.60

136

562

Alcoholic liver disease

124

440

2.88

25.76

1.3

1.6

0.84

0.88

g/l

0.13

331

Selective serotonin reuptake inhibitors

1131

4185

1.43

25.61

1.4

1.6

0.70

0.81

g/l

2.57

835

3166

Spinal stenosis

473

2181

1.71

25.55

1.5

1.6

0.70

0.87

g/l

2.53

350

1615

Atopic dermatitis, strict definition with reimbursement

376

2031

1.81

25.55

1.5

1.6

0.74

0.71

g/l

0.15

302

1550

Intestinal stricture

319

1692

1.91

25.50

1.5

0.67

0.83

g/l

1.36

234

1268

Temporomandibular joint disorders, including avohilmo

488

2926

1.68

25.48

1.5

0.58

0.68

g/l

1.87

347

2233

Disorders of the thyroid gland

1031

4698

1.44

25.47

1.6

1.5

0.67

0.75

g/l

1.50

738

3590

Benign neoplasm: Pancreas

106

5.26

25.46

1.8

1.5

0.46

0.75

g/l

1.16

Acute suppurative otitis media

349

1774

1.86

25.44

1.6

0.75

0.72

g/l

0.18

268

1369

Care involving dialysis

114

390

3.00

25.37

1.4

1.6

0.60

0.91

g/l

1.84

300

Non-selective monoamine reuptake inhibitors

415

2313

1.76

25.34

1.5

1.6

0.62

0.79

g/l

3.60

311

1750

Gastric ulcer

171

717

2.41

25.20

1.5

1.6

0.81

0.85

g/l

0.17

131

533

Other or unspecified ileus, impaction or obstruction

183

792

2.34

25.09

1.4

1.6

0.67

0.83

g/l

0.70

127

587

Non-rheumatic valve diseases

460

1965

1.72

25.04

1.5

1.6

0.80

0.84

g/l

0.32

321

1477

Exophthalmic conditions

8.09

25.02

2.2

1.9

1.02

0.88

g/l

0.19

Other inflammation of eyelid

165

686

2.45

24.91

1.6

0.70

0.76

g/l

0.33

128

521

Hernia

1025

4870

1.44

24.88

1.7

1.5

0.77

0.76

g/l

0.10

773

3641

Sequelae of external causes of morbidity and mortality

278

1421

1.98

24.87

1.5

1.6

0.79

g/l

0.00

209

1071

Congenital malformations, deformations and chromosomal abnormalities

685

4293

1.54

24.77

1.5

1.6

0.64

0.74

g/l

2.22

503

3264

Valvular heart disease excluding rheumatic fever

464

1997

1.71

24.68

1.5

1.6

0.80

0.84

g/l

0.31

324

1500

Other diseases of stomach and duodenum

238

3.57

24.66

1.3

1.5

0.59

0.89

g/l

1.90

175

Disorders of lipoprotein metabolism and other lipidaemias

831

3511

1.50

24.64

1.5

1.6

0.78

0.80

g/l

0.15

630

2623

Papulosquamous disorders

433

2543

1.72

24.61

1.6

0.63

0.78

g/l

2.10

327

1894

Extracorporeal dialysis

289

3.32

24.44

1.5

1.7

0.58

0.87

g/l

1.25

226

Internal derangement of knee

401

2304

1.75

24.38

1.5

1.7

0.74

0.84

g/l

1.04

296

1744

Diabetes, varying definitions

1142

4873

1.41

24.30

1.7

1.6

0.76

0.75

g/l

0.07

832

3703

Seronegative rheumatoid arthritis

134

510

2.67

24.30

1.4

1.5

0.55

0.73

g/l

1.33

367

Acetic acid derivatives and related substances

321

862

1.96

24.29

1.5

1.7

0.75

0.83

g/l

0.58

247

654

Migraine without aura and triptan purchases

217

1023

2.15

24.28

1.5

1.6

0.52

0.69

g/l

2.92

166

779

Stomatitis and related lesions

117

416

2.87

24.25

1.5

1.6

0.88

0.81

g/l

0.17

314

Dizziness and giddiness

773

4211

1.50

24.14

1.4

1.6

0.68

0.76

g/l

1.65

579

3181

Other arthrosis

520

2270

1.65

24.11

1.5

1.6

0.69

0.85

g/l

2.70

399

1714

Pollen allergy

265

1334

1.99

24.05

1.7

1.6

0.82

0.71

g/l

0.86

229

1025

Benign neoplasm: Stomach

119

429

2.83

24.04

2.0

1.6

0.74

0.82

g/l

0.39

322

Paroxysmal tachycardia

251

1048

2.05

23.97

1.5

0.77

0.78

g/l

0.04

185

791

Migraine, single triptan purchase ok & required. ICD-code if available is included

901

4203

1.46

23.92

1.5

0.64

0.72

g/l

1.62

681

3180

Triptan medication for migraine, single purchase ok

901

4203

1.46

23.92

1.5

0.64

0.72

g/l

1.62

681

3180

Genitourinary diseases

734

2401

1.54

23.87

1.6

1.7

0.78

0.86

g/l

1.13

544

1822

Cervicalgia

222

1062

2.12

23.85

1.8

1.6

0.71

0.79

g/l

0.54

170

795

Insulin, fast-acting or short human

412

2410

1.72

23.72

1.8

1.6

0.81

g/l

0.03

297

1840

Diabetes mellitus

1143

4895

1.40

23.66

1.7

1.6

0.76

0.75

g/l

0.04

835

3718

Unspecified kidney failure

104

351

3.02

23.65

1.4

1.6

0.52

0.88

g/l

3.84

272

Coxibs

316

874

1.94

23.54

1.4

1.7

0.67

0.83

g/l

1.75

237

663

Nephrotic syndrome

155

4.24

23.45

2.4

1.7

0.78

0.73

g/l

0.07

118

Disorders of lens

698

2884

1.54

23.44

1.5

0.74

0.80

g/l

0.51

500

2219

Hypoparathyroidism

142

4.38

23.44

2.3

1.7

0.61

0.86

g/l

0.63

109

Other disorders of eye and adnexa

181

806

2.28

23.38

1.6

1.7

0.57

0.75

g/l

2.98

145

611

Pneumococcal septicemia

151

4.27

23.36

1.8

0.54

0.82

g/l

1.09

118

Gonarthrosis [arthrosis of knee](FG)

714

2763

1.53

23.22

1.5

0.75

0.81

g/l

0.75

548

2064

Disorders of parathyroid gland

202

931

2.17

23.08

1.7

1.5

0.68

0.74

g/l

0.23

148

686

Cervicobrachial syndrome

247

1244

2.01

23.07

1.6

1.5

0.65

0.80

g/l

1.16

206

932

Iridocyclitis

268

1391

1.95

22.99

1.7

1.6

0.65

0.77

g/l

1.23

206

1061

Disorders of synovium and tendon

552

3146

1.59

22.97

1.5

1.6

0.62

0.80

g/l

4.32

410

2349

Arthrosis

734

2668

1.52

22.94

1.5

1.6

0.73

0.83

g/l

1.53

551

2012

Obesity and other hyperalimentation

673

4420

1.52

22.92

1.4

1.6

0.68

0.74

g/l

0.90

514

3357

Ulcerative proctitis

316

3.12

22.92

1.8

1.6

0.66

0.86

g/l

1.25

242

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1023

4731

1.41

22.86

1.7

1.5

0.76

g/l

0.04

758

3573

Suppurative and unspecified otitis media

442

2351

1.68

22.79

1.6

0.76

0.73

g/l

0.20

330

1802

Ovarian cyst

414

1382

1.75

22.65

1.4

1.5

0.58

0.63

g/l

0.35

309

1026

Pneumonia due to Streptococcus pneumoniae

172

3.95

22.62

1.9

1.8

0.62

1.00

g/l

1.13

138

Obesity

668

4403

1.51

22.45

1.4

1.6

0.67

0.74

g/l

0.94

509

3345

Zoster [herpes zoster]

187

858

2.21

22.42

1.6

0.43

0.79

g/l

9.49

147

639

Other abnormal immunological findings in serum

5.65

22.38

1.8

1.6

1.20

0.80

g/l

0.51

Myocarditis

210

3.61

22.37

1.4

1.5

0.90

0.80

g/l

0.18

161

Other diseases of arteries and capillaries

107

379

2.88

22.35

1.7

1.6

0.78

0.80

g/l

0.04

292

Other metabolic disorders

166

727

2.32

22.32

1.9

1.6

0.71

0.73

g/l

0.04

116

550

Unspecified chronic bronchitis

106

4.84

22.29

1.4

1.3

0.81

0.72

g/l

0.13

Other viral diseases

365

2100

1.75

22.21

1.6

0.60

0.76

g/l

3.08

280

1619

Lung diseases due to external agents

140

570

2.49

22.11

1.4

1.6

0.66

0.90

g/l

1.95

101

443

Excessive, frequent and irregular menstruation

437

1431

1.71

22.11

1.5

0.55

0.63

g/l

1.24

317

1066

Atopic dermatitis

618

3449

1.54

22.05

1.5

1.6

0.75

0.72

g/l

0.32

487

2642

Exclusions for E4_PCOS_CONSORTIUM

812

3485

1.47

22.03

1.5

0.64

0.66

g/l

0.23

549

2697

Other encephalitis

124

4.55

21.99

1.4

1.8

0.43

0.94

g/l

2.40

Other and unspecified tonsillitis

385

1903

1.73

21.98

1.5

1.7

0.74

0.80

g/l

0.55

292

1429

Systemic sclerosis

104

4.93

21.97

1.4

1.6

0.50

0.75

g/l

0.79

Other viral diseases, not elsewhere classified

241

1223

1.99

21.95

1.6

0.60

0.80

g/l

2.97

192

946

Hypothyreosis and Thyroxine purchase for inclusion criteria

974

4567

1.41

21.82

1.5

0.66

0.74

g/l

1.60

699

3488

Enteropathic arthropathies

5.06

21.76

1.9

2.0

0.53

0.87

g/l

1.04

Encephalitis

134

4.35

21.63

1.3

1.8

0.42

0.89

g/l

2.33

102

Convulsions, not elsewhere classified

239

1201

1.98

21.62

1.4

1.6

0.61

0.81

g/l

3.18

183

913

Volume depletion

337

2.96

21.58

1.5

1.6

0.67

0.90

g/l

1.03

254

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

151

4.08

21.57

2.0

1.6

0.75

0.95

g/l

0.53

119

Adverse effects, not elsewhere classified

242

1241

1.98

21.56

1.7

1.6

0.70

0.71

g/l

0.02

186

946

Other diseases of gallbladder

138

4.24

21.56

1.5

1.6

0.70

0.84

g/l

0.49

115

Ocular pain

115

434

2.71

21.37

1.5

1.7

0.59

0.77

g/l

1.75

325

Hypothyroidism, other/unspecified

939

4395

1.42

21.29

1.6

1.5

0.67

0.74

g/l

1.42

670

3364

Recurring oral aphthae, including avohilmo

167

749

2.27

21.25

1.5

1.6

0.74

0.75

g/l

0.03

132

559

Benign neoplasm: Stomach

119

459

2.65

21.14

2.0

1.6

0.74

0.79

g/l

0.24

334

Diseases of spleen

5.89

21.12

1.7

2.0

0.54

0.95

g/l

0.90

Other and unspecified vasculitis limited to skin

5.11

21.08

1.8

1.7

0.81

0.76

g/l

0.09

Type 2 diabetes

1053

4520

1.39

20.93

1.7

1.5

0.74

0.75

g/l

0.08

774

3424

Ankylosing spondylitis

121

473

2.61

20.91

1.6

1.7

0.60

0.87

g/l

2.09

365

Other diseases of jaws

334

2.94

20.79

1.7

1.8

0.77

0.88

g/l

0.29

246

Vasculitis limited to skin, not elsewhere classified

101

4.85

20.76

1.7

1.8

0.79

0.86

g/l

0.11

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

112

423

2.70

20.76

1.5

0.60

0.76

g/l

1.15

320

Falls/tendency to fall

1275

4744

1.35

20.64

1.5

1.6

0.75

0.76

g/l

0.03

964

3571

Nonorganic sleeping disorders, excluding more controls

215

1075

2.03

20.60

1.5

1.6

0.69

0.76

g/l

0.48

158

808

Other diseases of anus and rectum

276

1499

1.86

20.51

1.5

1.6

0.71

0.83

g/l

1.14

217

1128

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

415

1954

1.67

20.51

1.7

1.6

0.87

0.86

g/l

0.02

305

1473

Diseases of the myoneural junction and muscle

138

582

2.41

20.28

1.6

0.56

0.84

g/l

2.92

105

451

Benign neoplasm: Transverse colon

113

434

2.65

20.26

1.9

1.6

0.59

0.94

g/l

3.38

332

Triptan medication for migraine, min. 3 purchases

630

3321

1.51

20.21

1.5

0.59

0.66

g/l

1.40

494

2517

Reactive arthropathies, FINNGEN

345

2.87

20.18

1.4

1.7

0.53

0.76

g/l

2.08

258

Inflammatory diseases of female pelvic organs

631

3173

1.51

20.18

1.5

0.58

0.61

g/l

0.28

476

2397

Other arrhythmias

650

3345

1.50

20.09

1.5

1.6

0.72

0.76

g/l

0.34

467

2539

Other and unspecified effects of external causes

322

1847

1.76

20.08

1.6

0.75

0.72

g/l

0.20

245

1408

Suppurative and necrotic conditions of lower respiratory tract

221

3.39

20.05

1.5

1.7

0.71

0.91

g/l

0.75

171

Exposure to other specified factors

797

5256

1.43

20.04

1.6

0.80

0.76

g/l

0.30

592

3985

Lymphoid leukaemia

221

3.39

20.04

1.4

1.6

0.40

0.86

g/l

3.50

172

Somatoform disorder

199

979

2.06

19.98

1.4

1.6

0.66

0.75

g/l

0.69

142

732

Other skin changes

178

840

2.15

19.95

2.0

1.5

0.65

0.74

g/l

0.74

137

634

Algoneurodystrophy

156

3.92

19.91

1.4

1.7

0.70

g/l

0.01

120

Dermatitis due to substances taken internally

242

3.26

19.90

1.6

0.47

0.77

g/l

2.53

180

Acute and subacute iridocyclitis

225

1162

1.96

19.69

1.6

0.64

0.80

g/l

1.64

168

893

Enthesopathies of lower limb, excluding foot

238

1252

1.92

19.67

1.6

0.58

0.83

g/l

4.02

191

930

Other CVD

174

819

2.15

19.59

1.6

0.66

0.85

g/l

1.48

121

616

Myositis

4.77

19.54

1.2

1.9

0.53

1.01

g/l

1.82

Unknown and unspecified causes of morbidity

297

2.98

19.47

1.4

1.5

0.46

0.76

g/l

3.75

235

Rotator cuff syndrome

593

2922

1.52

19.45

1.5

1.6

0.72

0.84

g/l

1.27

464

2168

Recurring oral aphthae

226

3.33

19.40

1.6

0.83

0.79

g/l

0.06

173

Disorders of mineral metabolism

101

375

2.75

19.39

1.6

1.7

0.89

0.83

g/l

0.10

282

Lymphoid leukaemia

226

3.31

19.35

1.4

1.6

0.40

0.86

g/l

3.38

172

Anterior Iridocyclitis

236

1249

1.91

19.20

1.6

0.64

0.79

g/l

1.46

177

951

Seropositive rheumatoid arthritis, strict definition

174

827

2.14

19.19

1.5

1.6

0.80

0.74

g/l

0.28

135

617

Other external causes of accidental injury

975

3520

1.39

19.13

1.5

1.6

0.73

0.76

g/l

0.37

734

2666

Diseases of tongue

269

3.08

19.08

1.5

1.8

0.61

0.83

g/l

1.28

205

Systemic sclerosis, icd10

117

4.38

19.04

1.4

1.8

0.50

0.86

g/l

1.16

Psoriasis

313

1809

1.75

19.03

1.5

1.6

0.60

0.79

g/l

3.36

237

1361

Other peripheral vascular diseases

362

2.76

19.00

1.4

1.5

0.54

0.75

g/l

1.59

278

Other diseases of oesophagus

101

379

2.71

18.95

1.5

0.76

0.85

g/l

0.44

285

Disorders of optic nerve and visual pathways

125

521

2.45

18.93

1.5

1.7

0.53

0.74

g/l

2.00

398

Viral hepatitis, IBD co-morbidity

204

3.39

18.90

1.6

1.7

0.75

0.78

g/l

0.08

160

Other infectious diseases

352

2.78

18.89

1.5

0.54

0.83

g/l

2.68

269

Heart failure and bmi 25plus

305

1186

1.79

18.85

1.4

1.5

0.85

0.86

g/l

0.01

210

851

Type 2 diabetes, wide definition

715

3216

1.46

18.83

1.7

1.5

0.76

0.81

g/l

0.37

551

2487

Other specified/unspecified soft tissue disorders

176

3.60

18.79

1.5

1.8

0.59

0.90

g/l

1.31

135

Misadventures to patients during surgical and medical care

157

723

2.20

18.77

1.4

1.5

0.80

g/l

0.02

111

556

Pruritus

126

529

2.42

18.74

1.6

0.66

0.73

g/l

0.39

101

399

Fenamates

169

523

2.20

18.71

1.5

0.73

0.82

g/l

0.49

139

397

Drug-induced osteoporosis

6.82

18.64

2.2

2.0

0.55

0.79

g/l

0.38

Haemorrhoids and perianal venous thrombosis

265

1466

1.82

18.63

1.5

1.6

0.75

0.85

g/l

0.40

188

1084

External causes of morbidity and mortality

788

2754

1.44

18.62

1.6

0.71

0.77

g/l

0.83

593

2084

Benign neoplasm: Transverse colon

113

453

2.54

18.60

1.9

1.7

0.59

0.89

g/l

2.73

345

Fissure and fistula of anal and rectal regions

250

1361

1.85

18.59

1.4

1.6

0.59

0.83

g/l

3.79

182

1005

Diabetes insipidus

7.38

18.55

1.8

1.3

0.82

0.61

g/l

0.42

Non-ischemic cardiomyopathy

265

1194

1.84

18.54

1.4

1.6

0.77

0.90

g/l

0.77

195

904

Localized swelling, mass and lump of skin and subcutaneous tissue

323

1897

1.72

18.53

2.1

1.5

1.07

0.75

g/l

2.50

273

1415

Gout, idiopatic and unspecified

221

1158

1.93

18.52

1.5

1.7

0.66

0.99

g/l

3.79

160

883

Ulcer of lower limb, not elsewhere classified

136

594

2.32

18.46

1.3

1.6

0.93

0.90

g/l

0.07

104

452

Dental operations

670

2331

1.48

18.44

1.6

0.79

0.82

g/l

0.25

496

1778

Pure hypercholesterolaemia

686

3168

1.46

18.44

1.6

0.78

0.81

g/l

0.15

515

2356

Personal history of allergy to drugs, medicaments and biological substances

6.50

18.39

2.0

1.7

1.01

0.85

g/l

0.23

Dental caries 1 and operation codes

919

3393

1.40

18.31

1.6

0.75

0.80

g/l

0.50

683

2590

Other enthesopathies

309

1800

1.73

18.26

1.6

0.64

0.82

g/l

2.79

239

1336

Irregular menses

505

2677

1.54

18.12

1.5

0.55

0.61

g/l

1.10

388

2043

Reactive arthropathies

113

460

2.50

18.01

1.4

1.7

0.50

0.81

g/l

4.06

343

Subjective visual disturbances

259

1442

1.82

17.95

1.6

1.5

0.67

0.73

g/l

0.52

202

1071

Hypotension

143

646

2.24

17.90

1.6

0.66

0.90

g/l

1.74

487

Malignant neoplasm of other and unspecified parts of biliary tract

6.49

17.89

2.3

1.2

1.05

0.75

g/l

0.54

Radiculopathy

162

770

2.13

17.85

1.5

1.6

0.71

0.90

g/l

1.21

120

581

Dermatopolymyositis (FG)

6.03

17.80

1.2

1.9

0.39

0.80

g/l

1.00

Heartburn

108

433

2.53

17.75

1.4

1.5

0.82

0.79

g/l

0.06

334

Soft tissue disorders related to use, overuse and pressure

261

1462

1.80

17.70

1.5

1.6

0.70

0.86

g/l

1.79

212

1079

Dermatopolymyositis

5.79

17.64

1.3

1.8

0.50

0.77

g/l

0.54

Personality disorders, excluding more controls

287

1655

1.75

17.62

1.4

1.6

0.70

0.74

g/l

0.23

207

1242

Benign neoplasm: Small intestine

165

3.63

17.62

1.5

1.8

0.83

0.97

g/l

0.21

130

Diseases of pulp and periapical tissues, including avohilmo

1183

4633

1.33

17.61

1.5

1.6

0.73

0.77

g/l

0.45

876

3512

Other/unspecified rheumatoid arthritis

129

563

2.32

17.58

1.6

0.54

0.79

g/l

2.21

101

411

Panic disorder

184

924

2.02

17.52

1.5

1.6

0.68

0.74

g/l

0.29

142

698

Dental pulpitis 4

1184

4641

1.33

17.51

1.5

1.6

0.74

0.77

g/l

0.44

880

3517

Dental pulpitis 1

1183

4643

1.33

17.37

1.5

1.6

0.74

0.77

g/l

0.42

878

3520

Gonarthrosis

615

2392

1.48

17.36

1.5

1.6

0.74

0.85

g/l

1.44

471

1809

Haemolytic anaemias

148

3.77

17.34

2.3

1.7

0.80

0.87

g/l

0.13

113

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

148

3.76

17.32

1.8

1.7

0.53

0.83

g/l

1.18

109

Hyperlipidaemia, other/unspecified

336

1918

1.67

17.30

1.5

1.6

0.68

0.87

g/l

2.62

261

1422

Pyogenic arthritis

269

2.95

17.21

1.4

1.8

0.70

0.86

g/l

0.71

209

Fall on same level

1259

5380

1.31

17.17

1.5

1.6

0.72

0.76

g/l

0.59

963

4051

Emphysema

212

3.21

17.12

1.5

1.6

0.79

0.92

g/l

0.38

167

Accidents

959

3520

1.37

17.10

1.5

1.6

0.73

0.76

g/l

0.36

730

2666

Acquired haemolytic anaemia

4.51

17.03

2.3

1.6

0.71

0.85

g/l

0.26

Psoriatic arthropathies

125

547

2.32

16.98

1.4

1.7

0.65

0.82

g/l

1.06

416

Hepatomegaly and splenomegaly, not elsewhere classified

6.88

16.90

1.3

0.42

0.63

g/l

1.01

Sequelae with surgical and medical care as external cause

205

1082

1.92

16.89

1.5

1.6

0.84

0.79

g/l

0.13

154

814

Cluster headache, strict

165

3.56

16.87

1.3

1.8

0.71

0.89

g/l

0.70

130

Deforming dorsopathies

277

1602

1.74

16.85

1.5

1.6

0.61

0.82

g/l

2.50

211

1191

Vascular disorders of the intestines

199

3.27

16.83

1.5

1.6

0.76

0.89

g/l

0.38

154

Tuberculosis, IBD comorbidity

252

2.98

16.69

1.7

0.82

0.89

g/l

0.16

196

Obesity, other/unspecified

366

2283

1.62

16.68

1.5

1.6

0.70

0.73

g/l

0.23

299

1732

Oter anti-inflammatory and antirheumatic agents, non-steroids

222

644

1.93

16.61

1.5

0.74

0.85

g/l

0.48

171

479

Otitis media, unspecified

146

630

2.16

16.52

1.5

1.7

0.74

0.78

g/l

0.19

103

511

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1001

4562

1.35

16.52

1.7

1.6

0.76

0.77

g/l

0.07

726

3465

Thyroiditis

373

2.60

16.42

1.5

1.6

0.72

0.75

g/l

0.09

284

Disorders of muscles

117

506

2.35

16.34

1.3

1.7

0.66

0.80

g/l

0.77

385

Benign neoplasm: Small intestine

174

3.44

16.27

1.5

1.8

0.83

0.90

g/l

0.09

134

Chronic iridocyclitis

246

3.00

16.24

1.6

1.7

0.63

0.79

g/l

0.65

188

Conjunctivitis (acute, non atopic)

302

1802

1.69

16.21

1.6

0.70

0.75

g/l

0.48

233

1376

Substance abuse, excluding more controls

558

3343

1.47

16.19

1.4

1.7

0.70

0.82

g/l

2.05

411

2499

Viral pneumonia (known virus, not influenza)

4.40

16.13

1.3

1.6

0.83

0.79

g/l

0.07

Persons encountering health services for specific procedures, not carried out

394

2.53

16.11

1.4

1.7

0.66

0.83

g/l

0.71

295

Other and unspecified urticaria

226

1250

1.83

16.09

1.6

0.65

0.71

g/l

0.39

170

947

Postprocedural disorders of nervous system

401

2.52

16.03

1.5

1.7

0.63

0.72

g/l

0.44

313

Invasive ventilation

337

2.66

15.99

1.3

1.7

0.46

0.88

g/l

3.77

262

Other pulmonary heart/vessel disease

161

3.50

15.98

1.6

1.7

0.71

0.90

g/l

0.49

126

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

349

1389

1.64

15.88

1.5

0.55

0.58

g/l

0.29

269

1068

Benign neoplasm: Duodenum

4.42

15.87

1.5

1.9

0.86

0.88

g/l

0.01

Chronic ulcer of skin, not elsewhere classified

255

2.92

15.78

2.0

1.6

0.93

0.87

g/l

0.13

198

Other disorders of skin and subcutaneous tissue, not elsewhere classified

147

708

2.10

15.74

2.0

1.5

0.86

0.80

g/l

0.23

104

539

Ischaemic heart disease, wide definition

741

3328

1.40

15.74

1.6

0.80

0.82

g/l

0.13

538

2504

Persons with potential health hazards related to communicable diseases

435

2838

1.53

15.70

1.7

1.6

0.64

0.72

g/l

1.01

299

2195

Cluster headache, wide

178

3.35

15.68

1.3

1.8

0.69

0.85

g/l

0.60

141

Chronic tubulo-interstitial nephritis

149

3.58

15.62

1.4

1.8

0.90

0.84

g/l

0.10

115

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

154

3.53

15.60

1.7

1.8

0.58

1.04

g/l

1.74

119

Chronic lymphocytic leukaemia, helper endpoint

4.51

15.55

1.2

1.6

0.30

1.08

g/l

3.20

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

4.51

15.55

1.2

1.6

0.30

1.08

g/l

3.20

Ischemic heart diseases

753

3401

1.39

15.54

1.6

0.79

0.81

g/l

0.17

554

2553

Tuberculosis, wide

268

2.84

15.53

1.7

0.81

0.87

g/l

0.13

206

Psoriasis vulgaris

207

1130

1.85

15.41

1.5

1.6

0.60

0.79

g/l

2.72

160

860

Other medical care

363

2247

1.59

15.41

1.4

1.6

0.72

0.80

g/l

0.62

279

1666

Senile cataract

585

2504

1.46

15.41

1.5

0.74

0.82

g/l

0.81

416

1923

Dental caries 3 and operation codes

951

3635

1.35

15.40

1.6

0.74

0.79

g/l

0.58

704

2783

Benign neoplasm: Ascending colon

126

577

2.22

15.38

1.8

1.6

0.65

0.85

g/l

1.46

100

435

Gout, unspecified

180

940

1.94

15.35

1.5

1.6

0.65

0.98

g/l

3.15

132

719

Benign neoplasm: Caecum

104

440

2.40

15.31

1.8

1.6

0.72

0.87

g/l

0.57

336

Presence of other functional implants

501

2390

1.49

15.29

1.5

0.76

0.80

g/l

0.18

305

1828

Cardiomyopathy

168

858

1.98

15.29

1.6

0.75

0.91

g/l

0.85

126

651

Other disorders of bone

225

1263

1.80

15.28

1.5

1.6

0.76

0.73

g/l

0.13

175

963

Cellulitis

228

1285

1.79

15.27

1.6

0.69

0.77

g/l

0.58

191

982

Behavioural syndromes associated with physiological disturbances and physical factors

353

2231

1.59

15.24

1.5

1.6

0.69

0.71

g/l

0.19

260

1723

Secondary right heart disease

147

3.56

15.20

1.5

1.7

0.69

0.93

g/l

0.60

116

Dermatographic urticaria

364

2.55

15.17

1.9

1.7

0.71

0.74

g/l

0.09

273

Benign neoplasm: Caecum

104

442

2.39

15.16

1.8

1.6

0.72

0.91

g/l

0.80

337

Disorders of plasma-protein metabolism, not elsewhere classified

7.36

15.13

1.8

1.5

0.64

0.69

g/l

0.10

Meniscus derangement

528

2464

1.47

15.07

1.5

1.6

0.70

0.85

g/l

2.49

371

1859

Endocarditis

129

3.74

15.07

1.5

0.79

0.82

g/l

0.07

106

Obesity due to excess calories

476

3221

1.49

15.02

1.3

1.6

0.69

0.74

g/l

0.60

362

2419

STROKE

567

2724

1.45

15.01

1.6

0.81

0.80

g/l

0.04

437

2031

Benign neoplasm: salivary glands, exclude unknown (D119)

408

2.44

14.97

2.2

1.6

1.08

0.83

g/l

0.56

314

Benign neoplasm of major salivary glands

106

457

2.36

14.96

2.1

1.6

1.05

0.82

g/l

0.54

348

Abnormal findings on diagnostic imaging of central nervous system

204

3.12

14.96

1.7

1.5

0.64

0.76

g/l

0.29

159

Other obstetric conditions, not elsewhere classified

352

1428

1.61

14.92

1.5

0.55

0.59

g/l

0.36

273

1096

Other neurological diseases

666

3837

1.40

14.91

1.5

1.6

0.67

0.80

g/l

3.17

495

2864

Cluster headache, strict, including avohilmo

264

2.83

14.89

1.3

1.7

0.61

0.80

g/l

1.08

203

Adjustment and management of implanted device

158

798

2.00

14.85

1.4

1.6

0.77

0.83

g/l

0.31

115

606

Postprocedural endocrine and metabolic disorders, not elsewhere classified

139

671

2.10

14.85

1.9

1.6

0.73

0.71

g/l

0.04

100

507

Ankylosing spondylitis, ICD10

118

535

2.25

14.83

1.6

0.60

0.80

g/l

1.35

411

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.62

14.81

1.4

1.7

0.95

1.01

g/l

0.07

Lung cancer and mesothelioma

120

462

2.24

14.75

1.2

1.4

0.74

0.82

g/l

0.30

348

Acute pharyngitis

164

837

1.97

14.67

1.5

1.7

0.84

0.80

g/l

0.09

125

631

Acute lymphadenitis

347

2.56

14.62

2.3

1.7

1.06

0.76

g/l

0.62

273

Benign neoplasm: Rectum, anus and anal canal

180

956

1.90

14.61

1.6

1.7

0.79

0.87

g/l

0.31

147

720

Scleritis and episcleritis

312

2.65

14.61

1.5

1.7

0.71

0.78

g/l

0.26

238

Benign neoplasm of major salivary glands

106

464

2.32

14.47

2.1

1.6

1.05

0.86

g/l

0.43

349

Cluster headache, wide,, including avohilmo

274

2.76

14.44

1.3

1.7

0.60

0.80

g/l

1.20

209

Other/unspecified reactive arthropathies

361

2.52

14.43

1.3

1.7

0.54

0.81

g/l

2.29

277

Dental operations, only avohilmo

709

2611

1.40

14.38

1.6

0.78

0.82

g/l

0.38

521

1977

Iron deficiency anaemia secondary to blood loss (chronic)

147

733

2.03

14.36

1.7

1.5

0.69

0.79

g/l

0.45

117

544

Type 2 diabetes, definitions combined

948

4282

1.33

14.24

1.6

1.5

0.77

0.76

g/l

0.00

697

3242

Cytomegalovirus infection, IBD co-morbidity

4.14

14.22

1.3

1.6

0.57

0.83

g/l

0.65

Injuries to the ankle and foot

728

4876

1.37

14.20

1.6

0.77

0.75

g/l

0.15

569

3668

Benign neoplasm: Ascending colon

126

597

2.14

14.16

1.8

1.6

0.65

0.84

g/l

1.31

100

449

Pneumothorax

272

2.73

14.03

1.3

1.6

0.84

0.88

g/l

0.09

217

Coxarthrosis [arthrosis of hip](FG)

436

2106

1.50

13.98

1.4

1.5

0.71

0.83

g/l

1.39

344

1559

Tongue abnormality

273

2.73

13.97

1.6

1.8

0.61

0.83

g/l

1.16

209

Other and unspecified drugs and medicaments

403

2.40

13.96

1.4

1.7

0.61

0.82

g/l

1.35

302

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

285

1749

1.64

13.96

1.4

1.6

0.65

0.72

g/l

0.70

209

1329

Diabetes, insulin treatment (Kela reimbursement)

1029

4836

1.31

13.95

1.7

1.6

0.75

0.77

g/l

0.10

751

3664

Other meningitis

4.66

13.93

1.9

1.5

0.57

0.58

g/l

0.01

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

4.50

13.90

1.5

1.7

0.31

0.86

g/l

2.27

Multiple myeloma

4.50

13.90

1.5

1.7

0.31

0.86

g/l

2.27

Nonorganic sleeping disorders

215

1227

1.77

13.86

1.5

1.6

0.69

0.74

g/l

0.37

158

932

Oxicams

232

746

1.78

13.80

1.7

1.6

0.70

0.82

g/l

0.92

185

558

Dental pulpitis 4, only avohilmo

1178

4800

1.29

13.76

1.5

1.6

0.74

0.77

g/l

0.33

866

3639

Postprocedural disorders of digestive system, not elsewhere classified

133

3.56

13.70

2.1

1.5

0.86

0.79

g/l

0.13

101

Paralytic ileus

133

3.54

13.67

1.6

1.8

0.53

0.95

g/l

1.87

105

Other and unspecified types of non-Hodgkin lymphoma, hilmo

168

3.23

13.65

1.7

0.58

0.95

g/l

1.35

131

Other noninfective disorders of lymphatic vessels and lymph nodes

148

3.40

13.64

1.5

1.7

0.78

0.86

g/l

0.18

115

Phlebitis and thrombophlebitis (not including DVT)

222

1285

1.74

13.61

1.6

0.66

0.77

g/l

0.73

168

977

Sleep disorders

237

1398

1.71

13.58

1.4

1.6

0.69

0.75

g/l

0.42

174

1066

Disorders of vestibular function (Vertigo)

423

2835

1.49

13.58

1.5

0.64

0.79

g/l

3.17

304

2137

Secondary and unspecified malignant neoplasm of lymph nodes

378

2.42

13.53

1.4

1.6

0.67

0.89

g/l

0.89

286

Menorrhagia

356

1254

1.58

13.49

1.6

1.5

0.59

0.63

g/l

0.42

258

930

Other cataract

388

1979

1.53

13.48

1.7

1.5

0.73

0.82

g/l

0.58

283

1527

Dental caries, including avohilmo

799

3027

1.35

13.48

1.6

0.74

0.79

g/l

0.57

591

2301

Chronic nephritic syndrome

185

3.11

13.47

1.9

1.5

0.61

0.78

g/l

0.62

143

Diabetes medication

1065

5020

1.29

13.47

1.6

0.76

0.75

g/l

0.10

783

3804

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.91

13.46

1.7

0.39

0.84

g/l

1.22

Aortic aneurysm

188

1021

1.82

13.43

1.7

0.81

0.99

g/l

0.90

126

784

Faecal incontinence

319

2.54

13.41

1.3

1.4

0.60

0.71

g/l

0.44

231

Type 2 diabetes, strict (exclude DM1)

949

4329

1.31

13.37

1.6

1.5

0.77

g/l

0.01

697

3269

Dental caries 1

799

3031

1.35

13.35

1.6

0.75

0.79

g/l

0.54

591

2304

Rash and other nonspecific skin eruption

111

514

2.19

13.27

1.6

1.5

0.52

0.74

g/l

2.34

395

Hyperkalaemia

176

3.12

13.24

1.5

1.8

0.58

0.97

g/l

1.63

136

Cytomegaloviral disease

104

3.89

13.12

1.3

1.7

0.57

0.86

g/l

0.77

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

103

465

2.25

13.11

1.7

1.5

0.94

0.81

g/l

0.28

354

Atopic dermatitis, strict definition

340

2166

1.55

13.07

1.5

1.6

0.74

0.71

g/l

0.22

275

1659

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

118

3.66

13.06

1.8

1.7

0.34

0.91

g/l

2.58

Asthma mixed form (mode), excluding more controls

172

3.13

13.06

1.6

1.5

0.62

0.81

g/l

1.02

134

Benign neoplasm: Duodenum

109

3.80

13.05

1.5

1.6

0.86

0.77

g/l

0.08

Keratitis

348

2276

1.54

13.03

1.8

1.6

0.76

0.77

g/l

0.07

252

1706

Substance use, excluding alcohol

220

1287

1.73

13.02

1.3

1.7

0.62

0.78

g/l

1.75

161

982

Chronic lymphocytic leukaemia

100

3.91

12.99

1.2

1.5

0.30

0.82

g/l

2.85

Viral infections of the central nervous system

392

2.36

12.96

1.4

1.7

0.48

0.81

g/l

3.39

297

Hypertensive heart and/or renal disease

206

907

1.77

12.91

1.4

1.6

0.76

0.96

g/l

0.96

156

669

Benign neoplasm: Rectum

158

840

1.90

12.87

1.5

1.6

0.78

0.85

g/l

0.26

132

632

Type 2 diabetes, definitions combined, including avohilmo

953

4336

1.31

12.87

1.6

1.5

0.78

0.76

g/l

0.21

700

3276

Correction of physiology of bite - demanding therapy visit

388

2.36

12.81

1.4

1.7

0.47

0.74

g/l

2.58

290

Fentanyl

344

2.44

12.80

1.3

1.6

0.62

0.97

g/l

2.68

264

Endometriosis

348

1334

1.56

12.77

1.5

0.68

0.62

g/l

0.49

264

990

Complications of internal orthopaedic prosthetic devices, implants and grafts

182

1014

1.81

12.74

1.3

1.6

0.67

0.80

g/l

1.26

137

754

Injuries to the head

1120

5744

1.27

12.73

1.6

0.76

0.75

g/l

0.03

842

4339

Dental pulpitis 1, only avohilmo

1174

4832

1.27

12.72

1.5

1.6

0.74

0.77

g/l

0.28

862

3666

Pyoderma gangrenosum

6.08

12.67

1.2

2.0

0.63

0.93

g/l

0.42

Injuries to the abdomen, lower back, lumbar spine and pelvis

355

2330

1.52

12.65

1.3

1.6

0.80

0.78

g/l

0.08

273

1753

Vitamin B12 deficiency anaemia

408

2.31

12.65

1.8

1.6

0.76

0.88

g/l

0.49

305

Polycystic ovarian syndrome, consortium definition

698

3104

1.36

12.63

1.5

0.57

0.62

g/l

0.84

521

2350

Generalized skin eruption due to drugs and medicaments

187

3.02

12.61

1.6

1.7

0.42

0.79

g/l

2.52

139

Hernia of abdominal wall

420

2875

1.47

12.60

1.6

0.71

0.83

g/l

1.71

313

2165

Disorders of ocular muscles, binocular movement, accommodation and refraction

480

3340

1.43

12.60

1.5

1.6

0.59

0.76

g/l

4.74

359

2547

Paracetamol of NSAID medication

198

548

1.83

12.58

1.6

1.8

0.81

0.91

g/l

0.48

147

438

Other disorders of ear

906

4638

1.31

12.54

1.6

1.5

0.72

0.77

g/l

0.52

664

3514

Etanercept

355

2.41

12.53

1.6

1.7

0.71

0.77

g/l

0.19

274

Asthma mixed form (mode)

177

3.04

12.46

1.6

1.5

0.62

0.82

g/l

1.09

136

Acute laryngitis and tracheitis

138

698

1.97

12.43

1.5

1.7

0.67

0.84

g/l

1.24

103

532

Sacroiliitis, not elsewhere classified

238

2.74

12.42

1.4

1.9

0.48

0.75

g/l

1.44

185

Other embolism and thrombosis

131

663

2.00

12.37

1.9

1.6

0.91

0.82

g/l

0.28

503

Acute generalized exanthematous pustulosis

222

2.81

12.37

1.5

1.6

0.44

0.77

g/l

2.65

167

Carrier of infectious disease

118

3.60

12.36

2.0

1.7

1.27

0.82

g/l

0.85

Special screening examination for other diseases and disorders

350

2.40

12.36

1.5

0.67

0.82

g/l

0.51

251

Diseases of external ear

323

2104

1.55

12.36

1.5

1.6

0.70

0.79

g/l

0.70

245

1600

Adenocarcinoma of pancreas

4.00

12.36

1.4

1.6

0.95

0.85

g/l

0.11

Dental caries 3

849

3291

1.32

12.32

1.6

0.73

0.79

g/l

0.77

625

2513

Benign neoplasm: Rectum, anus and anal canal

180

1011

1.80

12.31

1.6

1.5

0.79

0.83

g/l

0.12

147

755

Other bursopathies

127

637

2.02

12.29

1.5

1.6

0.82

0.85

g/l

0.13

477

Injury, poisoning and certain other consequences of external causes

614

2219

1.39

12.27

1.7

1.6

0.70

0.76

g/l

0.62

468

1645

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

920

4189

1.30

12.26

1.5

1.6

0.68

0.76

g/l

1.40

689

3163

Other and unspecified rosacea

440

2.24

12.25

1.2

1.6

0.55

0.77

g/l

1.89

334

Cerebral cysts

263

2.64

12.22

1.6

1.7

0.61

0.81

g/l

0.93

202

Malignant neoplasm, wide definition for exclusion

920

4191

1.30

12.22

1.5

1.6

0.68

0.76

g/l

1.39

689

3164

Injuries to the knee and lower leg

1217

5555

1.26

12.19

1.5

1.6

0.73

0.76

g/l

0.32

938

4167

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

919

4189

1.30

12.16

1.5

1.6

0.68

0.76

g/l

1.37

688

3162

Cardiomyopathy, other and unspecified

342

2.40

12.07

1.5

1.6

0.58

0.84

g/l

2.09

270

TMD related pain

176

3.03

12.05

1.4

1.8

0.59

0.79

g/l

0.73

135

Gout, strict definition

149

795

1.89

12.03

1.4

1.6

0.53

0.99

g/l

7.68

110

610

Metatarsalgia

456

2.20

12.03

1.5

1.6

0.56

0.76

g/l

1.60

348

Polyarthritis, unspecified

155

3.17

12.02

1.7

1.8

0.53

0.87

g/l

1.70

124

Congenital malformations of the musculoskeletal system, not elsewhere classified

4.24

12.02

1.3

1.4

0.73

0.50

g/l

0.54

Pyothorax

171

3.05

11.98

1.6

1.8

0.76

0.89

g/l

0.30

130

Polyuria

202

1182

1.72

11.98

1.4

1.6

0.82

0.84

g/l

0.09

152

893

Other coagulation defects

376

2.33

11.88

1.8

1.6

0.62

0.77

g/l

0.71

280

Diseases of inner ear

483

3357

1.42

11.88

1.4

1.6

0.64

0.79

g/l

3.32

346

2534

Disorders of calcium metabolism

267

2.59

11.86

1.6

1.7

1.04

0.85

g/l

0.26

201

Unspecified haematuria

358

2051

1.50

11.84

1.7

1.6

0.81

0.83

g/l

0.11

278

1532

Arthropathic psoriasis

127

647

1.99

11.82

1.3

1.6

0.64

0.78

g/l

0.86

493

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

4.03

11.81

2.0

1.7

0.58

1.12

g/l

1.64

Retention of urine

280

1500

1.59

11.81

1.6

0.88

g/l

0.00

206

1123

Abnormal findings on examination of urine, without diagnosis

200

2.86

11.77

1.7

1.5

0.65

0.77

g/l

0.52

151

Other postsurgical states

298

2.49

11.74

1.7

0.78

0.82

g/l

0.12

237

Synovial cyst of popliteal space [Baker]

292

2.50

11.72

1.3

1.7

0.63

0.81

g/l

0.87

220

Viral and other specified intestinal infections

221

1302

1.67

11.65

1.9

1.6

0.73

0.76

g/l

0.06

161

1000

Failure and rejection of transplanted organs and tissues

4.59

11.60

1.5

0.57

0.73

g/l

0.26

Benign neoplasm: Descending colon

270

2.56

11.60

1.5

1.7

0.67

0.96

g/l

1.45

211

Hard cardiovascular diseases

731

3538

1.33

11.55

1.6

0.80

0.81

g/l

0.04

567

2615

Nummular dermatitis

362

2.33

11.52

1.8

1.7

1.01

0.86

g/l

0.47

277

Other and unspecified coagulation defects

248

2.64

11.51

1.9

1.6

0.69

0.75

g/l

0.16

188

Duodenal ulcer

387

2.27

11.49

1.5

0.70

0.87

g/l

1.08

298

Cerebral palsy and other paralytic syndromes

123

626

1.99

11.48

1.4

1.7

0.67

0.79

g/l

0.48

479

Elevated blood glucose level

389

2.27

11.40

2.2

1.6

1.08

0.81

g/l

0.65

290

Cardiac murmurs and other cardiac sounds

428

2.20

11.40

1.3

1.7

0.81

0.82

g/l

0.02

342

Diplopia

131

683

1.94

11.40

1.9

1.6

0.94

0.79

g/l

0.57

520

Filling of root of tooth

145

3.19

11.36

1.9

1.7

0.58

0.89

g/l

1.18

107

Trochanteric bursitis

123

628

1.98

11.36

1.6

0.62

0.75

g/l

0.92

100

464

Psoriatic arthropathies, ICD10

123

629

1.98

11.35

1.4

1.7

0.64

0.76

g/l

0.69

476

Other enthesopathy of foot (+metatarsalgia)

103

495

2.11

11.25

1.5

1.6

0.56

0.77

g/l

1.79

375

Pleural plaque

322

2.39

11.25

1.4

1.5

0.76

1.04

g/l

1.12

245

Coxarthrosis

410

1916

1.46

11.25

1.4

1.6

0.71

0.87

g/l

2.00

321

1444

Mouth breathing

409

2850

1.44

11.20

1.6

0.78

0.83

g/l

0.26

304

2156

Other congenital malformations

108

530

2.07

11.17

1.4

1.6

0.70

0.72

g/l

0.08

416

Anaemia in chronic diseases classified elsewhere

3.72

11.17

1.5

1.7

0.52

0.74

g/l

0.66

Subacute thyroiditis

157

3.06

11.15

1.6

1.7

0.73

0.84

g/l

0.28

127

Phobic anxiety disorders

151

830

1.84

11.14

1.7

1.6

0.67

0.75

g/l

0.49

116

630

Bullous disorders

229

2.67

11.11

1.7

1.6

0.84

0.86

g/l

0.04

173

Noninflammatory disorders of female genital tract

424

1467

1.46

11.10

1.5

0.61

0.64

g/l

0.32

318

1097

Speech therapy

254

1608

1.59

11.10

1.5

0.77

g/l

0.02

230

1198

Allergic purpura

137

3.22

11.05

1.5

1.4

0.84

0.64

g/l

0.41

106

Autoimmune thyroiditis

3.94

11.04

1.3

1.7

0.56

0.76

g/l

0.42

Other disorders of optic [2nd] nerve and visual pathways

301

2.43

11.04

1.5

1.7

0.57

0.80

g/l

1.16

235

Barrett oesophagus

185

2.87

11.01

1.6

1.5

0.77

0.87

g/l

0.27

136

Erythema multiforme

3.68

11.00

1.5

1.6

0.56

0.76

g/l

0.57

Insomnia

176

1018

1.75

10.96

1.5

1.6

0.70

0.74

g/l

0.16

135

779

Oesophagitis

208

2.74

10.93

1.3

1.5

0.62

0.89

g/l

1.14

157

Other disorders of kidney and ureter

122

631

1.96

10.89

1.5

1.6

0.77

0.83

g/l

0.21

481

Coronary atherosclerosis

600

2861

1.36

10.87

1.5

1.6

0.83

0.84

g/l

0.07

440

2139

Pacemaker

237

1440

1.61

10.85

1.4

1.6

0.76

0.84

g/l

0.51

174

1087

Rosacea

124

647

1.94

10.81

1.3

1.6

0.58

0.73

g/l

1.36

488

Presence of cardiac and vascular implants and grafts

357

1835

1.48

10.78

1.5

1.6

0.78

0.88

g/l

0.80

274

1394

Combined immunodeficiencies

5.49

10.70

1.4

1.3

0.31

0.61

g/l

1.32

Hyperparathyroidism

145

788

1.83

10.67

1.4

1.5

0.69

0.74

g/l

0.18

111

586

Benign neoplasm: Rectum

158

893

1.79

10.66

1.5

0.78

0.83

g/l

0.19

132

661

Fracture of rib(s), sternum and thoracic spine

259

1663

1.57

10.65

1.4

1.6

0.72

0.87

g/l

1.81

202

1253

Other demyelinating diseases of the central nervous system

200

2.77

10.65

1.6

1.7

0.66

0.76

g/l

0.27

151

TMD muscular pain linked with fibromyalgia

5.08

10.65

1.8

1.5

0.93

0.41

g/l

1.80

ILD medications: pirfenidone

7.83

10.65

1.1

0.63

0.70

g/l

—

Meningitis

258

2.53

10.63

1.9

1.7

0.68

0.87

g/l

0.64

198

Benign neoplasm: Descending colon

282

2.45

10.62

1.5

1.6

0.67

0.90

g/l

1.00

212

Hyperkinetic disorders, excluding more controls

119

599

1.96

10.58

1.6

1.8

0.76

0.78

g/l

0.10

459

Other or ill-defined heart diseases

229

2.62

10.56

1.5

1.8

0.89

0.85

g/l

0.10

173

Other specified/unspecified bacterial intestinal infections

289

2.43

10.54

1.5

1.7

0.80

0.82

g/l

0.04

223

Other obstructive and reflux uropathy

184

2.82

10.54

1.6

1.7

0.97

0.76

g/l

0.46

142

Lichen simplex chronicus and prurigo

277

2.46

10.53

1.2

1.6

0.80

0.84

g/l

0.11

211

Rare circulating lymphoid malignancy

136

3.17

10.53

1.8

1.6

0.34

0.70

g/l

1.77

106

Other psoriatic arthropathies

117

605

1.96

10.50

1.4

1.7

0.65

0.76

g/l

0.57

457

Otitis externa

220

1367

1.62

10.43

1.5

1.6

0.69

0.77

g/l

0.43

178

1042

Tuberculosis

213

2.66

10.43

1.6

1.7

0.80

0.91

g/l

0.26

162

Calcific aortic valvular stenosis, diagnosis (helper)

206

1231

1.65

10.41

1.4

1.6

0.86

0.87

g/l

0.06

153

930

Operations 2 for CAVS

206

1231

1.65

10.41

1.4

1.6

0.86

0.87

g/l

0.06

153

930

Calcific aortic valvular stenosis

207

1239

1.65

10.39

1.4

1.6

0.86

0.87

g/l

0.06

154

938

Calcific aortic valvular stenosis, operated

207

1239

1.65

10.39

1.4

1.6

0.86

0.87

g/l

0.06

154

938

Unspecified fall

445

3168

1.40

10.38

1.6

0.65

0.80

g/l

2.86

324

2390

Disorders of vitreous body and globe

430

2991

1.41

10.38

1.6

1.5

0.76

0.78

g/l

0.06

333

2245

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.82

10.37

1.5

1.7

1.03

1.01

g/l

0.02

Isolated proteinuria

148

3.06

10.37

1.5

0.67

0.78

g/l

0.34

113

Congenital malformations and deformations of the musculoskeletal system

112

570

1.98

10.37

1.5

1.7

0.68

0.73

g/l

0.20

454

Other abnormalities of plasma proteins

4.70

10.35

2.2

1.7

2.10

0.93

g/l

0.45

Hypertensive Heart Disease

174

826

1.73

10.33

1.4

1.6

0.63

0.94

g/l

2.88

130

610

Diffuse large B-cell lymphoma, helper endpoint

170

2.88

10.28

1.6

1.8

0.55

1.04

g/l

1.92

133

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

170

2.88

10.28

1.6

1.8

0.55

1.04

g/l

1.92

133

Abnormality of white blood cells, not elsewhere classified

5.59

10.27

1.3

2.1

0.33

0.89

g/l

0.90

Unspecified privation

110

561

1.99

10.26

1.7

1.6

0.81

0.79

g/l

0.05

430

Tonsillectomy and adenotomy

624

3270

1.34

10.26

1.5

1.6

0.53

0.72

g/l

8.27

480

2483

Erythema nodosum

133

3.16

10.25

1.8

1.7

0.78

0.79

g/l

0.02

101

Benign paroxysmal vertigo

249

1601

1.57

10.21

1.4

1.5

0.63

0.76

g/l

1.63

176

1201

Benign neoplasm: other/unspecified salivary gland

108

3.42

10.21

2.7

1.7

1.55

1.00

g/l

0.50

Benign neoplasm: other/unspecified salivary gland

108

3.42

10.21

2.7

1.8

1.55

0.86

g/l

0.68

Allergic urticaria

454

2.10

10.21

1.5

1.7

0.85

0.74

g/l

0.28

349

Non-Hodgkin lymphoma, all

128

3.19

10.20

1.3

1.6

0.87

g/l

0.01

Other disorders of conjunctiva

128

688

1.88

10.20

1.5

0.55

0.81

g/l

4.28

519

Demyelinating diseases of the central nervous system

104

522

2.02

10.18

1.5

1.7

0.58

0.72

g/l

0.93

400

Benign neoplasm of other and unspecified endocrine glands

128

689

1.88

10.17

1.5

1.6

0.61

0.78

g/l

1.48

522

Injuries to the thorax

391

2754

1.43

10.17

1.5

1.6

0.73

0.83

g/l

1.01

306

2050

Conduction disorders

231

1206

1.60

10.16

1.5

1.6

0.76

0.87

g/l

0.71

161

912

Calcific aortic valvular stenosis, including rheumatic fever

206

1238

1.64

10.15

1.4

1.6

0.86

0.87

g/l

0.05

153

937

Dental pulpitis 2

697

2715

1.32

10.02

1.6

0.74

0.80

g/l

0.60

515

2055

Other follicular disorders

418

2.14

10.01

1.5

1.7

0.61

0.77

g/l

0.92

321

Diffuse large B-cell lymphoma

173

2.83

9.97

1.6

0.55

0.88

g/l

1.18

133

Amyloidosis

4.24

9.97

1.6

1.9

0.63

0.94

g/l

0.45

Erosion of teeth, including avohilmo

202

1200

1.64

9.96

1.5

1.6

0.71

0.74

g/l

0.14

155

891

Dental caries 3, only avohilmo

854

3417

1.28

9.94

1.6

0.74

0.78

g/l

0.48

632

2606

Disorders of vitreous body

417

2919

1.41

9.94

1.6

1.5

0.76

0.78

g/l

0.06

321

2190

Other/unspecified cytomegaloviral diseases

3.74

9.93

1.3

1.7

0.60

0.83

g/l

0.51

Optic neuritis

243

2.52

9.92

1.6

1.8

0.48

0.77

g/l

2.14

184

Intestinal adhesions without obstruction

329

2.28

9.87

1.9

1.6

0.72

0.86

g/l

0.41

254

Small fibre neuropathy

121

3.23

9.83

1.7

1.6

0.54

0.77

g/l

0.97

Maternal care for other conditions predominantly related to pregnancy

219

1361

1.60

9.83

1.4

1.5

0.50

0.62

g/l

1.76

169

1032

Glucagon-like peptide-1 (GLP-1) analogues

471

2822

1.38

9.83

1.6

1.5

0.81

0.84

g/l

0.21

359

2092

Other and unspecified disorders of vitreous body

348

2404

1.45

9.82

1.6

1.5

0.75

0.76

g/l

0.06

273

1794

CR(E)ST syndrome

4.22

9.81

1.5

1.4

0.36

0.55

g/l

0.97

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

297

1982

1.49

9.72

1.5

1.6

0.65

0.70

g/l

0.40

234

1515

Hodgkin lymphoma

127

3.15

9.71

1.6

1.7

0.72

0.94

g/l

0.51

Disorder of lipoprotein metabolism, unspecified

115

607

1.91

9.70

1.4

1.6

0.78

0.91

g/l

0.54

452

Abscess of lung

4.07

9.70

1.4

1.7

0.54

0.90

g/l

0.88

Neuromuscular dysfunction of bladder

423

2.11

9.68

1.3

1.6

0.80

0.83

g/l

0.10

327

Pneumonitis due to solids and liquids

288

2.35

9.67

1.2

1.6

0.66

0.90

g/l

0.93

225

Golimumab

182

2.76

9.66

1.4

1.8

0.61

0.79

g/l

0.58

142

Benign neoplasm of other and unspecified endocrine glands

128

702

1.84

9.61

1.5

1.6

0.61

0.79

g/l

1.65

528

Benign neoplasm: Pituitary gland, craniopharyngeal duct

253

2.46

9.58

1.5

1.7

0.77

0.90

g/l

0.37

194

Other specified and unspecified disorders of eye and adnexa

177

2.77

9.57

1.9

1.7

0.59

0.79

g/l

0.72

138

Episcleritis

266

2.41

9.52

1.6

1.7

0.76

0.80

g/l

0.13

204

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

108

3.30

9.48

1.5

1.7

0.93

1.00

g/l

0.09

Dental pulpitis 2, only avohilmo

708

2785

1.31

9.48

1.6

0.76

0.80

g/l

0.41

521

2116

Postmenopausal osteoporosis with pathological fracture

195

2.66

9.45

1.4

1.5

0.79

0.73

g/l

0.07

147

Dental caries 1, only avohilmo

795

3174

1.29

9.45

1.6

0.76

0.78

g/l

0.15

585

2411

Generalized anxiety disorder

160

941

1.72

9.44

1.5

1.6

0.62

0.73

g/l

1.18

136

706

Superficial injury of lower leg

234

1512

1.56

9.43

1.4

1.6

0.73

0.74

g/l

0.03

186

1141

Other and unspecified follicular disorders

190

2.69

9.42

1.7

1.8

0.78

0.83

g/l

0.11

143

Abnormalities of gait and mobility

103

530

1.97

9.40

1.5

1.6

0.69

0.88

g/l

1.24

413

Mental and behavioural disorders due to psychoactive substance use

577

4130

1.32

9.39

1.4

1.7

0.70

0.81

g/l

1.90

422

3108

TMD related operations

179

1087

1.66

9.38

1.4

1.6

0.62

0.74

g/l

0.50

110

823

Acute gastritis

311

2.28

9.38

1.6

0.62

0.82

g/l

1.14

232

Procreative management

348

2049

1.44

9.37

1.6

0.67

0.72

g/l

0.40

253

1541

Bronchitis, not specified as acute or chronic

389

2.13

9.34

1.5

1.6

0.95

0.81

g/l

0.24

291

Colonic or urogenital fistula

258

1707

1.52

9.34

1.4

1.6

0.60

0.82

g/l

3.25

189

1285

Other disorders of gingiva or/and edentulous alveolar ridge

214

2.57

9.33

1.4

1.7

0.49

0.89

g/l

3.22

167

Other and unspecified vaccines and biological substances

5.65

9.31

2.0

1.4

0.45

0.44

g/l

0.02

Substance abuse

558

4032

1.33

9.31

1.4

1.7

0.70

0.81

g/l

1.88

411

3027

Unspecific neurodegenerative disorder

1201

0.51

9.29

1.5

1.6

0.67

0.89

g/l

1.24

901

Umbilical hernia

246

1614

1.53

9.26

1.7

1.6

0.75

0.86

g/l

0.77

183

1225

Lupus erythematosus

3.46

9.25

1.4

1.7

0.80

0.85

g/l

0.06

Heart failure and coronary heart disease

225

1068

1.58

9.23

1.4

1.6

0.79

0.91

g/l

0.73

167

804

Other retinal disorders

525

3155

1.34

9.22

1.5

1.6

0.78

0.80

g/l

0.11

375

2375

Artrosis, including avohilmo

849

3686

1.27

9.19

1.5

1.6

0.74

0.76

g/l

0.14

645

2756

Osteonecrosis due to drugs

4.76

9.17

1.3

1.8

0.63

1.00

g/l

0.47

Chorioretinal inflammation

121

3.13

9.16

1.8

1.6

0.54

0.77

g/l

0.84

Other protozoal intestinal diseases

4.12

9.15

2.3

1.5

0.99

0.59

g/l

0.78

Personality disorders

287

1950

1.48

9.14

1.4

1.6

0.70

0.72

g/l

0.08

207

1475

Disorders of choroid and retina

709

4022

1.29

9.13

1.6

0.78

g/l

0.00

518

3026

Benign neoplasm: Pituitary gland, craniopharyngeal duct

259

2.40

9.12

1.5

1.6

0.77

0.85

g/l

0.20

198

Atypical facial pain

241

2.45

9.09

1.7

1.6

0.66

0.78

g/l

0.48

183

Open wound of lower leg

139

795

1.77

9.09

1.5

1.6

0.89

0.84

g/l

0.10

109

607

Chronic periodontitis, complicated

489

1.99

9.06

1.5

1.7

0.58

0.86

g/l

2.59

376

Spondylolisthesis/Spondylolysis

157

930

1.70

9.04

1.6

0.65

0.79

g/l

0.81

115

698

Acute bronchiolitis

353

2.12

9.01

1.6

1.7

0.84

g/l

0.00

294

Disorders of adult personality and behaviour

300

2065

1.46

8.95

1.5

1.6

0.72

0.71

g/l

0.07

219

1571

Other disorders of eyelid

347

2367

1.42

8.94

1.6

1.5

0.80

0.78

g/l

0.06

268

1784

Autoimmune hyperthyroidism

249

2.40

8.92

1.5

1.6

0.70

0.73

g/l

0.10

190

Superficial injury of abdomen, lower back and pelvis

147

861

1.72

8.84

1.4

1.7

0.73

0.78

g/l

0.30

114

656

Nonspecific lymphadenitis

339

2.19

8.84

1.7

1.6

1.02

0.78

g/l

0.65

265

Unspecified/other endometriosis

507

1.95

8.84

1.5

1.6

0.50

0.59

g/l

0.66

379

Hyperhidrosis

3.33

8.79

1.5

1.3

0.64

0.77

g/l

0.34

Neuralgia and neuritis, unspecified

221

2.48

8.75

1.4

1.7

0.58

0.85

g/l

0.74

163

Secondary uncertain malignant neoplasm

107

572

1.89

8.74

1.4

1.6

0.69

0.86

g/l

0.73

440

Other diseases of blood and blood-forming organs

302

2.25

8.72

1.7

1.6

0.78

0.80

g/l

0.05

230

Peripheral artery disease

317

1772

1.45

8.72

1.4

1.6

0.77

0.89

g/l

0.59

245

1322

Dystonia

271

2.33

8.69

1.3

1.7

0.80

g/l

0.02

199

Hypothyroidism, strict autoimmune, 3 medication purchases required

786

4253

1.26

8.67

1.5

0.65

0.73

g/l

1.40

580

3252

Hodgkin lymphoma, hilmo

136

2.94

8.66

1.6

1.5

0.72

0.82

g/l

0.23

101

Injuries to the shoulder and upper arm

782

5219

1.26

8.63

1.5

1.6

0.70

0.79

g/l

1.38

604

3912

Cardiodefibrillation

281

1920

1.47

8.63

1.4

1.6

0.75

0.88

g/l

1.06

199

1444

Abnormal findings in cerebrospinal fluid

8.33

8.59

1.8

1.4

0.71

0.47

g/l

—

Abscess of anal and rectal regions

457

1.99

8.59

1.5

1.7

0.69

0.87

g/l

0.97

342

Type 1 diabetes

256

1720

1.50

8.59

1.7

1.6

0.70

0.80

g/l

0.45

190

1324

Other noninflammatory disorders of vulva and perineum

457

1.99

8.58

1.5

0.59

0.64

g/l

0.22

336

Malignant neoplasm of digestive organs

282

1903

1.47

8.56

1.6

0.95

0.84

g/l

0.51

197

1415

Diseases of peritoneum

492

1.95

8.56

1.5

1.6

0.50

0.82

g/l

2.79

372

Other hearing loss

205

1293

1.57

8.53

1.7

1.6

0.67

0.82

g/l

1.50

141

964

Carpal tunnel syndrome

546

3761

1.32

8.52

1.5

1.6

0.67

0.76

g/l

1.29

411

2838

Other and unspecified myopathies

357

2.13

8.52

1.7

1.8

0.57

0.90

g/l

2.11

270

Intracranial injury

524

3846

1.32

8.52

1.6

0.75

0.80

g/l

0.39

394

2892

Infections with a predominantly sexual mode of transmission

311

2175

1.44

8.50

1.6

0.68

0.69

g/l

0.02

241

1629

Trigger finger

130

745

1.76

8.47

1.5

1.6

0.65

0.78

g/l

0.86

560

Covid-19 suspected case

217

1415

1.55

8.47

1.8

1.6

0.70

0.74

g/l

0.19

188

1072

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

398

2.05

8.43

1.5

1.8

0.78

0.92

g/l

0.43

304

Pure hyperglyceridaemia

3.38

8.41

1.5

1.8

0.69

0.84

g/l

0.29

Kidney transplant status

288

2.26

8.41

1.6

1.8

0.54

0.84

g/l

1.40

228

Post-traumatic stress disorder

433

2.01

8.41

1.4

1.7

0.59

0.75

g/l

1.02

322

Cardiomyopathy (excluding other)

108

587

1.86

8.39

1.6

0.81

0.94

g/l

0.47

451

Preparatory care for dialysis

184

2.60

8.38

1.2

1.7

0.58

0.81

g/l

0.85

144

Adhesive capsulitis of shoulder

150

898

1.68

8.34

1.4

1.6

0.60

0.81

g/l

3.03

120

668

Other and unspecified visual disturbances

476

1.96

8.33

2.0

1.6

0.88

0.76

g/l

0.27

362

Benign neoplasm: Parotid gland

354

2.12

8.32

1.8

1.7

0.82

0.90

g/l

0.24

269

Appendectomy

633

4766

1.28

8.30

1.4

1.6

0.60

0.75

g/l

3.22

467

3604

Cardiomyopathies, Primary/intrinsic

106

575

1.86

8.29

1.6

0.81

0.94

g/l

0.41

445

Otalgia

429

2.01

8.28

1.7

1.6

0.60

0.74

g/l

0.89

337

Excessive attrition of teeth

389

1518

1.40

8.28

1.5

0.70

0.77

g/l

0.60

295

1124

Acute posthaemorrhagic anaemia

118

3.02

8.23

1.6

0.58

0.70

g/l

0.33

Oral leukoplakia and related diseases, including avohilmo

423

2.01

8.23

1.4

1.6

0.60

0.83

g/l

1.39

321

Atherosclerosis, excluding cerebral and coronary sclerosis

289

1595

1.45

8.22

1.4

1.6

0.74

0.89

g/l

0.76

221

1201

Fibroblastic disorders

187

1187

1.59

8.21

1.4

1.6

0.73

0.89

g/l

1.48

143

889

Osteonecrosis

259

2.31

8.21

1.3

1.7

0.52

0.84

g/l

1.67

201

Sequelae of other external causes

247

2.34

8.17

1.4

1.6

0.68

0.85

g/l

0.76

192

Thoracic aortic aneurysm

117

658

1.80

8.16

1.8

1.6

0.77

0.95

g/l

0.67

511

Benign neoplasm of mouth and pharynx

102

550

1.87

8.16

2.0

1.6

0.78

0.84

g/l

0.25

411

Myocardial infarction

404

2122

1.37

8.13

1.5

1.6

0.79

0.89

g/l

0.83

306

1564

Juvenile arthritis (FINNGEN)

254

2.32

8.12

1.6

0.55

0.67

g/l

0.49

196

Acute peritonitis

261

2.29

8.06

1.5

1.7

0.53

0.89

g/l

1.75

202

Erosion of teeth

3.37

8.03

1.3

1.7

0.46

0.68

g/l

0.68

Ulcer of oesophagus

255

2.30

8.03

1.3

1.5

0.68

0.91

g/l

1.30

193

Other and unspecified nerve root and plexus disorders, also in other diseases

179

1132

1.59

8.02

1.4

1.6

0.73

0.75

g/l

0.10

102

870

Endometriosis of pelvic peritoneum

157

949

1.65

8.00

1.5

0.62

g/l

0.02

106

715

Respiratory tuberculosis

194

2.51

8.00

1.7

0.82

0.88

g/l

0.12

149

Respiratory tuberculosis, confirmed and not-confirmed

194

2.51

8.00

1.7

0.82

0.88

g/l

0.12

149

Vascular diseases of the intestine

120

2.96

7.99

1.6

1.7

0.86

0.92

g/l

0.08

Other/unspecified enthesopathies of lower limb, excluding foot

360

2.08

7.98

1.4

1.8

0.68

0.81

g/l

0.60

277

Vitamin deficiency, wide

213

2.43

7.95

1.3

1.7

0.66

0.81

g/l

0.43

158

Vitamin deficiency

213

2.43

7.95

1.3

1.7

0.66

0.81

g/l

0.43

158

Hypersensitivity pneumonitis due to organic dust

3.69

7.93

1.2

1.7

0.64

0.82

g/l

0.35

Other bullous disorders

121

2.96

7.92

1.4

1.6

0.83

0.73

g/l

0.20

Idiopathic gout

368

2.06

7.90

1.4

1.6

0.75

0.88

g/l

0.33

284

Mental and behavioural disorders due to tobacco

444

1.96

7.87

1.3

1.6

0.49

0.79

g/l

2.65

331

Brachial plexus disorders

102

557

1.85

7.87

1.4

1.6

0.47

0.75

g/l

3.61

423

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

369

2.06

7.85

1.5

1.6

0.66

0.79

g/l

0.21

282

Smoking dependency

445

1.96

7.82

1.3

1.6

0.49

0.79

g/l

2.74

332

conjunctival haemorrhage

317

2.14

7.78

1.6

0.57

0.90

g/l

2.88

243

Type 1 diabetes, wide definition, subgroup 1

197

1281

1.55

7.78

1.6

0.67

0.82

g/l

0.54

148

1016

Benign neoplasm: Parotid gland

364

2.06

7.76

1.8

1.6

0.82

0.83

g/l

0.02

276

Infective dermatitis

107

596

1.81

7.73

1.5

1.6

0.70

0.78

g/l

0.43

455

Viral meningitis

198

2.47

7.72

1.5

1.8

0.54

0.78

g/l

1.08

158

Myocardial infarction, without ST-elevation

281

1811

1.44

7.71

1.6

0.74

0.89

g/l

1.41

222

1355

Unspecified misadventure during surgical and medical care

241

2.32

7.71

1.4

1.7

0.98

0.90

g/l

0.19

184

Alzheimer disease, including avohilmo

972

0.50

7.71

1.6

1.5

0.76

0.84

g/l

0.26

730

Thyroiditis, unspecified

3.82

7.70

1.7

2.1

0.88

0.95

g/l

0.08

Other juvenile arthritis

229

2.35

7.68

1.6

1.8

0.49

0.71

g/l

1.16

177

Allergic colitis

129

2.86

7.64

1.3

1.4

0.54

0.68

g/l

0.65

108

Opening and dilatation of root channel of tooth

353

2.07

7.64

1.8

1.7

0.58

0.79

g/l

1.52

273

Ankylosing spondylitis, strict definition

269

2.23

7.56

1.7

1.8

0.64

0.84

g/l

0.57

210

Other/unspecified enthesopathies, not elsewhere classified

409

1.98

7.53

1.8

1.6

0.77

0.82

g/l

0.13

313

Thyrotoxicosis, other and/or unspecified

176

1126

1.57

7.53

1.5

1.6

0.78

0.72

g/l

0.20

129

842

Amiodarone users

430

1.95

7.53

1.2

1.6

0.61

0.91

g/l

3.02

332

Squamous cell neoplasms and carcinomas of the skin

416

1.96

7.51

1.5

1.6

0.78

0.94

g/l

0.49

314

IgA nephropathy (IgA glomerulonephritis)

114

2.97

7.50

1.3

1.8

0.69

0.85

g/l

0.30

Angina pectoris

484

2486

1.32

7.49

1.6

0.73

0.86

g/l

1.72

344

1839

Injuries to the wrist and hand

962

5758

1.21

7.45

1.5

1.6

0.76

0.75

g/l

0.03

728

4341

Malignant neoplasm of breast

234

2453

0.69

7.43

1.3

1.5

0.59

0.63

g/l

0.36

168

1852

Childhood allergy (age < 16)

158

809

1.62

7.42

1.5

1.6

0.72

0.68

g/l

0.20

125

626

Benign neoplasm: Sigmoid colon

142

866

1.65

7.41

1.5

1.6

0.70

0.85

g/l

0.66

107

656

Viral warts

101

561

1.82

7.40

1.7

0.68

0.75

g/l

0.26

425

Supplementary factors related to causes of morbidity and mortality classified elsewhere

283

2001

1.42

7.39

1.6

0.75

0.77

g/l

0.12

210

1514

Anti-inflammatory and antirheumatic products, non-steroids

282

980

1.45

7.37

1.8

1.7

0.83

0.84

g/l

0.06

217

758

Sacrococcygeal disorders, not elsewhere classified

126

2.83

7.37

2.1

1.8

0.68

0.86

g/l

0.44

Benign neoplasm of mouth and pharynx

102

569

1.81

7.36

2.0

1.6

0.78

0.82

g/l

0.15

428

Abnormal involuntary movements

120

703

1.72

7.31

1.5

1.6

0.64

0.79

g/l

1.00

537

Social phobias

492

1.87

7.27

1.7

1.8

0.71

0.80

g/l

0.39

372

Other problems related to primary support group, including family circumstances

130

760

1.68

7.25

1.6

1.7

0.73

0.75

g/l

0.04

106

593

Artificial opening status

229

2.31

7.23

1.5

1.7

0.95

0.86

g/l

0.10

181

Other superficial mycoses

3.13

7.23

1.8

1.6

0.87

0.75

g/l

0.20

Impingement syndrome of shoulder

211

1418

1.50

7.21

1.6

0.60

0.88

g/l

5.25

167

1061

Oral lichen ruber planus, including avohilmo

294

2.14

7.21

1.5

1.7

0.58

0.78

g/l

1.19

222

Persistent mood disorders

179

1163

1.55

7.18

1.4

1.6

0.63

0.77

g/l

1.41

145

861

Other extrapyramidal and movement disorders in other diseases

190

1251

1.53

7.17

1.5

0.64

0.78

g/l

1.35

149

945

Familial hypercholesterolemia

120

707

1.71

7.15

1.8

1.6

0.67

0.85

g/l

1.36

527

Arthropathies in other diseases classified elsewhere

151

2.63

7.15

1.4

1.8

0.63

0.95

g/l

0.79

119

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

4.17

7.15

1.3

1.7

0.78

1.04

g/l

0.20

AV-block

117

619

1.73

7.14

1.4

1.6

0.83

0.93

g/l

0.37

478

Other symptoms and signs involving cognitive functions and awareness

346

2384

1.37

7.13

1.4

1.6

0.76

0.83

g/l

0.49

256

1775

KRA_PSY_EATING, excluding more controls

423

1.93

7.12

1.4

1.7

0.64

0.68

g/l

0.17

323

Cervicocranial syndrome

510

1.84

7.10

1.4

1.7

0.71

0.78

g/l

0.33

388

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

225

2.31

7.09

1.4

1.9

0.63

0.71

g/l

0.20

179

Amyloidosis, other/unspecified

3.95

7.03

1.6

1.8

0.65

0.90

g/l

0.28

Other specified and unspecified retinal disorders

141

2.67

7.01

1.7

0.52

0.89

g/l

1.57

109

Non-allergic asthma

448

1.89

7.01

1.8

1.7

0.66

0.81

g/l

0.81

338

Other abnormal findings of blood chemistry

183

2.44

6.97

2.0

1.7

0.55

0.77

g/l

0.79

140

Ganglion

187

1235

1.52

6.96

1.5

1.6

0.60

0.73

g/l

1.35

143

928

Vasomotor rhinitis (mode)

359

2.00

6.95

2.0

1.6

0.83

0.82

g/l

0.02

271

Visual impairment including blindness (binocular or monocular)

272

2.16

6.93

1.3

1.6

0.57

0.80

g/l

1.29

215

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

158

1007

1.58

6.92

1.6

1.5

0.49

0.63

g/l

1.66

116

753

Other aneurysm

196

2.38

6.90

1.8

1.6

0.83

0.91

g/l

0.14

151

Disorders resulting from impaired renal tubular function

166

2.52

6.89

1.3

1.7

0.65

0.89

g/l

0.53

131

Benign neoplasm of eye and adnexa

465

1.87

6.89

1.6

1.7

0.87

0.85

g/l

0.03

358

Viral encephalitis, not elsewhere classified/unspecified

3.04

6.88

1.3

1.6

0.46

0.82

g/l

1.27

Gonarthrosis,primary

777

3976

1.23

6.88

1.5

1.6

0.75

0.78

g/l

0.26

592

2972

Other disorders of the musculoskeletal system and connective tissue

129

785

1.66

6.85

1.4

1.6

0.67

0.78

g/l

0.94

594

Dental caries 2 and operation codes

749

4845

1.23

6.82

1.6

1.5

0.67

0.74

g/l

1.10

608

3646

Abdominal aortic aneurysm (AAA)

345

2.00

6.77

1.7

1.6

0.83

0.99

g/l

0.45

266

Appendicitis, broad definition

712

5288

1.23

6.76

1.5

1.6

0.70

0.75

g/l

0.29

515

3991

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

208

1284

1.48

6.75

1.5

1.6

0.69

0.72

g/l

0.20

158

1002

Anosmia

3.45

6.73

1.3

1.6

1.11

0.84

g/l

0.35

Hordeolum and other deep inflammation of eyelid

269

2.15

6.73

1.7

1.6

0.59

0.79

g/l

1.15

207

Major coronary heart disease event excluding revascularizations

523

2819

1.28

6.73

1.5

1.6

0.75

0.86

g/l

1.11

394

2082

Specific personality disorders

239

1670

1.44

6.72

1.4

1.6

0.73

0.71

g/l

0.12

177

1269

Extreme obesity with alveolar hypoventilation

174

2.46

6.72

1.3

1.6

0.53

0.89

g/l

1.11

128

Dermatophytosis

114

675

1.70

6.72

1.6

0.67

0.87

g/l

1.35

515

Other disorders of patella

160

1030

1.56

6.72

1.3

1.6

0.68

0.78

g/l

0.81

125

781

Other specified and unspecified disorders of eyelid

3.82

6.70

2.1

1.9

0.62

0.94

g/l

0.56

Stenosis and insufficiency of lacrimal passages

434

1.89

6.69

1.5

1.6

0.62

0.78

g/l

0.78

328

Olecranon bursitis

283

2.11

6.67

1.3

1.7

0.83

0.93

g/l

0.23

219

Calculus of kidney and ureter

249

1755

1.43

6.67

1.6

0.87

0.86

g/l

0.05

186

1328

Thyrotoxicosis

214

1467

1.47

6.66

1.6

0.77

0.69

g/l

0.40

156

1087

Pemphigoid

3.10

6.66

2.0

1.5

0.77

0.76

g/l

0.00

Other localized connective tissue disorders

3.18

6.65

2.2

1.6

0.85

0.79

g/l

0.09

Papilloedema, unspecified

100

2.97

6.64

1.5

2.0

0.59

0.82

g/l

0.42

Diseases of appendix

715

5306

1.23

6.63

1.5

1.6

0.70

0.75

g/l

0.32

518

4004

Tuberculosis of other organs, strict

3.22

6.60

1.7

1.6

0.76

0.75

g/l

0.02

Benign neoplasm of eye and adnexa

472

1.84

6.59

1.6

0.87

0.81

g/l

0.08

356

Amenorrhoea

387

1.93

6.59

1.8

1.6

0.54

0.64

g/l

0.43

289

Other and unspecified diseases of blood and blood-forming organs

106

2.89

6.58

1.7

1.8

0.84

0.87

g/l

0.03

Malignant neoplasm of breast, HER2-negative

231

2412

0.70

6.55

1.3

1.5

0.59

0.64

g/l

0.46

166

1824

Spontaneous rupture of synovium and tendon

346

1.99

6.55

1.7

0.62

0.80

g/l

0.85

262

Visual field defects

381

1.94

6.54

1.7

1.6

0.65

0.84

g/l

0.93

290

Restless leg syndrome

107

628

1.72

6.53

1.6

0.61

0.76

g/l

1.13

465

Tinnitus

207

1416

1.47

6.53

1.7

1.6

0.74

0.80

g/l

0.44

150

1071

Other and unspecified glaucoma

259

2.15

6.52

1.6

0.72

0.90

g/l

0.52

195

Symptoms and signs involving emotional state

147

2.57

6.49

1.5

1.8

0.71

0.83

g/l

0.21

117

Chronic suppurative otitis media, including avohilmo

432

1.87

6.47

1.8

1.7

0.67

0.84

g/l

0.86

334

Inflammation of lacrimal passages (acute and unspecified)

3.37

6.47

2.5

1.7

0.78

0.75

g/l

0.04

Achalasia of cardia

3.47

6.47

1.2

1.3

0.40

0.65

g/l

—

Ventral hernia

196

1329

1.48

6.46

1.5

0.61

0.80

g/l

2.34

152

1000

Other maternal disorders predominantly related to pregnancy

540

2672

1.28

6.46

1.4

1.5

0.57

0.61

g/l

0.72

420

2018

Urolithiasis

263

1883

1.40

6.46

1.6

0.86

g/l

0.01

192

1426

Disturbance of activity and attention

114

674

1.69

6.45

1.6

1.8

0.74

g/l

0.01

525

Tubulo-interstitial nephritis, not specified as acute or chronic

280

2.09

6.45

1.5

1.6

0.55

0.81

g/l

1.46

214

Superficial injury of wrist and hand

197

1339

1.48

6.43

1.7

0.95

0.74

g/l

0.73

153

1029

Later onset COPD

167

854

1.54

6.43

1.3

1.7

0.88

0.93

g/l

0.18

129

636

Problems related to lifestyle

564

1.75

6.42

1.4

1.6

0.77

0.76

g/l

0.03

427

Abnormal blood-pressure reading, without diagnosis

184

2.37

6.42

1.4

1.7

0.47

0.92

g/l

3.70

142

Melanocytic naevi

257

1837

1.41

6.38

1.6

0.62

0.77

g/l

1.47

209

1400

Nail disorders

463

1.84

6.38

1.2

1.7

0.53

0.82

g/l

3.14

358

Hydronephrosis

499

1.80

6.37

2.7

1.7

1.02

0.84

g/l

0.56

388

Unspecified nephritic syndrome

2.95

6.37

2.1

1.7

0.59

0.78

g/l

0.41

Type of accident

255

1822

1.41

6.35

1.6

0.74

0.76

g/l

0.10

190

1385

Fracture of lumbar spine and pelvis

155

1003

1.55

6.34

1.3

1.6

0.87

0.79

g/l

0.23

115

749

Ptosis of eyelid

479

1.81

6.30

1.8

1.6

0.78

0.82

g/l

0.14

361

Scar conditions and fibrosis of skin

192

2.33

6.30

1.2

1.7

0.49

0.86

g/l

2.15

149

Dronedarone medication

103

2.87

6.30

1.2

1.5

0.58

0.89

g/l

0.96

Disorders of refraction and accommodation

253

1802

1.41

6.28

1.3

1.6

0.56

0.73

g/l

3.54

185

1382

Mature T/NK-cell lymphomas, hilmo

3.77

6.26

1.3

1.7

0.78

0.89

g/l

0.07

Oral lichen ruber planus

2.92

6.26

1.8

0.59

0.91

g/l

0.91

Extrapyramidal and movement disorders

288

2105

1.37

6.26

1.6

0.65

0.83

g/l

2.24

216

1573

Peritonsillar abscess

178

1192

1.50

6.25

1.3

1.6

0.58

0.76

g/l

2.60

130

889

Open wound of ankle and foot

569

1.74

6.24

1.4

1.6

0.92

0.80

g/l

0.26

433

Dental caries 2

757

4896

1.22

6.24

1.6

1.5

0.71

0.74

g/l

0.29

617

3688

Dissection of aorta

115

2.74

6.21

1.5

1.6

0.68

0.90

g/l

0.64

Other (not insulin) diabetes medications

889

4466

1.20

6.20

1.6

1.5

0.76

g/l

0.01

664

3366

Acute appendicitis, no complications

535

4251

1.26

6.18

1.4

1.6

0.73

0.76

g/l

0.11

387

3205

Anogenital herpesviral [herpes simplex] infection

354

1.95

6.17

1.5

1.7

0.74

0.71

g/l

0.10

265

Excessive vomiting in pregnancy

468

1.81

6.17

1.4

1.6

0.54

0.64

g/l

0.58

349

Prurigo nodularis

3.01

6.15

1.1

1.6

1.07

0.79

g/l

0.48

Benign neoplasm: Sigmoid colon

142

910

1.57

6.13

1.5

0.70

0.83

g/l

0.54

107

681

Alzheimer disease

819

0.50

6.13

1.5

0.79

0.82

g/l

0.07

613

Drug-induced neutropenia

348

1.95

6.13

1.4

1.7

0.65

0.81

g/l

0.53

262

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

285

2088

1.37

6.12

1.4

1.6

0.65

0.71

g/l

0.54

209

1592

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

492

1.79

6.09

1.6

0.49

0.64

g/l

1.10

372

Lichen planus

106

634

1.69

6.06

1.8

1.5

0.60

0.76

g/l

1.12

473

Tuberculosis of other organs

3.22

6.06

1.8

1.7

0.79

0.80

g/l

0.01

273

1870

1.38

6.03

1.5

0.77

0.83

g/l

0.34

206

1377

Disorders of continuity of bone

523

1.76

6.03

1.4

1.6

0.57

0.73

g/l

0.97

394

Artificial joint operation, meniscal resection

809

4467

1.21

6.00

1.5

1.6

0.76

0.79

g/l

0.27

600

3342

Dementia

124

1351

0.63

6.00

1.4

1.6

0.75

0.89

g/l

0.64

1004

Acute nephritic syndrome

2.91

5.99

2.0

1.5

0.82

0.73

g/l

0.16

Acne

106

636

1.68

5.99

1.5

1.7

0.63

0.73

g/l

0.63

484

Other infective otitis externa

289

2.03

5.97

1.5

1.6

0.71

0.79

g/l

0.22

228

Alcohol abuse, main dg, excluding more controls

135

861

1.58

5.97

1.5

1.7

0.72

0.86

g/l

1.02

100

653

N06DA Anticholinesterases

1007

0.54

5.95

1.5

0.73

0.85

g/l

0.43

753

Use of anticholinesterases

1007

0.54

5.95

1.5

0.73

0.85

g/l

0.43

753

Degenerative diseases of the nervous system

1015

0.56

5.94

1.4

1.6

0.76

0.85

g/l

0.29

767

Other hammer toe(s) (acquired)

126

741

1.60

5.91

1.4

1.6

0.80

0.82

g/l

0.04

554

DVT of lower extremities

150

982

1.54

5.90

1.6

1.5

0.83

g/l

0.01

109

742

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

497

1.77

5.90

1.6

0.49

0.65

g/l

1.28

373

Preparation and fitting of bite rail to mouth

139

896

1.56

5.89

1.4

1.6

0.66

0.77

g/l

0.33

678

Other viral hepatitis

382

1.88

5.86

1.5

1.7

0.68

0.83

g/l

0.68

295

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

212

1959

0.70

5.85

1.2

1.5

0.54

0.65

g/l

1.56

153

1489

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

212

1959

0.70

5.85

1.2

1.5

0.54

0.65

g/l

1.56

153

1489

Carbimazole or st.post thyroidectomy, condition for graves disease

183

1252

1.47

5.83

1.9

1.6

0.84

0.69

g/l

0.74

133

933

Major coronary heart disease event

575

3085

1.25

5.82

1.6

0.78

0.85

g/l

0.63

440

2284

Adult respiratory distress syndrome

3.71

5.82

1.4

1.8

0.60

0.94

g/l

0.47

Viral hepatitis

441

1.81

5.80

1.6

1.7

0.70

0.81

g/l

0.52

343

Spirochaetal infections, other/unspecified

412

1.84

5.80

1.3

1.6

0.56

0.80

g/l

2.09

307

Lesion of lateral popliteal nerve

232

2.14

5.79

1.4

1.7

0.69

0.87

g/l

0.45

181

Hyperfunction of pituitary gland

259

2.07

5.77

1.3

1.7

0.62

0.76

g/l

0.47

195

Myocardial infarction, strict

357

1980

1.32

5.75

1.6

0.81

0.91

g/l

0.66

270

1458

Malignant neoplasm

855

4242

1.20

5.75

1.5

1.6

0.71

0.76

g/l

0.60

635

3216

Other noninflammatory disorders of vagina

377

1.87

5.75

1.3

1.5

0.51

0.64

g/l

0.89

283

Other local infections of skin and subcutaneous tissue

523

1.74

5.75

1.6

0.71

0.83

g/l

0.55

402

Statin medication

719

3315

1.22

5.74

1.6

0.74

g/l

0.04

544

2463

Other renal tubulo-interstitial diseases

103

2.77

5.73

2.2

1.8

0.59

0.78

g/l

0.43

Other keratitis

103

622

1.67

5.71

1.5

1.7

0.47

0.78

g/l

4.24

482

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

354

2703

1.31

5.71

1.6

0.71

0.72

g/l

0.09

284

2041

Other disorders of veins

327

2472

1.33

5.70

1.5

0.71

0.75

g/l

0.30

242

1873

Skin changes due to chronic exposure to nonionizing radiation

249

1707

1.39

5.70

1.5

0.80

0.84

g/l

0.19

186

1256

Poisoning by drugs, medicaments and biological substances

232

1665

1.40

5.69

1.5

1.6

0.67

0.71

g/l

0.27

177

1270

Hemiplegia

227

2.14

5.68

1.5

1.6

0.66

0.84

g/l

0.46

169

Decubitus ulcer and pressure area

188

2.26

5.68

1.7

1.6

0.71

0.91

g/l

0.56

147

Arterial embolism and thrombosis

188

2.26

5.67

1.5

1.6

0.73

0.89

g/l

0.35

146

Hyperkinetic disorders

119

738

1.61

5.64

1.6

1.8

0.76

0.74

g/l

0.06

576

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

261

1913

1.37

5.63

1.4

1.6

0.63

0.81

g/l

1.87

199

1435

Testicular hypofunction

183

2.29

5.63

1.5

1.7

0.62

1.03

g/l

1.57

138

Other sleep disorders

579

1.69

5.63

1.4

1.7

0.63

0.84

g/l

1.50

458

Other disorders of nervous system

317

1.95

5.60

1.3

1.7

0.44

0.86

g/l

3.91

248

Other and unspecified psoriasis

310

1.96

5.60

1.4

1.7

0.82

g/l

0.00

234

Valvular operations

107

656

1.64

5.59

1.6

1.7

0.86

0.97

g/l

0.37

510

Lesion of ulnar nerve

129

828

1.57

5.59

1.6

0.74

0.82

g/l

0.36

103

639

Trigeminal neuralgia

276

2.02

5.58

1.9

1.6

0.67

0.81

g/l

0.57

211

Personal history of other diseases and conditions

110

677

1.63

5.57

1.5

1.6

0.57

0.71

g/l

1.21

535

Other disorders of bladder

543

1.71

5.56

1.4

1.5

0.82

0.90

g/l

0.26

413

Acute appendicitis

657

5107

1.22

5.55

1.5

1.6

0.71

0.75

g/l

0.25

479

3865

Paralytic strabismus

311

1.95

5.55

1.7

0.66

0.89

g/l

1.26

235

Hallux valgus (acquired)

263

1390

1.37

5.54

1.4

1.6

0.71

0.74

g/l

0.14

198

1057

Osteomyelitis

270

2.02

5.53

1.6

1.02

0.88

g/l

0.11

211

Hypertensive Renal Disease

105

2.70

5.52

1.3

1.5

0.83

0.75

g/l

0.11

Seborrhoeic keratosis

164

1111

1.48

5.51

1.6

1.5

0.58

0.78

g/l

2.29

129

828

Other disorders of central nervous system

3.57

5.51

1.6

0.47

0.68

g/l

0.53

Campylobacter enteritis

129

2.53

5.49

1.5

1.7

0.68

0.80

g/l

0.29

100

Other and unspecified local infections of skin and subcutaneous tissue

493

1.74

5.49

1.6

1.7

0.71

0.84

g/l

0.58

380

Chondrocostal junction syndrome [Tietze]

160

2.35

5.45

1.3

1.8

0.71

0.80

g/l

0.20

123

Dementia, including avohilmo

142

1468

0.66

5.43

1.5

1.6

0.76

0.87

g/l

0.49

109

1087

Otitis externa, unspecified

101

616

1.65

5.42

1.3

1.6

0.60

0.75

g/l

1.38

468

Endometriosis of rectovaginal septum and vagina

385

1.84

5.41

1.9

1.5

0.64

0.63

g/l

0.03

282

Haemorrhage, not elsewhere classified

112

2.62

5.41

1.5

0.83

0.87

g/l

0.05

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.85

5.36

2.1

1.9

0.58

0.74

g/l

0.39

Lichen ruber planus, wide definition including periferal and oral lichen planus

174

1200

1.46

5.36

1.8

1.6

0.62

0.75

g/l

1.24

132

891

Dialysis

200

2.18

5.35

1.3

1.8

0.42

0.85

g/l

2.61

155

Actinic keratosis

237

1636

1.38

5.35

1.5

0.80

0.85

g/l

0.20

177

1198

Cramp and spasm

240

2.07

5.34

1.7

0.81

0.86

g/l

0.11

186

Malignant neoplasm of breast, HER-positive

142

2078

0.67

5.33

1.3

1.5

0.61

0.63

g/l

0.09

1564

Epilepsy

254

1866

1.36

5.32

1.5

1.7

0.71

0.83

g/l

0.84

197

1432

Vulvovaginal ulceration/inflammation in other diseases

302

1.94

5.32

1.6

0.68

0.65

g/l

0.10

230

Propionic acid derivatives

267

979

1.38

5.31

1.6

1.7

0.80

0.84

g/l

0.22

205

757

Chronic periodontitis, including avohilmo

811

5050

1.19

5.31

1.5

1.6

0.67

0.78

g/l

2.35

621

3778

Benign neoplasm of meninges

461

1.75

5.30

1.6

0.71

0.81

g/l

0.38

349

Chronic suppurative otitis media

338

1.88

5.28

1.9

1.7

0.71

0.79

g/l

0.23

263

Oligomenorrhoea

169

2.28

5.26

1.8

1.6

0.54

0.60

g/l

0.19

127

Deficiency of other B group vitamins

3.10

5.25

1.4

1.6

0.77

0.83

g/l

0.06

Contusion of toe(s) without damage to nail

114

2.59

5.25

1.1

1.6

0.45

0.68

g/l

0.83

Other female pelvic inflammatory diseases

142

945

1.51

5.24

1.3

1.5

0.67

0.64

g/l

0.08

100

703

Respiratory tuberculosis, not confirmed

138

2.42

5.23

1.9

1.7

0.79

0.92

g/l

0.19

105

Right bundle-branch block

120

2.53

5.23

1.3

1.8

0.81

0.84

g/l

0.05

Acute epiglottitis

3.41

5.20

1.9

2.3

0.75

1.04

g/l

0.39

Dementia in Alzheimer disease

478

0.37

5.19

1.1

1.5

0.88

0.85

g/l

0.03

356

Cerebrovascular diseases

597

3504

1.22

5.19

1.6

0.85

0.79

g/l

0.48

469

2592

Hidradenitis suppurativa

203

2.15

5.17

1.2

1.7

0.38

0.80

g/l

3.02

152

Chronic Coagulation defects

121

2.53

5.17

1.7

1.8

0.46

0.80

g/l

1.35

Autonomic disorders

2.77

5.14

1.4

1.9

0.64

0.87

g/l

0.43

Strabismus

244

1795

1.36

5.14

1.6

1.5

0.63

0.74

g/l

1.42

182

1368

Disorder of the sleep-wake schedule

2.72

5.13

1.3

1.7

0.60

0.86

g/l

0.70

Conductive and sensorineural hearing loss

665

3816

1.21

5.13

1.6

1.5

0.74

0.78

g/l

0.29

484

2879

Mixed and other personality disorders

511

1.70

5.13

1.5

1.7

0.80

0.78

g/l

0.04

399

Disorders of iron metabolism

3.16

5.12

1.5

1.9

0.60

0.80

g/l

0.33

Dislocation, sprain and strain of joints and ligaments of knee

574

4373

1.22

5.12

1.5

1.6

0.67

0.76

g/l

1.51

434

3278

Heterophoria

459

1.74

5.11

1.7

0.75

0.78

g/l

0.08

345

Sleep disorders, other/unspecified

178

2.23

5.10

1.4

1.8

0.77

g/l

0.01

133

Spondylopathies in diseases classified elsewhere

3.66

5.09

1.3

1.9

0.63

1.07

g/l

—

Complications following infusion, transfusion and therapeutic injection

3.25

5.09

1.5

1.4

1.42

0.75

g/l

0.28

Abrasion of teeth

242

1303

1.37

5.08

1.5

1.6

0.57

0.75

g/l

2.67

178

955

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

110

2.59

5.08

1.5

1.7

0.92

1.01

g/l

0.10

Malignant neoplasm of liver and intrahepatic bile ducts

110

2.58

5.07

1.7

1.6

0.76

0.90

g/l

0.16

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

416

1.77

5.06

1.7

1.6

0.44

0.65

g/l

2.23

314

Other otitis externa (chronic)

322

1.88

5.05

1.2

1.6

0.47

0.74

g/l

1.97

254

Benign neoplasm: Cerebral meninges

409

1.78

5.03

1.7

0.71

0.83

g/l

0.48

308

Other specified/unspecified hearing loss

358

1.83

5.03

1.5

0.67

0.84

g/l

0.90

277

Any dementia

101

1123

0.63

4.98

1.4

1.6

0.81

0.85

g/l

0.09

846

Use of pramipexole

169

1177

1.44

4.97

1.6

0.62

0.77

g/l

1.58

127

882

Parodontitis

809

5049

1.18

4.97

1.5

1.6

0.67

0.78

g/l

2.37

622

3775

Other bacterial agents as the cause of diseases classified to other chapters

3.60

4.95

1.3

1.9

0.46

0.88

g/l

0.89

Iron deficiency

2.71

4.95

1.3

1.7

0.43

0.75

g/l

1.03

Parodontitis or operation codes

809

5050

1.18

4.92

1.5

1.6

0.67

0.78

g/l

2.36

622

3776

Melanocytic naevi

257

1923

1.34

4.92

1.6

1.5

0.62

0.74

g/l

1.12

209

1456

Sequelae of injuries, of poisoning and of other consequences of external causes

213

1548

1.38

4.92

1.5

1.6

0.67

0.77

g/l

0.77

151

1179

Other/unspecified synovitis and tenosynovitis

594

1.63

4.90

1.5

1.6

0.47

0.80

g/l

4.64

454

Scoliosis

420

1.75

4.89

1.3

1.7

0.60

0.81

g/l

1.04

315

Unstable angina pectoris

267

1660

1.34

4.89

1.5

1.6

0.68

0.90

g/l

3.56

209

1236

Suicide or other Intentional self-harm

230

1694

1.36

4.89

1.5

1.6

0.65

0.73

g/l

0.75

171

1291

Intrahepatic Cholestasis of Pregnancy (ICP)

421

1.75

4.87

1.7

1.6

0.44

0.63

g/l

1.94

321

Striking against or struck by other objects

301

2307

1.31

4.85

1.5

1.6

0.79

0.81

g/l

0.08

215

1753

Monoamine oxidase A inhibitors

106

674

1.58

4.84

1.4

1.6

0.72

0.83

g/l

0.53

505

Lung transplant status

3.57

4.83

1.3

1.8

0.41

0.94

g/l

0.93

Lung transplantation

3.57

4.83

1.3

1.8

0.41

0.94

g/l

0.93

Superficial injury of hip and thigh

104

658

1.59

4.83

1.4

1.6

0.97

0.79

g/l

0.34

496

Other benign neoplasms of skin

283

2111

1.32

4.83

1.7

1.6

0.70

0.79

g/l

0.58

213

1581

Acute nasopharyngitis (common cold)

109

694

1.57

4.82

1.6

1.7

0.76

0.87

g/l

0.30

518

Benign lipomatous neoplasm of other sites/unspecified

378

1.79

4.80

1.4

1.6

0.63

0.89

g/l

1.01

290

Poisoning by medicine

206

1496

1.38

4.79

1.5

1.6

0.63

0.72

g/l

0.77

154

1132

Inflammatory disease of uterus

129

859

1.51

4.79

1.4

1.5

0.54

0.64

g/l

0.90

644

Acne vulgaris

483

1.69

4.79

1.4

1.8

0.63

0.70

g/l

0.31

369

Congenital malformations of the urinary system

321

1.86

4.78

1.4

1.8

0.62

0.83

g/l

0.99

252

Benign neoplasm of meninges

476

1.70

4.77

1.6

0.71

0.78

g/l

0.25

356

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

313

2120

1.30

4.76

1.4

1.6

0.88

0.84

g/l

0.18

225

1598

Other symptoms and signs involving general sensations and perceptions

151

2.28

4.75

1.2

1.9

0.52

0.87

g/l

1.74

114

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

164

2.23

4.74

2.4

1.7

0.80

0.95

g/l

0.36

128

Injuries to the neck

204

1482

1.38

4.74

1.5

1.6

0.61

0.75

g/l

2.16

165

1124

Female infertility

264

1219

1.34

4.74

1.5

0.53

0.63

g/l

1.38

204

919

Atrophic disorders of skin

120

789

1.53

4.73

1.5

1.6

0.56

0.72

g/l

1.65

100

593

Eustachian salpingitis and obstruction

523

1.66

4.73

1.9

1.7

0.76

g/l

0.00

397

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

432

1.73

4.73

1.9

1.6

0.80

0.76

g/l

0.09

327

Impetigo

238

2.00

4.72

1.7

1.6

0.85

0.74

g/l

0.21

184

Mental and behavioural disorders due to alcohol

445

3495

1.24

4.70

1.4

1.7

0.73

0.83

g/l

1.42

322

2613

Other peripheral vertigo

433

1.72

4.69

1.7

0.59

0.83

g/l

2.00

328

Localized scleroderma [morphea]

3.18

4.68

2.3

1.3

0.94

0.56

g/l

—

Bell's palsy

101

641

1.59

4.67

1.5

1.6

0.63

0.76

g/l

0.74

487

Dislocation, sprain and strain of joints and ligaments at neck level

142

970

1.47

4.66

1.5

1.6

0.59

0.74

g/l

1.86

115

725

Other contact dermatitis

419

1.73

4.66

1.5

1.6

0.67

0.77

g/l

0.41

321

Chronic mastoiditis

109

2.52

4.66

2.1

1.6

0.72

0.79

g/l

0.12

Hypertrophic cardiomyopathy

179

2.15

4.62

1.5

1.8

0.58

0.89

g/l

1.26

139

Gluteal tendinitis

153

2.25

4.62

1.5

1.9

0.50

0.87

g/l

1.67

113

Other disorders of glucose regulation and pancreatic internal secretion

428

1.72

4.60

2.2

1.6

1.09

0.80

g/l

0.64

326

MS-disease / Multiple Sclerosis

436

1.71

4.60

1.5

1.7

0.53

0.72

g/l

1.07

336

Superficial injury of ankle and foot

113

739

1.54

4.59

1.5

1.6

0.75

0.77

g/l

0.04

563

Allergic contact dermatitis

120

795

1.52

4.58

1.4

1.6

0.68

0.72

g/l

0.08

603

Use of memantine

743

0.53

4.58

1.7

1.5

0.77

0.84

g/l

0.15

551

Use of other anti-dementia drugs

743

0.53

4.58

1.7

1.5

0.77

0.84

g/l

0.15

551

Chondropathies

144

992

1.46

4.54

1.5

1.6

0.72

0.76

g/l

0.24

105

749

Other shoulder lesions

483

1.67

4.53

1.5

1.7

0.60

0.81

g/l

1.46

367

Schizophrenia

1104

0.59

4.53

1.3

1.7

0.49

0.78

g/l

1.90

840

Psychotic depression

305

1.85

4.53

1.2

1.8

0.46

0.89

g/l

4.87

231

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.23

4.53

1.8

1.7

0.42

1.00

g/l

—

Other and unspecified aplastic anaemias

3.36

4.52

1.3

1.4

0.54

0.58

g/l

—

Sensorineural hearing loss

613

3577

1.20

4.51

1.6

1.5

0.71

0.79

g/l

0.76

441

2689

Presbycusis

458

1.68

4.51

1.8

1.5

0.55

0.88

g/l

2.68

341

Normotensive glaucoma

313

1.84

4.49

1.4

1.6

0.67

0.88

g/l

0.95

238

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

113

743

1.53

4.48

1.4

1.6

0.92

0.85

g/l

0.14

562

Sub-endpoint used in defining T1D endpoints

258

1929

1.32

4.45

1.7

1.6

0.68

0.81

g/l

0.56

194

1483

Other and unspecified injuries of lower leg

410

1.72

4.45

1.6

0.66

0.80

g/l

0.45

306

Use of glatiramer acetate

2.67

4.44

1.4

1.7

0.70

0.62

g/l

0.12

Pain associated with micturition

595

1.59

4.42

1.5

0.63

0.78

g/l

1.15

448

Testicular dysfunction

217

2.01

4.40

1.5

1.7

0.59

1.00

g/l

1.78

164

Brain meningioma, excluding all cancers (controls excluding all cancers)

224

1.99

4.37

1.4

1.8

0.44

0.90

g/l

4.08

170

Other abnormal uterine and vaginal bleeding

186

956

1.39

4.36

1.4

1.5

0.58

0.65

g/l

0.55

135

696

Other and unspecified mood [affective] disorders

398

1.72

4.34

1.2

1.8

0.65

0.78

g/l

0.60

300

Disorders of eyelid in diseases classified elsewhere

138

2.28

4.34

1.6

1.5

1.35

0.80

g/l

0.32

109

Myeloid leukaemia

2.57

4.32

2.2

1.7

0.87

0.98

g/l

0.12

Perforation of tympanic membrane

498

1.64

4.30

1.7

1.11

0.78

g/l

0.49

388

Female infertility, cervigal, vaginal, other or unspecified origin

237

1191

1.34

4.25

1.5

0.51

0.63

g/l

1.70

185

898

Other and unspecified nail disorders

2.61

4.25

1.1

1.9

0.47

0.94

g/l

1.32

Other misadventures during surgical and medical care

2.61

4.25

1.5

1.9

0.70

0.86

g/l

0.31

Flat foot [pes planus] (acquired)

446

1.67

4.24

1.2

1.6

0.65

0.79

g/l

0.54

341

Correction of physiology of bite - very demanding therapy visit

146

2.23

4.24

1.3

1.7

0.46

0.75

g/l

1.52

111

Adenomyosis (Endometriosis of uterus)

108

713

1.52

4.23

1.3

1.5

0.71

0.67

g/l

0.17

524

Residual foreign body in soft tissue

241

1.93

4.22

1.4

1.8

0.59

0.88

g/l

1.50

181

Agoraphobia

166

2.14

4.21

1.5

2.0

0.65

0.84

g/l

0.68

121

Other and unspecified erythematous conditions

140

2.25

4.21

1.6

1.7

0.64

0.85

g/l

0.70

114

Fracture of foot, except ankle

213

1591

1.35

4.20

1.6

1.5

0.84

0.74

g/l

0.33

167

1197

Use of donepezil

630

0.49

4.18

1.9

1.5

0.80

0.87

g/l

0.15

469

Vitamin D deficiency

2.58

4.17

1.2

1.4

0.49

0.57

g/l

0.22

Degeneration of macula and posterior pole

302

1946

1.28

4.17

1.5

0.78

0.83

g/l

0.26

214

1454

Other diseases of spinal cord

128

2.30

4.15

1.3

1.8

0.55

0.85

g/l

1.05

103

Respiratory tuberculosis, confirmed

2.84

4.15

1.3

1.7

0.77

0.84

g/l

0.10

Convalescence

264

1.88

4.14

1.5

1.6

0.67

0.80

g/l

0.52

198

Melanocytic naevi of lower limb, including hip

208

2.00

4.14

1.8

1.7

0.63

0.89

g/l

0.77

154

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

174

2.10

4.13

2.4

1.6

0.80

0.83

g/l

0.06

131

Any dementia, excluding more controls

1042

0.66

4.13

1.4

1.6

0.82

0.88

g/l

0.16

773

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

389

1.71

4.13

2.0

1.7

0.79

g/l

0.00

293

Medicines for HER+ breast cancer

163

2187

0.72

4.11

1.3

1.5

0.58

0.64

g/l

0.43

115

1653

Benign neoplasm: Cerebral meninges

435

1.67

4.11

1.7

1.6

0.71

0.77

g/l

0.21

328

Type 1 diabetes, wide definition

204

1518

1.35

4.10

1.6

0.66

0.79

g/l

0.47

153

1180

Medical abortion

558

2522

1.21

4.10

1.4

1.5

0.61

g/l

0.01

421

1897

Haemorrhage in early pregnancy

246

1837

1.31

4.09

1.4

1.5

0.52

0.61

g/l

1.53

190

1386

Mental and behavioural disorders due to sedatives or hypnotics

398

1.70

4.09

1.3

1.7

0.61

0.84

g/l

1.18

309

Postmenopausal bleeding

211

857

1.36

4.07

1.3

1.5

0.58

0.68

g/l

1.01

163

625

Malignant neoplasm of prostate

162

1416

0.72

4.07

1.5

1.7

1.04

0.98

g/l

0.15

122

1066

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

142

1623

0.71

4.06

1.3

1.5

0.61

0.67

g/l

0.35

1227

Heart failure and hypertrophic cardiomyopathy

2.81

4.05

1.3

1.5

0.67

0.92

g/l

0.38

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

339

1.76

4.05

2.0

1.7

0.83

0.79

g/l

0.09

252

Disorders of tooth development and eruption

294

1.81

4.04

1.8

0.52

0.86

g/l

1.97

237

Other congenital malformations of skin

218

1.95

3.99

1.4

1.7

0.67

0.78

g/l

0.28

168

Parodontitis and operation codes

752

5024

1.17

3.98

1.5

1.6

0.67

0.78

g/l

2.14

572

3766

Benign lipomatous neoplasm of other sites/unspecified

401

1.68

3.97

1.4

1.7

0.63

0.84

g/l

0.75

308

Stroke, excluding SAH

444

2705

1.22

3.97

1.5

1.6

0.90

0.82

g/l

0.48

346

2000

Artificial joint re-operation

268

1.85

3.96

1.3

1.7

1.01

0.87

g/l

0.38

207

Hypertrophic disorders of skin

312

1.78

3.95

1.5

1.7

0.59

0.79

g/l

0.94

240

Diseases of male genital organs

491

2045

1.22

3.95

1.6

1.8

0.85

0.94

g/l

0.85

361

1545

Lateral epicondylitis

112

757

1.49

3.95

1.5

1.6

0.62

0.76

g/l

0.99

569

Other erythematous conditions

164

2.10

3.94

1.6

1.7

0.65

0.83

g/l

0.63

128

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

219

1.94

3.94

1.9

1.6

0.53

0.82

g/l

1.57

175

Thyrotoxicosis with diffuse goitre

116

790

1.48

3.94

1.6

0.86

0.70

g/l

0.49

603

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

7.77

3.94

2.3

1.3

0.39

0.51

g/l

—

Deep endometriosis

526

1.59

3.93

1.8

1.6

0.61

0.60

g/l

0.01

396

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

380

1.70

3.92

1.3

1.7

0.62

0.77

g/l

0.67

290

Certolizumab pegol

2.61

3.92

1.6

1.7

0.64

0.67

g/l

0.05

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

192

2.01

3.90

1.4

1.8

0.65

0.74

g/l

0.20

144

Achilles tendinitis

535

1.58

3.89

1.9

1.6

0.58

0.86

g/l

1.94

411

Cyst of kidney

277

1.82

3.89

1.5

1.6

0.89

0.87

g/l

0.02

209

Lichen planus, including avohilmo

143

1016

1.42

3.88

1.9

1.6

0.62

0.76

g/l

1.17

110

751

Papillary adenocarcinoma of thyroid gland

256

1.86

3.87

2.1

1.6

0.81

0.77

g/l

0.08

195

Other acquired deformities of musculoskeletal system and connective tissue

242

1.88

3.85

1.9

1.7

0.65

0.84

g/l

0.86

182

Benign neoplasm: Skin, unspecified

186

2.01

3.85

1.2

1.6

0.51

0.86

g/l

1.84

140

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.72

3.85

1.3

1.6

0.77

0.83

g/l

0.09

Other endocrine disorders

324

1.74

3.85

1.4

1.7

0.76

0.83

g/l

0.16

267

Myeloid leukaemia

101

2.41

3.84

2.2

1.6

0.87

0.77

g/l

0.12

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

121

836

1.46

3.82

1.3

1.6

0.90

0.84

g/l

0.17

633

Benign lipomatous neoplasm

226

1729

1.31

3.81

1.3

1.6

0.58

0.80

g/l

3.30

156

1306

malignant neoplasm of male genital organs

172

1481

0.74

3.81

1.6

1.7

1.02

0.97

g/l

0.12

133

1118

All dysplastic lesions of the vagina

114

2.32

3.81

1.4

1.6

0.52

0.76

g/l

0.60

Transport accidents

407

2955

1.22

3.80

1.6

0.73

0.77

g/l

0.23

312

2235

Peripheral artery operations in Hilmo

491

1.60

3.79

1.4

1.6

1.30

0.92

g/l

0.48

378

Other specified/unspecified dorsopathies

140

2.17

3.78

1.6

1.9

0.62

0.90

g/l

0.81

105

Alzheimer’s disease, wide definition

671

0.56

3.77

1.4

1.5

0.65

0.86

g/l

0.86

500

Other dialysis

147

2.14

3.77

1.2

1.8

0.50

0.87

g/l

1.39

113

Fall on and from stairs and steps

202

1524

1.33

3.77

1.6

0.88

0.76

g/l

0.44

150

1157

Other menopausal disorders

227

992

1.32

3.77

1.7

1.5

0.66

0.65

g/l

0.03

170

735

Other disorders starting during childhood or adolecense, excluding more controls

284

1.78

3.76

1.4

1.7

0.57

0.81

g/l

1.32

233

Alzheimer disease, excluding more controls

485

0.53

3.75

1.7

1.5

0.93

0.90

g/l

0.05

341

Meralgia paraesthetica

154

2.11

3.75

1.4

1.7

0.94

0.85

g/l

0.15

117

Somnolence, stupor and coma

181

2.01

3.74

1.4

1.8

0.42

0.90

g/l

2.91

138

Injury of muscle and tendon at forearm level

2.55

3.74

1.5

1.8

0.78

0.91

g/l

0.16

Glaucoma

406

2924

1.22

3.73

1.5

1.6

0.62

0.82

g/l

3.83

283

2216

Torsion of ovary, ovarian pedicle and fallopian tube

109

2.33

3.71

1.1

1.7

0.37

0.66

g/l

1.37

Mixed conductive and sensorineural hearing loss

582

1.54

3.69

1.5

1.6

0.73

0.85

g/l

0.59

441

Other other unspecified disorders of the circulatory system

155

2.09

3.69

1.9

1.6

0.67

0.86

g/l

0.50

120

Disorders of male genital organs in diseases classified elsewhere

3.80

3.68

1.1

1.3

0.56

0.86

g/l

—

Endometriosis ASRM stages 1,2

159

1162

1.38

3.67

1.5

0.62

0.61

g/l

0.02

106

871

Dermatitis herpetiformis

2.52

3.66

1.6

1.7

0.92

0.80

g/l

0.22

Kyphosis

2.92

3.66

1.3

1.5

0.69

0.72

g/l

0.06

Melanocytic naevi of lower limb, including hip

218

1.90

3.65

1.8

1.6

0.63

0.78

g/l

0.38

163

Other eating disorders

283

1.78

3.65

1.5

1.7

0.74

0.65

g/l

0.32

210

Benign neoplasm: Skin of eyelid, including canthus

111

762

1.46

3.65

1.8

1.6

0.83

0.77

g/l

0.20

578

Benign neoplasm: Skin, unspecified

190

1.97

3.65

1.2

1.6

0.51

0.87

g/l

1.93

141

Congenital malformations of ovaries, fallopian tubes and broad ligaments

313

1.74

3.64

1.4

1.6

0.41

0.63

g/l

2.21

239

Benign neoplasm: Adrenal gland

343

1.71

3.63

1.4

1.7

0.49

0.93

g/l

4.72

264

Benign neoplasm: Rectosigmoid junction

156

2.08

3.63

1.3

1.8

0.85

1.01

g/l

0.38

122

L02BG Aromatase inhibitors

123

1732

0.71

3.62

1.3

1.5

0.60

0.64

g/l

0.24

1301

Exposure to other and unspecified inanimate mechanical forces

397

1.65

3.61

1.8

1.7

0.62

0.86

g/l

1.66

307

Left ventricular outflow tract obstruction (LVOTO), broad definition

634

1.51

3.61

1.7

1.6

0.89

0.83

g/l

0.18

495

Perioral dermatitis

2.39

3.60

1.6

0.55

0.71

g/l

0.39

Benign neoplasm of middle ear and respiratory system

359

1.68

3.60

2.0

1.6

0.93

0.89

g/l

0.06

270

Varicella [chickenpox]

292

1.77

3.60

1.3

1.6

1.01

0.86

g/l

0.18

228

Plantar fascial fibromatosis

483

1.58

3.59

1.5

1.6

0.70

0.78

g/l

0.29

364

Background retinopathy and retinal vascular changes

2.48

3.58

1.8

1.9

0.54

0.88

g/l

0.64

Benign neoplasm: Adrenal gland

345

1.70

3.56

1.4

1.7

0.49

0.86

g/l

3.75

262

Retinal vascular occlusion

461

1.59

3.54

1.5

1.6

0.72

0.86

g/l

0.38

345

Amputation

368

1.67

3.54

1.4

1.6

1.38

0.88

g/l

0.52

280

Myeloproliferative diseases

361

1.67

3.53

1.7

1.6

0.75

0.84

g/l

0.26

273

Brain meningioma

228

1.86

3.52

1.4

1.7

0.44

0.79

g/l

2.81

170

Other/unspecified disorders of vestibular function

158

2.05

3.52

1.1

1.8

0.60

0.88

g/l

0.99

122

Neovascular glaucoma

158

2.05

3.51

1.5

0.37

0.74

g/l

2.44

119

Fall on same level involving ice and snow

474

3978

1.19

3.51

1.6

0.74

0.75

g/l

0.09

365

3001

Other condition

120

843

1.43

3.51

1.6

0.73

0.81

g/l

0.42

641

Contusion of other and unspecified parts of foot

272

1.78

3.51

1.6

0.99

0.77

g/l

0.32

204

Salpingitis and oophoritis

151

1104

1.38

3.50

1.5

0.65

g/l

0.03

117

822

Other disorders of Eustachian tube

125

2.19

3.50

1.4

1.6

0.74

0.66

g/l

0.17

Suppurative otitis media, unspecified

112

2.26

3.50

1.5

1.9

0.68

0.74

g/l

0.10

Embedded teeth, including avohilmo

542

1.54

3.49

1.7

0.73

0.70

g/l

0.12

410

Lichen simplex chronicus

145

2.09

3.49

1.3

1.7

0.66

0.87

g/l

0.61

111

Benign neoplasm: Rectosigmoid junction

159

2.04

3.46

1.3

1.7

0.85

0.90

g/l

0.11

126

Follicular lymphoma

173

1.99

3.45

1.8

0.45

1.03

g/l

2.08

136

Diabetic neuropathy

589

1.51

3.44

1.6

0.65

0.83

g/l

1.21

429

Degenerative macular diseases

465

1.58

3.42

1.5

0.73

0.86

g/l

0.34

344

Palmar fascial fibromatosis [Dupuytren]

101

690

1.47

3.42

1.3

1.7

0.77

0.98

g/l

1.17

523

Biomechanical lesions, not elsewhere classified

216

1.87

3.42

1.2

1.7

0.65

0.87

g/l

0.81

164

Alcohol abuse, main dg

135

974

1.39

3.40

1.5

1.7

0.72

0.80

g/l

0.54

100

736

Familial hypercholesterolemia, with ischemic heart disease

365

1.65

3.40

1.8

1.6

0.83

1.01

g/l

0.61

277

Other specified and unspecified personality disorders

554

1.53

3.39

1.4

1.7

0.75

0.78

g/l

0.12

425

Use of antiglaucoma preparations and miotics

282

1.75

3.39

1.4

1.5

0.52

0.87

g/l

2.46

212

Malignant neoplasm of thyroid gland

335

1.69

3.39

1.9

1.6

0.79

0.73

g/l

0.12

257

Malignant neoplasm of endocrine gland

366

1.65

3.37

1.9

1.6

0.77

0.75

g/l

0.05

279

Benign neoplasm of middle ear and respiratory system

366

1.65

3.37

2.0

1.7

0.93

0.95

g/l

0.04

285

Other symptoms and signs involving the urinary system

483

1.56

3.37

1.6

0.56

0.83

g/l

2.70

363

Retinal vascular disorders

467

1.57

3.37

1.5

1.6

0.72

0.85

g/l

0.36

349

Cholesteatoma of middle ear

210

1.87

3.36

2.0

1.5

0.49

0.81

g/l

1.50

162

Hyperprolactinaemia

175

1.97

3.35

1.3

1.7

0.67

0.76

g/l

0.21

131

Ischaemic Stroke, excluding all haemorrhages

404

2530

1.21

3.34

1.5

1.6

0.92

0.83

g/l

0.52

310

1871

Localized skin eruption due to drugs and medicaments

2.99

3.33

2.1

2.0

0.41

0.92

g/l

—

Discitis, unspecified

2.67

3.33

1.4

1.8

0.89

g/l

0.01

Oral leukoplakia and related diseases

240

1.81

3.32

1.6

1.7

0.54

0.87

g/l

2.13

183

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

407

1.61

3.30

1.3

1.7

0.59

0.84

g/l

1.87

313

Stroke, including SAH

472

2939

1.19

3.30

1.6

0.88

0.82

g/l

0.41

371

2175

Single spontaneous delivery

225

1535

0.78

3.30

1.6

1.5

0.70

0.62

g/l

0.49

155

1178

Bacterial, viral and other infectious agents

542

1.52

3.29

1.4

1.6

0.65

0.81

g/l

0.92

415

Ménière disease

470

1.56

3.29

1.8

1.6

0.69

0.81

g/l

0.62

350

Urethritis and urethral syndrome

2.33

3.29

1.4

1.6

0.46

0.82

g/l

1.54

Transient ischemic attack

373

2550

1.22

3.28

1.5

1.6

0.70

0.81

g/l

1.56

281

1895

Glaucoma-related operations

212

1.86

3.27

1.7

1.6

0.79

0.89

g/l

0.20

162

Pustulosis palmaris et plantaris

205

1.87

3.27

1.2

1.6

0.54

0.79

g/l

1.20

155

Other predominantly sexually transmitted diseases, not elsewhere classified

158

1178

1.35

3.26

1.6

0.66

0.71

g/l

0.25

122

892

Biguanides

839

4541

1.14

3.26

1.6

0.75

0.77

g/l

0.18

639

3411

Cysts of oral region, not elsewhere classified

191

1.90

3.25

2.0

1.7

0.86

0.93

g/l

0.13

149

Coxarthrosis, primary

425

3085

1.20

3.25

1.4

1.6

0.70

0.82

g/l

1.65

338

2299

Radial styloid tenosynovitis [de Quervain]

264

1.76

3.24

1.6

1.7

0.34

0.80

g/l

5.86

199

Emotionally unstable personality disorder

114

807

1.42

3.23

1.5

1.7

0.73

0.72

g/l

0.02

615

Dermatitis due to ingested food

219

1.82

3.23

1.6

1.7

1.42

0.77

g/l

1.01

184

Impacted cerumen

425

1.59

3.23

1.2

1.6

0.67

0.85

g/l

0.94

328

Superficial injury of head

175

1326

1.32

3.23

1.6

0.71

0.75

g/l

0.13

141

1001

Follicular cysts of skin and subcutaneous tissue

150

1112

1.36

3.22

1.6

0.60

0.78

g/l

2.27

114

847

Fracture of shoulder and upper arm

276

2215

1.25

3.22

1.5

1.6

0.68

0.80

g/l

1.27

217

1659

Alcohol use disorder, ICD-based

346

2847

1.22

3.21

1.4

1.6

0.73

0.86

g/l

1.39

247

2133

Eating disorders

642

1.47

3.21

1.4

1.6

0.59

0.66

g/l

0.46

484

Dental caries 2, only avohilmo

707

4859

1.15

3.20

1.6

0.71

0.74

g/l

0.25

573

3664

Speech and linguistic disorders, excluding more controls

438

1.56

3.19

1.3

1.9

0.59

0.86

g/l

2.40

346

Primary open-angle glaucoma, strict

159

1188

1.34

3.19

1.5

1.6

0.66

0.83

g/l

1.39

105

883

Injuries to the hip and thigh

335

2514

1.22

3.18

1.4

1.6

0.83

0.79

g/l

0.14

258

1878

Eating disorder

538

1.51

3.17

1.4

1.6

0.64

0.65

g/l

0.02

410

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

451

1.57

3.17

1.3

1.8

0.64

0.80

g/l

0.77

346

Desensitization to allergens

342

1.65

3.16

1.5

1.8

0.59

0.71

g/l

0.60

258

Obsessive-compulsive disorder

350

1.64

3.15

1.5

1.8

0.55

0.81

g/l

1.60

263

Other and unspecified disorders of skin and subcutaneous tissue

289

1.71

3.15

2.1

1.7

0.95

0.86

g/l

0.19

221

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.57

3.14

1.6

0.83

0.75

g/l

0.12

Carcinoma in situ of skin of other and unspecified parts of face

230

1.79

3.12

1.2

1.5

0.67

0.90

g/l

0.57

176

Injuries to unspecified part of trunk, limb or body region

509

1.52

3.11

1.6

1.7

0.65

0.83

g/l

0.80

388

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

146

1049

1.35

3.10

1.4

1.7

0.69

0.79

g/l

0.73

113

815

Glaucoma secondary to other eye disorders

166

1.95

3.10

1.5

1.6

0.37

0.80

g/l

3.02

125

Superficial injury of forearm

566

1.49

3.10

1.6

1.7

0.84

0.79

g/l

0.10

428

Pustular psoriasis

231

1.79

3.09

1.3

1.7

0.53

0.82

g/l

1.40

173

Cardiomyopathy, Hypertrophic obstructive

2.41

3.08

1.3

1.8

0.48

0.77

g/l

0.61

Muscle strain

132

2.07

3.08

1.3

1.5

1.10

0.79

g/l

0.36

102

Leisure time condition

143

1061

1.35

3.07

1.7

1.6

0.77

0.78

g/l

0.04

103

813

Benign neoplasm: Skin of eyelid, including canthus

111

790

1.41

3.07

1.8

1.5

0.83

0.74

g/l

0.31

584

Corneal ulcer

151

1130

1.34

3.07

1.8

1.6

0.73

0.78

g/l

0.37

113

867

Other spirochaetal diseases

203

1583

1.29

3.06

1.5

0.72

0.75

g/l

0.21

164

1190

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.96

3.06

1.2

1.4

0.26

0.61

g/l

—

Unspecified urinary incontinence

408

1.58

3.04

1.4

1.6

0.67

0.75

g/l

0.27

302

Other benign neoplasms of skin

283

2296

1.24

3.03

1.7

1.6

0.70

0.79

g/l

0.63

213

1719

155

1031

1.34

3.02

1.4

1.6

0.80

0.87

g/l

0.18

106

775

Secondary polycythaemia

100

2.23

3.01

2.1

1.8

0.92

0.82

g/l

0.13

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

153

1151

1.34

3.01

1.6

0.64

0.74

g/l

0.79

110

868

Prolonged pregnancy

917

0.65

3.00

1.3

1.6

0.64

g/l

0.00

694

105

702

1.42

3.00

1.3

1.6

0.90

0.81

g/l

0.17

536

Other facial nerve disorders

120

2.11

3.00

2.4

1.7

0.63

0.93

g/l

0.72

Leiomyoma of uterus

407

1916

1.20

2.99

1.5

0.64

0.63

g/l

0.06

289

1482

Herpesviral keratitis and keratoconjunctivitis

190

1.86

2.98

1.9

1.7

1.65

0.84

g/l

0.52

145

Alzheimer’s disease, wide definition, excluding more controls

424

0.56

2.98

1.6

1.5

0.70

0.89

g/l

0.52

297

Congenital malformations of genital organs

625

1.46

2.98

1.4

1.7

0.50

0.71

g/l

1.92

490

Left bundle-branch block

256

1.73

2.97

1.5

1.6

0.81

g/l

0.01

193

Acute inflammation of orbit

3.25

2.97

2.7

1.7

0.79

0.78

g/l

0.01

Endometriosis of ovary

133

979

1.36

2.96

1.5

0.63

g/l

0.02

102

733

Recurrent and persistent haematuria

3.22

2.96

1.0

1.5

0.57

0.63

g/l

—

Complications of genitourinary prosthetic devices, implants and grafts

2.30

2.95

1.6

1.2

0.77

0.76

g/l

0.02

Recurrent dislocation of patella

272

1.71

2.95

1.3

1.9

0.79

0.73

g/l

0.12

204

Speech disturbances, not elsewhere classified

357

1.61

2.93

1.9

1.5

0.89

0.82

g/l

0.10

269

Other strabismus

192

1492

1.29

2.93

1.6

0.62

0.74

g/l

1.20

141

1136

Benign neoplasm: Anus and anal canal

108

2.16

2.92

2.0

1.8

0.88

1.05

g/l

0.27

Carcinoma in situ of skin

288

1.68

2.91

1.5

1.7

0.72

0.93

g/l

0.57

219

Sixth [abducent] nerve palsy

142

2.00

2.91

1.8

0.57

0.89

g/l

1.22

110

Secondary thrombocytopenia

2.65

2.90

1.9

1.8

0.14

0.89

g/l

—

Hyperaldosteronism

115

2.11

2.90

1.9

1.8

1.30

0.92

g/l

0.34

Primary gonarthrosis, bilateral

364

2658

1.20

2.90

1.5

1.6

0.73

0.82

g/l

1.00

287

2002

Ingrowing nail

304

1.66

2.90

1.2

1.7

0.55

0.81

g/l

1.74

236

Hypertrophy of breast in women and men

165

1262

1.31

2.90

1.4

1.5

0.67

g/l

0.00

117

946

Alzheimer’s disease (Late onset)

592

0.59

2.88

1.5

0.68

0.82

g/l

0.44

446

Insulin, fast-acting (human)

122

893

1.37

2.88

1.5

1.7

0.71

0.78

g/l

0.11

675

Myeloproliferative diseases (CML excluded)

320

1.64

2.87

1.8

1.6

0.83

g/l

0.01

240

Bipolar affective disorders

165

1264

1.31

2.87

1.5

1.6

0.73

0.75

g/l

0.08

132

941

Disorders of optic nerve, not elsewhere classified

2.32

2.86

1.2

1.7

0.60

0.78

g/l

0.38

Embedded and impacted teeth

236

1604

1.25

2.86

1.6

0.67

0.73

g/l

0.44

189

1227

Endometriosis ASRM stages 3,4

185

1440

1.29

2.86

1.6

1.5

0.65

0.61

g/l

0.24

144

1072

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

424

1.54

2.83

1.3

1.6

0.59

0.80

g/l

1.49

321

Other secondary gonarthrosis

238

1.74

2.82

1.7

1.8

0.86

0.81

g/l

0.07

183

Benign neoplasm: Conjunctiva

130

2.02

2.82

2.4

1.7

0.48

0.91

g/l

1.73

Respiratory conditions due to other external agents

2.43

2.82

1.6

1.7

0.45

0.93

g/l

1.44

False labour

272

1384

1.24

2.82

1.4

1.5

0.57

0.59

g/l

0.25

207

1056

Benign neoplasm of other and unspecified sites

137

1.99

2.81

1.4

1.7

0.66

0.89

g/l

0.54

106

Bruxism

110

2.13

2.81

1.3

1.7

0.57

0.67

g/l

0.18

Fracture at wrist and hand level

295

2425

1.22

2.80

1.5

1.6

0.74

0.80

g/l

0.37

211

1832

Benign lipomatous neoplasm

226

1807

1.25

2.80

1.3

1.6

0.58

0.80

g/l

3.29

156

1362

Colitis due to radiation

3.29

2.79

1.8

2.1

0.65

1.35

g/l

—

Disturbances of smell and taste

180

1.85

2.79

1.3

1.9

0.89

g/l

0.00

135

Benign neoplasm: Tongue

117

2.08

2.79

2.3

1.7

0.84

0.87

g/l

0.03

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.93

2.78

1.4

2.0

0.31

1.01

g/l

—

Vertical strabismus

166

1.89

2.78

1.3

1.6

0.57

0.86

g/l

1.27

128

Follicular lymphoma, hilmo

188

1.83

2.76

1.8

1.7

0.45

0.89

g/l

1.49

141

Other noninflammatory disorders of uterus, except cervix

162

845

1.31

2.73

1.6

1.5

0.67

0.66

g/l

0.02

128

615

Dental pulpitis 3

124

657

1.37

2.73

1.4

1.7

0.64

0.74

g/l

0.55

512

Disorders of porphyrin and bilirubin metabolism

2.65

2.73

2.1

1.8

0.73

0.89

g/l

0.22

Female genital prolapse

230

1058

1.26

2.72

1.5

0.59

0.64

g/l

0.51

164

782

Other salmonella infections

160

1.89

2.72

1.3

1.6

0.64

0.82

g/l

0.56

123

Primary open-angle glaucoma

190

1456

1.28

2.71

1.5

0.67

0.82

g/l

1.36

127

1086

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

123

992

0.74

2.69

1.4

1.7

1.06

1.02

g/l

0.08

744

Hypoglycaemia, other or unspecified

342

1.59

2.68

2.4

1.6

1.06

0.77

g/l

0.48

261

Open wound of head

412

3455

1.18

2.68

1.6

0.88

0.82

g/l

0.33

304

2579

Other and unspecified epidermal thickening

126

2.01

2.67

1.4

1.7

0.51

0.86

g/l

0.94

Mental and behavioural disorders due to alcohol, excluding acute intoxication

366

3085

1.19

2.66

1.4

1.6

0.73

0.86

g/l

1.54

262

2314

Blepharochalasis

190

1499

1.27

2.66

1.6

1.4

0.66

0.74

g/l

0.56

146

1109

Mental and behavioural disorders due to opioids

228

1.73

2.64

1.4

1.9

0.46

0.77

g/l

1.58

172

Other specified disorders of muscle

113

2.06

2.63

1.5

1.9

0.59

0.88

g/l

0.78

Fourth [trochlear] nerve palsy

2.18

2.63

1.9

1.6

0.66

0.85

g/l

0.49

Arterial embolism and thrombosis of lower extremity artery

113

2.05

2.62

1.1

1.5

0.68

0.82

g/l

0.31

Moderate visual impairment, binocular

2.17

2.62

1.3

1.5

0.44

0.71

g/l

0.68

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

246

2004

1.23

2.61

1.3

1.6

0.64

0.73

g/l

1.11

193

1529

Carcinoma in situ of skin of other and unspecified parts of face

244

1.69

2.60

1.2

1.5

0.67

0.92

g/l

0.65

186

Event of undetermined intent

361

1.56

2.60

1.3

1.7

0.74

0.81

g/l

0.17

281

Benign neoplasm of urinary organs

192

1.79

2.59

1.9

1.7

0.80

1.01

g/l

0.33

143

Bicipital tendinitis

207

1.75

2.58

1.3

1.7

0.72

0.91

g/l

0.50

154

Other specified disorders of kidney and ureter

149

1.90

2.57

1.7

0.78

0.79

g/l

0.02

115

Benign neoplasm: Tongue

121

2.01

2.57

2.3

1.8

0.84

0.97

g/l

0.15

Primary coxarthrosis, bilateral

184

1453

1.27

2.57

1.5

1.6

0.68

0.85

g/l

1.58

147

1079

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

383

2846

1.18

2.56

1.4

1.5

0.54

0.61

g/l

1.41

297

2164

Acidosis

2.26

2.56

1.3

1.7

0.59

0.91

g/l

0.88

Hallux rigidus

649

1.41

2.55

1.6

0.77

0.81

g/l

0.14

492

Sudden idiopathic hearing loss

492

1.47

2.54

2.0

1.6

0.79

0.83

g/l

0.10

380

Glaucoma suspect

249

2037

1.23

2.54

1.5

1.6

0.62

0.80

g/l

2.49

167

1534

Amputation of toe

269

1.65

2.53

1.2

1.6

1.40

0.87

g/l

0.39

202

Aortic valve malfunction, age under 60 years

567

1.44

2.53

1.8

1.7

0.92

0.84

g/l

0.22

442

Panniculitis affecting regions of neck and back

157

1.86

2.53

2.1

1.8

0.73

0.94

g/l

0.51

114

Delivery

236

1537

0.81

2.53

1.6

1.5

0.68

0.62

g/l

0.39

167

1180

Blood alcohol or alcohol intoxication level

129

1.96

2.52

1.2

1.8

0.84

0.77

g/l

0.14

101

Other and unspecified mononeuropathies of lower limb

122

1.99

2.52

1.4

1.8

0.41

0.91

g/l

2.33

Cardiac arrest

198

1.71

2.51

1.1

1.5

0.40

0.99

g/l

3.88

155

Glucosamine medication

345

2320

1.19

2.51

1.4

1.5

0.65

0.82

g/l

3.05

253

1745

L01XX Other antineoplastic agents

209

1.74

2.51

1.3

1.7

0.51

0.90

g/l

2.27

158

Alzheimer’s disease (Late onset), excluding more controls

377

0.58

2.48

1.6

1.5

0.75

0.88

g/l

0.32

265

Benign neoplasm of bone and articular cartilage

462

1.48

2.48

2.4

1.6

1.09

0.77

g/l

0.86

359

Maltreatment syndromes

310

1.59

2.48

1.2

1.8

0.89

0.75

g/l

0.30

244

Other diseases of peritoneum

210

1.73

2.47

1.4

1.6

0.47

0.83

g/l

2.01

159

Carcinoma in situ of skin

302

1.60

2.47

1.5

0.72

0.85

g/l

0.30

231

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

136

1085

0.76

2.46

1.4

1.7

1.00

1.02

g/l

0.06

103

816

Tooth eruption problems

124

926

1.33

2.46

1.7

0.75

0.72

g/l

0.13

719

Lyme disease

195

1560

1.25

2.46

1.6

1.5

0.71

0.76

g/l

0.32

159

1175

2.11

2.44

1.4

1.7

0.53

0.58

g/l

0.10

310

0.45

2.43

1.2

1.6

0.81

0.86

g/l

—

230

Benign neoplasm of urinary organs

196

1.75

2.43

1.9

1.6

0.80

0.93

g/l

0.19

143

Tobacco use

257

1.65

2.43

1.5

1.7

0.75

0.83

g/l

0.18

194

Malignant neoplasm of small intestine

2.20

2.42

1.8

1.17

1.01

g/l

0.13

Tuberculosis of nervous system

6.77

2.42

1.6

1.05

0.43

g/l

—

Nonischemic cardiomyopathy

265

1.64

2.42

1.4

1.7

0.80

0.85

g/l

0.11

210

Alopecia areata

124

1.96

2.42

2.0

1.7

0.53

0.86

g/l

1.05

Crossbite

415

1.48

2.42

1.4

1.7

1.02

0.82

g/l

0.36

330

Any event in cancer register

849

4519

1.12

2.41

1.5

1.6

0.71

0.75

g/l

0.41

630

3436

Emotional disorders starting during childhood or adolecense, excluding more controls

252

1.64

2.41

1.4

1.8

0.67

0.78

g/l

0.35

200

Persons encountering health services in circumstances related to reproduction

548

3251

1.14

2.40

1.5

1.6

0.70

0.74

g/l

0.40

409

2469

Fracture of lower leg, including ankle

449

3873

1.16

2.40

1.5

1.6

0.70

0.77

g/l

0.85

357

2905

Medial epicondylitis

175

1.79

2.39

1.3

1.7

0.72

0.87

g/l

0.39

133

Assault

117

880

1.34

2.39

1.4

1.7

0.64

0.79

g/l

1.13

671

Macular pucker

641

1.39

2.38

1.9

1.6

0.81

0.87

g/l

0.25

486

Short stature, not elsewhere classified

178

1.76

2.38

1.4

1.7

0.54

0.75

g/l

1.15

160

Benign neoplasm: Anus and anal canal

118

1.97

2.36

2.0

1.7

0.88

0.87

g/l

0.01

Pregnancy with abortive outcome

556

2545

1.14

2.34

1.4

1.5

0.63

0.61

g/l

0.16

418

1915

Benign neoplasm of other and unspecified sites

147

1.86

2.34

1.4

1.7

0.66

0.86

g/l

0.47

114

Gonococcal infection

147

1.86

2.34

1.4

1.9

0.79

0.98

g/l

0.33

113

Other epidermal thickening

199

1.72

2.33

1.4

1.6

0.56

0.89

g/l

1.29

159

Injury of muscle and tendon at shoulder and upper arm level

265

2204

1.21

2.32

1.5

1.6

0.73

0.90

g/l

1.91

196

1639

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

230

1.67

2.30

1.3

1.8

0.54

0.82

g/l

1.45

173

Postprocedural musculoskeletal disorders, not elsewhere classified

308

1.57

2.30

1.3

1.7

0.67

0.85

g/l

0.96

236

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

207

1.71

2.30

1.5

1.9

0.54

0.79

g/l

0.80

165

Diabetic nephropathy, excluding more controls

108

672

1.35

2.30

1.4

1.7

0.68

0.83

g/l

0.86

489

Other benign neoplasms of connective and other soft tissue

520

1.43

2.29

1.5

1.7

0.51

0.84

g/l

3.20

402

Melanocytic naevi of trunk

663

1.38

2.29

1.5

1.6

0.54

0.78

g/l

2.58

512

Chromosomal abnormalities, not elsewhere classified

148

1.85

2.29

1.5

1.6

0.75

0.66

g/l

0.11

123

Organic, including symptomatic, mental disorders

219

1931

0.82

2.29

1.5

1.6

0.71

0.87

g/l

1.48

171

1427

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

475

3378

1.15

2.29

1.5

0.59

0.68

g/l

1.42

348

2578

Gonarthrosis, primary, with knee surgery

391

2744

1.17

2.29

1.5

0.74

0.82

g/l

0.73

293

2050

Benign neoplasm: Conjunctiva

141

1.86

2.29

2.4

1.7

0.48

0.82

g/l

1.49

108

Left hemicolectomy

2.09

2.28

1.6

1.5

0.82

0.84

g/l

0.01

Delivery, wide proxy

186

1233

0.80

2.27

1.6

1.5

0.66

0.62

g/l

0.16

137

929

Malignant neoplasm of mesothelium and soft tissue

178

1.76

2.27

1.4

1.6

0.76

0.92

g/l

0.35

135

Benign neoplasm: Choroid

247

1.63

2.25

1.3

1.7

1.31

0.94

g/l

0.23

192

Fracture of skull and facial bones

169

1346

1.26

2.25

1.4

1.6

0.60

0.80

g/l

2.44

111

1020

Contact with other hot fluids

164

1.79

2.24

1.4

1.7

0.65

0.78

g/l

0.35

126

Postprocedural disorders of ear and mastoid process, not elsewhere classified

2.84

2.22

1.0

1.3

0.31

0.68

g/l

—

Impotence

256

1.61

2.22

1.4

1.7

0.82

1.02

g/l

0.75

193

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

100

2.02

2.21

2.2

1.7

0.68

0.92

g/l

0.50

Occupational exposure to risk-factors

150

1.82

2.21

1.7

0.78

0.85

g/l

0.12

114

Hypertrophic scar

288

1.57

2.20

1.6

0.59

0.78

g/l

0.75

222

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

379

1.49

2.20

1.4

1.7

0.59

0.73

g/l

0.72

306

Disorders of synovium and tendon in diseases classified elsewhere

2.09

2.18

1.3

1.9

1.27

0.89

g/l

0.42

Other disorders of bone density and structure

108

1.96

2.16

1.6

1.9

0.52

0.83

g/l

0.79

Family history of other conditions

2.33

2.16

1.4

2.0

0.43

0.71

g/l

—

Convergence insufficiency and excess

2.33

2.16

1.3

1.4

0.60

0.59

g/l

—

Oesophageal obstruction

115

1.93

2.16

1.2

1.4

0.88

0.94

g/l

0.09

Sequelae of injuries of lower limb

552

1.40

2.16

1.5

1.6

0.60

0.79

g/l

1.30

423

Foreign body in respiratory tract

274

1.58

2.15

1.4

1.7

0.56

0.84

g/l

1.75

212

Sequelae of injuries of head

282

1.57

2.15

1.4

1.7

0.60

0.82

g/l

0.96

213

Contact with and exposure to communicable diseases

281

2360

1.19

2.15

1.6

0.65

0.70

g/l

0.49

169

1819

Contraceptive management

385

2334

1.16

2.14

1.5

1.6

0.66

0.71

g/l

0.57

286

1764

Other and unspecified injuries of ankle and foot

212

1.66

2.14

2.1

1.6

0.76

0.79

g/l

0.03

159

Presence of other devices

134

1044

1.29

2.14

1.5

1.6

0.81

0.80

g/l

0.03

108

816

Cerebral aneurysm, nonruptured

428

1.46

2.14

1.5

0.72

0.71

g/l

0.02

312

Nonpyogenic thrombosis of intracranial venous system

2.50

2.13

1.4

0.39

0.67

g/l

—

Effects of foreign body entering through natural orifice

199

1626

1.23

2.12

1.3

1.7

0.66

0.82

g/l

1.96

140

1235

Congenital malformations of the circulatory system

122

911

1.30

2.12

1.6

1.7

0.72

0.78

g/l

0.32

709

Diabetic retinopathy, excluding more controls

196

893

1.24

2.12

1.4

1.7

0.72

0.76

g/l

0.10

126

648

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

235

1.62

2.12

1.5

1.4

0.73

0.75

g/l

0.05

175

Melanocytic naevi of trunk

673

1.36

2.12

1.5

1.7

0.54

0.75

g/l

2.12

516

Disorders of breast

386

3097

1.16

2.11

1.4

1.5

0.57

0.62

g/l

0.63

291

2336

Other congenital malformations of the digestive system

266

1.58

2.10

1.8

1.6

0.77

0.79

g/l

0.05

214

Disorders of psychological development

105

735

1.33

2.10

1.3

1.8

0.60

0.80

g/l

1.77

572

Pathological resorption of teeth

138

1.83

2.10

1.8

0.94

0.90

g/l

0.07

105

Embolic stroke

145

1.80

2.10

1.7

1.4

0.93

0.81

g/l

0.12

106

Other appendicitis

480

1.42

2.09

1.3

1.7

0.59

0.77

g/l

0.82

364

Oral leukoplakia, including avohilmo

124

1.88

2.08

1.4

1.7

0.48

0.88

g/l

1.39

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

183

1.71

2.08

1.2

1.7

1.11

0.95

g/l

0.13

141

Lactose intolerance

146

1.80

2.07

1.1

1.7

0.74

0.89

g/l

0.35

112

Sequelae of infectious and parasitic diseases

407

1.46

2.05

1.5

1.7

0.64

0.82

g/l

0.92

309

Benign neoplasm: Long bones of lower limb

169

1.73

2.05

2.3

1.8

1.01

0.90

g/l

0.17

131

Impacted teeth

160

1193

1.25

2.04

1.6

1.7

0.66

0.72

g/l

0.41

130

916

Dissociative [conversion] disorders

192

1.68

2.04

1.4

1.7

0.73

0.82

g/l

0.20

136

Other benign neoplasms of connective and other soft tissue

533

1.40

2.04

1.5

1.6

0.51

0.82

g/l

2.99

405

Open wound of wrist and hand

367

3147

1.16

2.03

1.4

1.6

0.74

0.82

g/l

0.72

287

2367

Dental pulpitis 3, only avohilmo

110

612

1.32

2.02

1.4

1.7

0.69

0.75

g/l

0.24

476

Psoriasis (vulgaris), strict definition

148

1.77

1.99

1.3

1.7

0.70

0.85

g/l

0.40

118

Polyp of the female genital tract

238

1152

1.20

1.99

1.5

0.57

0.62

g/l

0.56

181

856

Carcinoma in situ of breast, intraductal

439

0.59

1.98

1.2

1.5

0.66

0.65

g/l

0.01

324

Injury of unspecified body region

369

1.47

1.98

1.6

0.67

0.82

g/l

0.46

281

Sequelae of injuries of upper limb

570

1.38

1.98

1.3

1.6

0.75

0.82

g/l

0.23

440

Pilonidal cyst

562

1.38

1.97

1.4

1.7

0.68

0.81

g/l

0.56

431

Infective bursitis

112

1.89

1.97

1.2

1.8

0.97

1.00

g/l

0.04

Other and unspecified abdominal hernia

156

1.74

1.97

1.4

1.5

0.74

0.75

g/l

0.03

124

Other and unspecified injuries of shoulder and upper arm

149

1.76

1.96

1.3

1.8

0.89

0.85

g/l

0.04

117

Benign neoplasm: Choroid

257

1.57

1.95

1.3

1.6

1.31

0.85

g/l

0.30

192

Dysplasia of cervi uteri

178

1120

1.23

1.95

1.4

1.5

0.52

0.63

g/l

1.46

129

848

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

188

1544

1.22

1.94

1.4

1.6

0.68

0.83

g/l

1.35

146

1146

Hypermetropia

404

1.44

1.94

1.4

1.6

0.58

0.80

g/l

1.32

309

Other nonscarring hair loss

2.61

1.94

1.7

1.6

0.27

0.55

g/l

—

Acute alcohol intoxication, ICD10

154

1239

1.25

1.93

1.4

1.7

0.66

0.83

g/l

1.63

108

943

Other and unspecified vascular occlusions

330

1.49

1.93

1.7

0.80

0.90

g/l

0.18

251

Other disorders of binocular movement

113

1.88

1.93

1.5

1.8

0.62

0.75

g/l

0.25

Delirium, not induced by alcohol and other psychoactive substances

412

1.44

1.92

1.5

1.6

0.58

0.87

g/l

2.16

314

Malnutrition

1.98

1.91

1.7

0.85

0.79

g/l

0.09

608

1.36

1.91

1.2

1.5

0.45

0.61

g/l

1.66

457

Other articular cartilage disorders

1.94

1.91

2.2

2.1

1.03

1.01

g/l

0.02

Dislocation, sprain and strain of joints and ligaments of head

243

1.58

1.91

1.5

1.8

0.59

0.76

g/l

0.64

185

Entropion and trichiasis of eyelid

291

1.52

1.89

1.3

1.6

0.94

0.87

g/l

0.08

225

Hypertrophy of breast

138

1100

1.26

1.89

1.4

1.5

0.63

0.62

g/l

0.05

819

Other disorders starting during childhood or adolescence

354

1.47

1.88

1.4

1.7

0.57

0.74

g/l

0.90

284

Leiomyoma of uterus

505

2544

1.13

1.88

1.5

0.62

g/l

0.02

367

1945

Graves disease, strict definition

585

1.36

1.86

1.5

1.7

0.95

0.72

g/l

0.50

447

Dependent personality disorder

1.96

1.86

1.5

1.9

0.67

0.96

g/l

0.57

Early lumbar disc prolapse, operated

620

1.34

1.85

1.3

1.7

0.55

0.82

g/l

3.03

475

Molar incisor enamel hypoplasia

217

1.60

1.85

2.2

1.5

0.69

0.71

g/l

0.03

186

Melanocytic naevi of other and unspecified parts of face

285

1.52

1.85

1.9

1.7

0.92

0.84

g/l

0.11

214

Retinal detachments and breaks

234

1973

1.19

1.84

1.9

1.6

0.85

0.83

g/l

0.07

184

1489

Inflammatory diseases of prostate (prostatitis)

681

1.33

1.84

1.5

1.7

0.81

1.03

g/l

0.90

518

Benign neoplasm: Long bones of lower limb

175

1.67

1.84

2.3

1.6

1.01

0.77

g/l

0.47

132

Benign neoplasm of bone and articular cartilage

493

1.39

1.83

2.4

1.7

1.09

0.76

g/l

0.92

380

Coxarthrosis, primary, with hip surgery

302

2466

1.16

1.82

1.4

1.6

0.65

0.84

g/l

2.41

241

1827

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

101

1.90

1.82

1.5

1.9

0.50

0.94

g/l

—

Overexertion and strenuous or repetitive movements

588

1.35

1.81

1.2

1.7

0.84

0.80

g/l

0.04

444

Benign neoplasm: Skin of trunk

199

1.62

1.81

2.0

1.7

0.59

0.90

g/l

0.67

154

Urethral stricture

215

1.59

1.79

1.3

1.5

0.91

0.88

g/l

0.07

171

Carcinoma in situ of breast, intraductal

426

0.61

1.79

1.2

1.6

0.66

0.70

g/l

0.09

322

Schizoaffective disorder

475

0.63

1.79

1.0

1.7

0.36

0.80

g/l

5.62

362

Intentional self-harm by sharp object

131

1.77

1.78

1.3

1.9

0.85

0.76

g/l

0.15

100

Hereditary corneal dystrophies

131

1.77

1.78

2.0

1.7

0.99

0.89

g/l

0.13

Chalazion

633

1.33

1.78

1.8

1.6

0.72

0.75

g/l

0.13

481

Emotional disorders and disorders of social functioning with onset specific to childhood

316

1.48

1.78

1.4

1.7

0.74

0.70

g/l

0.11

253

Haemangioma and lymphangioma, any site

479

1.38

1.78

1.9

1.6

0.64

0.76

g/l

0.66

364

Injury of nerves at ankle and foot level

2.50

1.77

1.2

2.1

0.30

0.83

g/l

—

Traumatic subdural haemorrhage

479

1.38

1.77

1.5

0.80

0.89

g/l

0.29

356

Other conjunctival vascular disorders and cysts

102

1.88

1.77

1.5

1.8

0.53

0.91

g/l

1.09

Wet age-related macular degeneration

579

1.34

1.77

1.5

1.6

0.97

0.82

g/l

0.20

443

Anxious personality disorder

1.92

1.76

1.3

2.1

0.55

0.90

g/l

0.95

Retinoschisis and retinal cysts

1.91

1.76

2.1

1.5

1.44

0.83

g/l

0.40

Dipeptidyl peptidase 4 (DPP-4) inhibitors

574

1.35

1.76

1.6

0.73

0.89

g/l

0.75

432

Benign leiomyoma with endometriosis

106

827

1.29

1.75

1.4

1.5

0.61

0.68

g/l

0.40

613

Essential (haemorrhagic) thrombocythaemia

147

1.71

1.74

1.2

1.8

1.06

1.02

g/l

0.06

116

Haemangioma and lymphangioma, any site

481

1.38

1.74

1.9

1.6

0.64

0.82

g/l

1.13

369

D07AA Corticosteroids, weak (group I)

128

1022

1.26

1.74

1.5

1.6

0.78

0.73

g/l

0.24

794

Seborrhoeic dermatitis

490

1.37

1.73

1.4

1.7

0.70

0.85

g/l

0.69

385

Gestational [pregnancy-induced] hypertension

204

1708

1.19

1.72

1.5

0.55

0.61

g/l

0.56

155

1285

Myopia

103

803

1.29

1.72

1.3

1.7

0.59

0.75

g/l

1.28

612

Other and unspecified trigeminal disorders

2.09

1.71

1.1

1.4

0.99

0.57

g/l

—

Other disorders of the genitourinary system

620

1.33

1.71

1.4

1.6

0.60

0.73

g/l

0.72

449

Malignant neoplasm of breast, HER-negative

1153

0.77

1.71

1.3

1.5

0.55

0.67

g/l

0.99

858

Arthropod-borne viral fevers and viral haemorrhagic fevers

517

1.36

1.71

1.8

1.6

0.76

0.83

g/l

0.19

393

Sequelae of cerebrovascular disease

211

1558

1.19

1.70

1.6

0.92

0.81

g/l

0.56

169

1157

Anorexia (incl.atypical)

324

1.46

1.69

1.1

1.7

0.47

0.68

g/l

1.56

241

Other congenital malformations of circulatory system

126

1.76

1.69

2.3

1.7

0.50

0.88

g/l

1.30

Separation of retinal layers (serosa)

203

1.59

1.69

2.1

1.7

0.80

0.87

g/l

0.17

157

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

467

1.38

1.68

1.6

1.7

0.66

0.85

g/l

0.99

348

Peripheral arterial reconstruction

665

1.31

1.68

1.3

1.6

0.96

0.95

g/l

0.01

513

Acute alcohol intoxication

189

1581

1.20

1.66

1.5

1.7

0.68

0.88

g/l

2.48

136

1194

Haemangioma, any site

443

1.38

1.66

2.0

1.6

0.62

0.78

g/l

0.93

333

Sequelae of injuries of neck and trunk

142

1.71

1.65

1.8

1.6

1.12

0.78

g/l

0.55

110

Corneal scars and opacities

112

1.80

1.65

2.4

1.8

0.61

0.92

g/l

0.92

Pregnancy hypertension

336

2652

1.14

1.64

1.5

0.56

0.61

g/l

0.62

262

2016

Haemangioma, any site

444

1.38

1.64

2.0

1.6

0.62

0.84

g/l

1.45

340

Vestibular neuronitis

444

1.38

1.64

1.3

1.7

0.64

0.82

g/l

0.97

344

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

105

1.83

1.64

1.5

1.9

0.50

0.84

g/l

—

Early complications of trauma

197

1.58

1.63

1.4

1.8

0.58

0.90

g/l

0.74

152

!Aliquae complicationes praecoces traumatis

197

1.58

1.63

1.4

1.8

0.58

0.90

g/l

0.74

152

Cystic kidney disease

158

1.66

1.63

1.3

1.8

0.61

0.84

g/l

0.68

120

Alzheimer’s disease (Early onset)

131

0.38

1.62

1.2

1.5

0.39

0.89

g/l

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

286

1.48

1.62

1.6

1.7

0.82

0.94

g/l

0.30

221

Other puerperal infections

471

1.37

1.61

1.4

1.6

0.68

0.59

g/l

0.43

358

Other disorders of cornea

471

1.37

1.61

1.6

0.75

0.80

g/l

0.20

366

Benign neoplasm: Skin of trunk

206

1.56

1.60

2.0

1.7

0.59

0.85

g/l

0.54

159

Vitreous haemorrhage

455

1.37

1.59

1.9

1.7

0.96

0.83

g/l

0.21

352

Pregnancy examination and test

140

710

1.23

1.57

1.6

0.55

0.57

g/l

0.10

106

538

L02BA Anti-estrogens

936

0.76

1.57

1.3

1.5

0.52

0.64

g/l

1.15

699

Female infertility, tubal origin

280

1.47

1.57

1.3

1.6

0.65

0.66

g/l

0.03

216

Recurrent dislocation and subluxation of joint

406

1.39

1.55

1.6

1.7

0.67

0.84

g/l

0.74

305

Autism spe, excluding more controls

122

1.74

1.55

1.3

1.9

0.46

0.80

g/l

2.24

Granulomatous disorders of skin and subcutaneous tissue

107

1.79

1.55

1.7

1.6

0.44

0.86

g/l

1.49

Lactose intolerance, other/unspecified

122

1.74

1.55

1.1

1.7

0.83

0.89

g/l

0.09

Alcoholic gastritis

2.06

1.55

1.1

1.3

0.96

0.84

g/l

—

Oral leukoplakia

1.99

1.55

1.6

2.0

0.59

1.09

g/l

—

Female infertility, associated with anovulation

458

1.36

1.54

1.6

0.59

0.62

g/l

0.12

349

Amputation of foot

100

1.82

1.54

1.6

2.96

0.93

g/l

0.70

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

200

1.56

1.54

1.5

1.8

0.67

0.99

g/l

1.07

154

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

104

1251

0.80

1.53

1.3

1.5

0.53

0.68

g/l

1.71

940

Schizophrenia or delusion

193

2274

0.85

1.52

1.4

1.6

0.68

0.75

g/l

0.43

132

1700

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

137

939

1.23

1.52

1.3

1.6

0.72

0.88

g/l

0.80

708

Injuries involving multiple body regions

185

1.58

1.52

1.3

1.8

0.81

0.84

g/l

0.04

143

Major anomalies of jaw size

146

1.66

1.51

1.5

1.8

0.70

0.80

g/l

0.17

112

Injuries to the elbow and forearm

574

4712

1.10

1.51

1.5

1.6

0.77

0.74

g/l

0.22

439

3572

Perineal laceration during delivery

960

0.78

1.51

1.7

1.6

0.47

0.60

g/l

1.08

715

Schizophrenia, schizotypal and delusional disorders

194

2281

0.85

1.50

1.4

1.6

0.68

0.75

g/l

0.47

133

1708

Infectious mononucleosis

547

1.32

1.49

1.9

1.7

0.57

0.72

g/l

1.00

415

L02BB Anti-androgens

332

0.60

1.49

1.8

1.5

2.01

1.01

g/l

0.50

247

Gilbert syndrome

2.48

1.49

1.8

1.9

0.71

1.01

g/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

139

1.67

1.49

1.2

1.7

0.79

0.81

g/l

0.04

108

L01XE Protein kinase inhibitors

251

1.48

1.4

1.6

0.97

0.88

g/l

0.11

190

Astigmatism

359

1.40

1.48

1.2

1.7

0.46

0.84

g/l

3.65

277

Speech and linguistic disorders

576

1.31

1.47

1.4

1.8

0.58

0.83

g/l

2.59

460

Diabetic nephropathy

109

864

1.25

1.47

1.4

1.7

0.68

0.79

g/l

0.64

625

Traumatic subarachnoid haemorrhage

109

1.75

1.47

1.3

1.6

0.69

0.88

g/l

0.56

Other specified/unspecified deforming dorsopathies

1.86

1.47

1.2

1.9

0.52

0.94

g/l

1.02

Alcohol dependence

201

1714

1.18

1.46

1.4

1.7

0.75

0.90

g/l

1.10

144

1296

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

211

1.53

1.46

1.3

1.7

0.51

0.88

g/l

1.44

161

Other secondary coxarthrosis

148

1.63

1.45

1.5

1.7

1.07

0.87

g/l

0.19

110

Viral haemorrhagic fevers, not elsewhere classified/unspecified

412

1.37

1.44

1.9

1.6

0.80

0.83

g/l

0.04

312

Presbyopia

354

1.39

1.42

1.4

1.6

0.56

0.82

g/l

1.82

268

Melanocytic naevi of other and unspecified parts of face

304

1.42

1.40

1.9

1.5

0.92

0.74

g/l

0.29

228

LSIL lesion of the cervix uteri, vagina or vulva

111

900

1.24

1.39

1.5

0.58

0.63

g/l

0.26

670

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

2.03

1.39

1.4

1.8

0.84

0.71

g/l

—

Other disorders of penis

554

1.31

1.39

2.3

1.7

0.96

0.95

g/l

0.01

438

Injury of eye and orbit

111

901

1.24

1.38

1.4

1.7

0.70

0.81

g/l

0.70

682

Specific development disorders of scholastic skills

302

1.42

1.37

1.4

1.8

0.62

0.76

g/l

0.67

237

Melanocytic naevi, other sites/unspecified

399

1.36

1.37

1.6

1.7

0.52

0.84

g/l

1.28

311

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

215

1.50

1.36

1.3

1.7

0.51

0.95

g/l

1.81

169

Allergic contact dermatitis due to drugs in contact with skin

1.77

1.35

1.4

1.8

0.61

0.84

g/l

—

Unspecified event, undetermined intent

120

1.68

1.35

1.4

1.7

0.34

0.78

g/l

2.12

Corns and callosities

316

1.40

1.33

1.2

1.7

0.51

0.83

g/l

2.33

249

Malignant neoplasm of oral cavity

144

1.61

1.32

1.3

1.6

0.71

0.86

g/l

0.38

112

Injury of muscle and tendon at hip and thigh level

532

1.30

1.32

1.5

1.7

0.87

0.82

g/l

0.08

401

Complications of other internal prosthetic devices, implants and grafts

144

1.61

1.32

2.1

1.3

0.86

0.75

g/l

0.08

111

Fitting and adjustment of other devices

204

1636

1.16

1.31

1.5

1.6

0.77

0.83

g/l

0.25

176

1204

Contusion of ankle

209

1.49

1.30

1.4

1.7

1.11

0.86

g/l

0.21

153

Assault by bodily force

500

1.31

1.28

1.4

1.7

0.64

0.79

g/l

0.80

387

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

305

0.62

1.28

1.7

1.6

1.20

0.73

g/l

0.23

225

Anankastic personality disorder

202

1.50

1.27

1.2

1.7

0.68

0.82

g/l

0.35

150

Varicose veins of other sites

353

1.37

1.27

1.9

1.6

1.08

0.89

g/l

0.28

276

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

464

1.32

1.27

1.9

1.7

0.92

0.98

g/l

0.12

359

Other and unspecified mononeuropathies, also in other diseases

130

1.63

1.27

1.6

1.8

0.76

0.85

g/l

0.15

103

Other benign neoplasm of uterus: Other parts/unspecified

138

1.60

1.26

1.2

1.6

0.55

0.76

g/l

0.67

108

Anisometropia and aniseikonia

146

1.59

1.26

1.3

1.7

0.60

0.86

g/l

0.64

115

Persistent delusional disorders

400

0.67

1.26

1.1

1.7

0.65

0.81

g/l

0.47

303

Disorder of external ear, unspecified

139

1.59

1.23

1.8

1.6

0.75

0.78

g/l

0.04

106

Coronary revascularization (ANGIO or CABG)

295

1825

1.13

1.23

1.6

0.85

0.92

g/l

0.31

228

1353

Coronary angioplasty

229

1536

1.15

1.22

1.6

0.85

0.93

g/l

0.31

178

1153

Other mental disorders due to brain damage and dysfunction and to physical disease

460

1.31

1.22

1.3

1.6

0.59

0.86

g/l

2.14

348

Calcific tendinitis of shoulder

288

1.40

1.21

1.2

1.7

0.65

0.82

g/l

0.73

217

Routine general health check-up of defined subpopulation

1.81

1.21

1.2

1.5

0.54

0.67

g/l

0.35

Benign leiomyoma with endometriosis

106

871

1.22

1.21

1.4

1.5

0.61

0.63

g/l

0.11

633

Superficial injury of thorax

101

826

1.23

1.21

1.8

1.6

0.66

0.81

g/l

0.75

638

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

452

1.31

1.20

1.2

1.6

0.93

g/l

0.00

344

Ovarian dysfunction

409

1.33

1.20

1.6

0.37

0.62

g/l

2.65

308

Other blood glucose lowering drugs, excl. Insulins

104

854

1.22

1.20

1.3

1.6

0.68

0.85

g/l

1.13

638

Preterm labour and delivery

198

1719

1.15

1.20

1.4

1.5

0.53

0.61

g/l

0.77

142

1292

Endometriosis diagnosis and infertility diagnosis occurring together

693

1.25

1.19

1.5

0.62

0.63

g/l

0.06

521

Malignant melanoma, excluding all cancers (controls excluding all cancers)

103

846

1.22

1.19

1.6

0.61

0.84

g/l

2.04

641

Diffuse brain injury

157

1.54

1.17

1.1

1.6

0.59

0.88

g/l

1.05

123

Other disorders of breast

748

1.23

1.17

1.3

1.5

0.48

0.63

g/l

1.53

554

Other maltreatment syndromes

190

1.48

1.17

1.4

1.8

0.66

0.80

g/l

0.41

151

Other and unspecified injuries of wrist and hand

190

1.48

1.16

1.4

1.7

0.61

0.81

g/l

0.89

150

Other benign neoplasms of uterus

190

1.48

1.16

1.2

1.5

0.63

0.72

g/l

0.31

147

Redundant prepuce, phimosis and paraphimosis

160

1365

1.17

1.16

1.5

1.7

0.93

g/l

0.00

123

1036

Myocardial infarction, with ST-elevation

794

1.22

1.16

1.7

1.6

0.89

0.94

g/l

0.08

609

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

381

2352

1.11

1.15

1.7

1.6

0.63

0.83

g/l

3.41

292

1779

Hepatocellular carcinoma

1.82

1.15

1.5

1.6

0.36

1.01

g/l

—

Scabies

249

1.41

1.15

1.7

0.62

0.82

g/l

0.68

189

Benign neoplasm of ovary

115

959

1.20

1.15

1.2

1.5

0.64

0.66

g/l

0.06

703

Melanoma in situ

150

1.54

1.15

1.9

0.80

1.07

g/l

0.46

119

Foreign body in alimentary tract

266

1.40

1.14

1.4

1.6

0.79

0.83

g/l

0.09

208

Other degenerative diseases of the nervous system

161

1045

1.17

1.14

1.5

0.67

0.83

g/l

1.07

119

774

Bursitis of shoulder

1.70

1.14

1.4

2.1

0.37

0.95

g/l

2.18

Exposure to other and unspecified forces of nature

2.38

1.13

1.6

2.2

0.82

1.05

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

327

2013

1.12

1.13

1.7

1.6

0.68

0.84

g/l

1.73

251

1515

Inguinal hernia

467

2878

1.10

1.13

1.8

1.6

0.98

0.84

g/l

0.86

354

2143

Status post-ami

172

0.57

1.13

1.1

1.7

0.81

0.88

g/l

—

140

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

431

1.30

1.12

1.3

1.7

0.93

g/l

0.00

334

Alzheimer’s disease (Early onset), excluding more controls

108

0.44

1.12

1.2

1.5

0.39

0.87

g/l

—

Nontoxic multinodular goitre

122

1026

1.19

1.12

1.6

1.5

0.69

0.70

g/l

0.04

759

Other benign neoplasm of uterus: Other parts/unspecified

143

1.55

1.11

1.2

1.8

0.55

0.72

g/l

0.49

112

Infections of genitourinary tract in pregnancy

547

1.27

1.11

1.3

1.6

0.53

0.65

g/l

0.73

404

Melanocytic naevi, other sites/unspecified

415

1.31

1.10

1.6

0.52

0.80

g/l

1.03

316

Contact with heat and hot substances

294

1.37

1.10

1.5

1.7

0.75

0.83

g/l

0.18

226

Oral lichen ruber planus wide, hypothyreosis or thyroxin

243

1.41

1.10

2.1

1.7

0.40

0.81

g/l

3.11

183

Sequelae of other accidents

1.84

1.09

1.2

1.8

0.58

0.83

g/l

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

1.97

1.09

1.1

2.0

0.78

0.97

g/l

—

Postpartum haemorrhage due to retained placenta

806

0.79

1.08

1.4

1.5

0.71

0.61

g/l

0.50

616

Anomalies of dental arch relationship, including avohilmo

160

1239

1.16

1.08

1.4

1.6

0.71

0.76

g/l

0.30

118

954

Malignant neoplasm of bladder

227

1.41

1.07

2.1

1.4

0.85

0.90

g/l

0.08

175

In situ neoplasms

226

1906

1.13

1.07

1.6

1.5

0.74

0.75

g/l

0.04

159

1430

Premature rupture of membranes

124

1076

0.85

1.07

1.5

0.65

0.61

g/l

0.18

816

Pregnancy, childbirth and the puerperium

167

1011

0.86

1.07

1.6

1.5

0.63

0.65

g/l

0.06

124

756

Lichen sclerosus et atrophicus

479

1.28

1.07

1.7

1.5

0.69

0.73

g/l

0.13

355

Calculus of lower urinary tract

194

1.45

1.07

1.5

1.7

0.62

1.00

g/l

1.33

154

Superficial injury of shoulder and upper arm

631

1.24

1.06

1.9

1.7

0.68

0.81

g/l

0.78

483

Long labour

142

1445

0.86

1.06

1.5

0.69

0.60

g/l

0.64

115

1090

Other and unspecified corneal deformities and disorders

145

1.53

1.06

1.4

1.8

0.46

0.87

g/l

1.46

111

Pediculosis, acariasis and other infestations

331

1.34

1.05

1.6

1.7

0.58

0.81

g/l

1.16

250

Primary ovarian failure

1.68

1.04

1.7

1.6

0.48

0.78

g/l

—

Other benign neoplasms of uterus

195

1.44

1.04

1.2

1.8

0.63

0.71

g/l

0.27

147

Benign neoplasm of ovary

115

970

1.19

1.04

1.2

1.6

0.64

0.68

g/l

0.13

726

Asymptomatic human immunodeficiency virus [HIV] infection status

2.09

1.04

1.3

1.9

0.64

0.68

g/l

—

Foreign body entering into or through eye or natural orifice

473

1.27

1.03

1.4

1.6

0.73

0.80

g/l

0.23

371

Ill-defined and unknown causes of mortality

227

0.61

1.02

1.2

1.5

0.59

0.93

g/l

—

172

Car occupant injured in other and unspecified transport accidents

143

1231

1.16

1.02

1.8

1.6

0.66

0.76

g/l

0.89

118

937

Bitten or struck by other mammals

672

1.22

1.01

1.4

1.7

0.59

0.74

g/l

1.07

510

Foreign body in ear

1.63

1.00

1.3

1.8

0.47

0.77

g/l

0.63

Other disorders of pigmentation

197

1.43

1.00

1.6

1.7

0.50

0.84

g/l

1.77

153

Complications of the puerperium, not elsewhere classified

231

1.39

1.00

1.6

0.55

0.62

g/l

0.19

174

Emotional disorders starting during childhood or adolescence

315

1.33

0.99

1.4

1.7

0.67

0.72

g/l

0.13

255

Retinal breaks without detachment

101

848

1.19

0.98

2.3

1.5

0.93

0.80

g/l

0.46

640

Congenital malformations of eye, ear, face and neck

389

1.29

0.96

1.3

1.6

0.85

0.76

g/l

0.19

297

Mental and behavioural disorders due to cannabinoids

182

1.44

0.96

1.2

2.0

0.62

0.76

g/l

0.28

144

Additional codes for the location of defect, injury or illness

267

1.35

0.96

1.5

1.6

0.59

0.82

g/l

0.86

203

Chronic viral hepatitis

328

1.32

0.96

1.3

1.8

0.80

0.85

g/l

0.10

253

Juvenile osteochondrosis

174

1.45

0.95

1.9

0.69

0.84

g/l

0.33

137

Failed attempted abortion

1.79

0.95

1.9

1.5

0.22

0.53

g/l

—

Mental disorders, not otherwise specified

497

1.25

0.95

1.5

1.7

0.63

0.76

g/l

0.79

379

Convergent concomitant strabismus

373

1.29

0.94

1.6

1.8

0.55

0.80

g/l

1.87

286

Carcinoma in situ of cervix uteri

523

0.76

0.94

1.7

1.5

0.50

0.60

g/l

0.48

392

Injury of muscle and tendon at ankle and foot level

117

1.55

0.94

1.3

1.6

0.62

0.84

g/l

0.57

Labour and delivery complicated by umbilical cord complications

277

1.34

0.94

1.3

1.6

0.52

0.67

g/l

0.78

207

Other vitreous opacities

175

1.44

0.93

1.5

1.6

0.63

0.85

g/l

0.49

132

Malignant neoplasm of eye, brain and central nervous system

192

1.41

0.92

1.7

0.49

0.84

g/l

1.25

150

LSIL lesion of the cervix uteri

698

1.21

0.92

1.5

0.51

0.62

g/l

0.73

526

Use of interferon beta-1a

134

1.50

0.92

1.4

1.6

0.47

0.68

g/l

0.50

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

126

1.51

0.91

1.5

1.6

0.68

1.12

g/l

1.67

Bulimia nervosa (incl. atypical)

176

1.43

0.91

1.2

1.8

0.67

0.59

g/l

0.25

129

Congenital deformities of hip

102

1.58

0.91

1.9

1.5

0.69

0.48

g/l

0.42

Other sexually transmitted chlamydial diseases

402

1.27

0.90

1.4

1.7

0.63

0.71

g/l

0.35

299

Other and unspecified nonorganic psychotic disorders

117

1360

0.86

0.90

1.4

1.6

0.68

0.77

g/l

0.46

1020

Transient global amnesia

417

0.74

0.90

2.1

1.6

0.66

0.86

g/l

0.71

303

Hypoplasia of dental enamel , including avohilmo

208

1.39

0.89

2.4

1.5

0.48

0.74

g/l

0.93

177

HSIL lesion of the cervix uteri

103

1208

0.85

0.89

1.4

1.5

0.51

0.61

g/l

0.93

918

Fracture of femur

133

1052

1.16

0.89

1.4

1.6

0.59

0.82

g/l

3.02

794

Postpartum care and examination

621

0.83

0.89

1.5

1.6

0.51

0.57

g/l

0.39

470

Congenital malformations of great arteries

174

1.42

0.88

1.6

1.8

0.68

0.77

g/l

0.19

147

Malignant neoplasm of head and neck

350

1.29

0.88

1.2

1.7

1.01

0.90

g/l

0.13

268

Injury of muscle and tendon at lower leg level

106

904

1.18

0.88

1.9

1.6

0.73

0.83

g/l

0.37

686

Ectopic pregnancy

130

1127

1.16

0.88

1.5

0.66

0.62

g/l

0.18

848

Macular hole

212

1.37

0.86

1.1

1.7

0.44

0.96

g/l

3.91

166

HSIL lesion of the cervix uteri, vagina or vulva

114

1322

0.86

1.4

1.5

0.50

0.61

g/l

1.27

1003

Motorcycle rider injured in other and unspecified transport accidents

361

1.28

0.85

1.7

0.55

0.82

g/l

2.01

278

Right hemicolectomy

221

1.36

0.85

1.4

1.6

0.79

0.88

g/l

0.23

169

Femoral hernia

170

1.42

0.85

2.1

1.5

0.54

0.79

g/l

0.85

136

Benign neoplasm of thyroid gland

145

1.46

0.85

2.4

1.8

0.83

0.93

g/l

0.11

110

Non-small cell lung cancer

659

1.20

0.85

1.2

1.5

0.82

0.90

g/l

0.20

499

Amblyopia ex anopsia

213

1.37

0.84

1.6

1.5

1.26

0.70

g/l

0.39

169

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

145

1.45

0.84

1.4

1.8

0.72

1.05

g/l

0.52

113

Focal epilepsy

145

1272

1.14

0.84

1.5

1.6

0.76

0.78

g/l

0.07

113

975

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

327

1.29

0.83

1.5

1.7

0.44

0.90

g/l

3.51

253

Dental caries 1 and operation codes, only avohilmo

222

1242

0.90

0.83

1.8

1.6

0.80

0.72

g/l

0.39

162

941

Obstructed labour due to maternal pelvic abnormality

113

975

1.16

0.83

1.4

1.5

0.54

0.61

g/l

0.71

731

Parkinson's disease

645

0.80

0.82

2.0

1.5

0.57

0.89

g/l

2.70

478

Abnormal findings in secretions and smears from cervix uteri vagina vulva

375

2719

1.08

0.82

1.4

1.5

0.54

0.61

g/l

1.02

283

2073

Benign neoplasm of other and unspecified female genital organs

197

1.38

0.82

1.4

1.7

0.64

0.70

g/l

0.13

151

Melanoma in situ

163

1.42

0.82

1.9

1.7

0.80

0.90

g/l

0.15

126

138

1.46

0.82

2.0

1.8

0.75

0.84

g/l

0.13

106

Benign neoplasm: Kidney

138

1.46

0.82

1.8

0.82

1.00

g/l

0.17

104

Focal epilepsy, strict definition

132

1154

1.15

0.81

1.5

1.6

0.66

0.78

g/l

0.71

103

883

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

172

1.40

0.81

1.6

1.8

0.82

1.01

g/l

0.32

136

Inguinal hernia, bilateral

508

1.22

0.81

1.4

1.5

0.76

0.91

g/l

0.76

393

Wide developmental disorders, excluding more controls

179

1.39

0.80

1.2

1.9

0.43

0.73

g/l

2.45

148

Hyperplasia of prostate

242

1248

1.11

0.80

1.4

1.7

0.98

g/l

0.01

178

943

0.00

0.80

0.0

1.4

—

0.38

—

Inguinal or femoral hernia, bilateral

518

1.22

0.80

1.4

1.5

0.75

0.90

g/l

0.83

402

Complications of labour and delivery

503

2617

1.07

0.80

1.4

1.5

0.61

g/l

0.05

384

1968

Other ill-defined and unspecified causes of mortality

200

0.65

0.79

1.2

1.6

0.62

0.92

g/l

—

153

Toxic effect of contact with venomous animals

207

1.36

0.79

1.1

1.6

0.58

0.81

g/l

1.21

156

Struck by thrown, projected or falling objec

268

1.31

0.79

1.5

1.8

0.80

0.78

g/l

0.05

209

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

626

1.19

0.79

1.2

1.6

0.82

0.92

g/l

0.25

478

Carcinoma in situ of cervix uteri

508

0.79

1.7

1.5

0.50

0.60

g/l

0.52

384

Other and unspecified mental retardation

124

0.56

0.78

1.4

1.5

0.37

0.58

g/l

—

108

Retinal haemorrhage

1.56

0.78

1.3

1.6

0.52

0.77

g/l

—

Open wound of abdomen, lower back and pelvis

165

1.40

0.78

1.0

1.8

0.82

0.83

g/l

0.01

125

Status epilepticus

148

1.43

0.78

1.3

1.7

0.57

0.87

g/l

0.84

118

Adenocarcinoma and papillary adenocarcinoma of stomach

0.50

0.78

1.0

1.5

0.87

0.93

g/l

—

Crushed, pushed or stepped on by crowd or human stampede

466

1.23

0.77

1.2

1.7

0.70

0.76

g/l

0.26

356

Aneurysms, operations, SAH

100

861

1.16

0.77

1.6

1.5

0.68

0.74

g/l

0.32

641

Laparoscopic right hemicolectomy

217

1.34

0.77

1.5

1.7

0.90

0.95

g/l

0.08

166

Dementia in other diseases classified elsewhere

157

1.41

0.76

1.2

1.5

0.48

0.85

g/l

1.50

119

Certain conditions originating in the perinatal period

542

1.20

0.76

1.3

1.7

0.62

0.80

g/l

0.86

432

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

113

818

1.15

0.76

1.2

1.6

0.72

0.87

g/l

0.60

621

Non-small cell lung cancer, squamous, helper endpoint

132

1.44

0.76

1.5

1.6

0.68

1.01

g/l

1.09

101

Non-small cell lung cancer, squamous

132

1.44

0.76

1.5

1.6

0.68

1.01

g/l

1.09

101

Fracture of neck

235

1.32

0.76

1.2

1.7

0.53

0.93

g/l

1.83

183

Nontoxic single thyroid nodule

359

1.26

0.76

1.9

1.6

0.59

0.80

g/l

0.95

270

Varicose veins

446

3144

1.07

0.75

1.6

1.5

0.74

0.76

g/l

0.19

313

2385

Focal epilepsy, mode (most common among epilepsy diagnosis)

123

1078

1.14

0.75

1.6

0.79

0.78

g/l

0.02

826

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

570

0.81

0.74

1.3

1.6

1.03

0.89

g/l

0.20

432

Intracerebral haemorrhage

477

1.22

0.74

1.5

1.4

0.81

0.82

g/l

0.04

359

In situ neoplasms

226

2054

1.10

0.74

1.6

1.5

0.74

g/l

0.01

159

1538

Cicatricial alopecia [scarring hair loss]

1.86

0.74

1.4

0.55

0.56

g/l

—

Supervision of high-risk pregnancy

168

906

1.12

0.73

1.5

0.55

0.58

g/l

0.27

134

692

Sequelae of other and unspecified infectious and parasitic diseases

334

1.26

0.73

1.5

1.7

0.60

0.82

g/l

1.12

253

Dental caries 2 and operation codes, only avohilmo

646

3788

1.06

0.73

1.6

1.5

0.68

0.73

g/l

0.64

525

2799

Impacted maxillary molar

308

1.27

0.72

1.6

1.7

0.58

0.66

g/l

0.40

229

Conductive hearing loss, unspecified

435

1.22

0.71

1.4

1.6

1.01

0.79

g/l

0.21

340

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

508

1.20

0.70

1.3

1.7

0.92

0.91

g/l

0.02

388

Pre-eclampsia or poor fetal growth

230

2094

1.10

0.70

1.4

1.5

0.57

0.60

g/l

0.24

176

1586

Memory loss

381

1.24

0.70

1.7

1.5

0.79

0.85

g/l

0.16

285

Benign neoplasm: Kidney

143

1.41

0.70

1.8

1.6

0.82

0.87

g/l

0.04

108

Glaucoma, exfoliation

363

1.24

0.70

1.6

1.5

0.80

0.85

g/l

0.10

278

Vascular dementia

205

1.32

0.69

1.2

1.4

0.70

0.97

g/l

1.30

152

Benign neoplasm of thyroid gland

152

1.39

0.69

2.4

1.6

0.83

g/l

0.00

117

Unspecified maternal hypertension

1.65

0.69

1.1

1.4

0.67

0.55

g/l

—

Postmenopausal atrophic vaginitis

164

884

1.12

0.68

1.4

1.5

0.57

0.67

g/l

0.86

128

649

Parodontitis, under 40 years

602

1.18

0.68

1.3

1.7

0.52

0.70

g/l

1.68

459

Parodontitis, under 40 years, or operation codes

602

1.18

0.68

1.3

1.7

0.52

0.70

g/l

1.68

459

Unspecified lump in breast

104

909

1.15

0.68

1.5

0.51

0.63

g/l

0.95

680

Renal cell carcinoma of kidney

118

0.59

0.68

1.3

1.5

0.62

0.84

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

330

2417

1.08

0.68

1.7

1.5

0.68

0.85

g/l

1.87

247

1788

Bacterial meningitis

170

1.36

0.67

1.8

0.96

0.94

g/l

0.02

126

Malignant melanoma

714

1.16

0.67

1.7

1.6

0.60

0.86

g/l

2.04

534

Congenital malformations of the nervous system

136

1.41

0.67

1.2

1.8

1.45

0.77

g/l

0.74

108

Basal cell carcinoma

336

2488

1.08

0.66

1.7

1.5

0.66

0.84

g/l

2.64

259

1840

Traumatic amputation of wrist and hand

214

0.70

0.66

1.7

1.8

0.79

0.92

g/l

—

168

Behavioural disorders, excluding more controls

111

1.45

0.66

1.6

1.8

1.34

0.78

g/l

—

Deep bite

645

1.16

0.62

1.4

1.7

0.64

0.82

g/l

1.63

508

Placenta praevia

270

1.26

0.62

1.4

1.6

0.62

0.66

g/l

0.11

198

Single delivery by forceps and vacuum extractor

687

0.88

0.62

1.4

1.5

0.67

0.60

g/l

0.39

536

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

1.68

0.62

1.4

1.3

0.37

0.85

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

674

1.16

0.61

1.9

1.6

0.61

0.77

g/l

1.13

514

Abnormal spermatozoa

577

0.83

0.61

1.5

1.6

1.14

1.00

g/l

0.19

446

Alcohol withdrawal state with delirium

361

1.22

0.61

1.1

1.7

0.58

0.94

g/l

2.36

279

Autism spe

156

1.35

0.61

1.3

1.6

0.46

0.67

g/l

1.24

124

Polycystic ovarian syndrome

289

1.25

0.61

1.3

1.6

0.29

0.64

g/l

5.26

208

Contact with other sharp object(s)

401

0.80

0.61

1.7

0.64

0.79

g/l

0.54

309

Parodontitis, under 40 years and operation codes

564

1.17

0.60

1.3

1.7

0.50

0.69

g/l

1.72

431

Parodontitis, operation under 40 years and operation codes

564

1.17

0.60

1.3

1.7

0.50

0.69

g/l

1.72

431

Parkinson's disease, strict definition

575

0.83

0.59

2.1

1.5

0.58

0.91

g/l

2.50

429

Postpartum hemorraghe, all women as controls

158

1732

0.91

0.59

1.4

1.5

0.64

0.60

g/l

0.32

117

1317

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

301

1933

1.07

0.59

1.8

1.6

0.66

0.84

g/l

2.20

231

1454

malignant neoplasm of female genital organs

714

0.85

0.58

1.3

1.5

0.52

0.63

g/l

0.74

511

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

771

1.14

0.58

1.3

1.6

0.51

0.82

g/l

3.10

593

Malignant neoplasm of respiratory system and intrathoracic organs

105

856

1.13

0.58

1.3

1.6

0.77

0.91

g/l

0.52

649

Polymorphous light eruption

1.73

0.58

1.0

1.4

0.42

g/l

—

Use of levodopa decarboxylase inhibitor

529

0.83

0.57

2.2

1.6

0.59

0.92

g/l

2.08

397

Rubella [German measles]

202

1.29

0.57

2.3

1.7

0.79

0.95

g/l

0.44

154

Parkinson's disease, including avohilmo

669

0.85

0.57

1.9

1.5

0.55

0.89

g/l

3.29

498

Other osteochondropathies

420

1.19

0.56

1.6

0.69

0.82

g/l

0.60

319

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

485

1.18

0.56

1.4

1.5

0.63

0.64

g/l

0.03

370

Dental caries 3 and operation codes, only avohilmo

272

1470

0.93

0.56

1.7

1.6

0.70

0.72

g/l

0.12

199

1122

Nontoxic goitre/thyroid nodule

189

1735

1.09

0.56

1.9

1.5

0.73

0.68

g/l

0.23

141

1288

Slow fetal growth and fetal malnutrition

1.53

0.55

1.9

1.7

0.42

0.70

g/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

120

0.65

0.55

1.9

1.5

1.03

0.68

g/l

—

102

Hydrocele

588

1.16

0.55

2.0

1.7

0.73

1.00

g/l

1.38

459

Malignant neoplasm of ovary

194

0.72

0.55

1.9

1.7

0.38

0.73

g/l

—

150

Burn and corrosion of hip and lower limb, except ankle and foot

116

1.39

0.54

1.9

1.8

1.15

0.77

g/l

0.38

Benign neoplasm of other and unspecified female genital organs

213

1.27

0.54

1.4

1.7

0.64

0.74

g/l

0.23

159

Specific development disorders of speech and language

371

1.20

0.54

1.3

1.7

0.70

0.77

g/l

0.19

302

Postpartum haemorrhage

158

1506

0.91

0.54

1.4

1.5

0.64

0.59

g/l

0.42

117

1144

Acute myeloid leukaemia, helper endpoint

1.55

0.53

1.8

1.2

0.54

0.62

g/l

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.55

0.53

1.8

1.2

0.54

0.62

g/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

121

1297

0.90

0.53

1.4

1.6

0.91

0.88

g/l

0.09

968

Foreign body on external eye

105

939

1.12

0.53

1.3

1.7

0.69

0.84

g/l

1.03

718

HSIL lesion of the vulva

1.52

0.53

1.2

1.7

0.38

0.60

g/l

—

Colorectal cancer

1109

0.89

0.52

1.4

1.6

0.94

0.85

g/l

0.23

842

Post-traumatic wound infection, not elsewhere classified

126

1.36

0.52

1.1

1.8

0.39

0.96

g/l

2.64

Lesion of sciatic nerve

161

1.31

0.51

1.6

1.08

0.94

g/l

0.11

122

Outcome of delivery

107

740

0.89

0.51

1.4

1.5

0.59

0.58

g/l

0.08

561

Personal history of risk-factors, not elsewhere classified

1.41

0.51

1.1

2.0

0.68

0.85

g/l

—

Lesion of radial nerve

170

1.30

0.51

2.5

1.6

2.14

0.84

g/l

0.76

130

Complications predominantly related to the puerperium

193

1782

1.08

0.51

1.5

0.61

0.62

g/l

0.07

148

1348

Foreign body or object entering through skin

351

1.20

0.51

1.3

1.7

0.38

0.83

g/l

7.38

275

Autism

162

1.30

0.50

1.3

1.7

0.46

0.73

g/l

1.70

126

Inguinal hernia, unilateral

101

1.39

0.49

2.7

1.6

0.73

0.78

g/l

—

Inguinal of femoral hernia, unilateral

101

1.39

0.49

2.7

1.6

0.73

0.78

g/l

—

Femoral hernia, unilateral

101

1.39

0.49

2.7

1.6

0.73

0.78

g/l

—

Fall on and from ladder

371

1.19

0.49

1.5

1.6

1.16

0.87

g/l

0.71

290

Diabetes mellitus in pregnancy

249

1507

1.07

0.48

1.4

1.5

0.56

0.61

g/l

0.42

201

1156

Benign neoplasm: Skin of other and unspecified parts of face

493

1.16

0.48

1.4

1.6

0.58

0.81

g/l

1.52

372

Follow-up examination after treatment for malignant neoplasms

354

1.19

0.48

1.3

1.5

0.68

0.85

g/l

0.63

240

Colorectal adenocarcinoma

911

0.89

0.48

1.5

1.6

0.97

0.87

g/l

0.20

689

Other disorders of amniotic fluid and membranes

892

0.89

0.48

1.7

1.6

0.52

0.62

g/l

0.79

674

Open bite

327

1.20

0.47

1.4

1.7

0.99

0.77

g/l

0.43

251

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

522

1.15

0.47

1.1

1.6

0.49

0.66

g/l

1.06

382

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

701

1.13

0.47

1.7

1.6

0.58

0.83

g/l

2.49

532

Contact with machinery

607

1.14

0.47

1.3

1.6

0.69

0.93

g/l

1.12

478

All dysplastic lesions of the cervix uteri, vagina or vulva

208

1924

1.08

0.47

1.4

1.5

0.55

0.60

g/l

0.49

157

1458

Generalized epilepsy, mode (most common among epilepsy diagnosis)

173

1.28

0.46

1.3

1.7

0.52

0.80

g/l

1.03

133

Unspecified abortion

282

1.21

0.46

1.6

1.5

0.51

0.64

g/l

0.58

208

Maternal care related to the fetus and amniotic cavity and possible delivery problems

358

1994

1.06

0.46

1.5

0.64

0.60

g/l

0.48

288

1519

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.61

0.46

1.0

1.5

0.87

0.92

g/l

—

Type1 diabetes, definitions combined, early onset

502

0.85

0.46

1.6

1.8

0.72

0.70

g/l

0.04

392

Dislocation, sprain and strain of joints and ligaments of elbow

375

1.18

0.45

1.8

1.7

0.67

0.82

g/l

0.79

292

Multiple gestation

590

1.14

0.45

1.5

1.6

0.57

0.65

g/l

0.38

441

Universal erythroderma, KELA reimbursement

1.46

0.44

1.1

1.7

0.69

0.92

g/l

—

Injury of muscle and tendon at wrist and hand level

838

1.11

0.44

1.5

1.7

0.67

0.81

g/l

0.65

653

Other disorders of male genital organs

211

1.24

0.43

2.1

1.6

0.87

0.95

g/l

0.13

166

Malignant neoplasm of bronchus and lung

713

1.12

0.43

1.2

1.6

0.75

0.89

g/l

0.44

531

Other and unspecified disorders of adult personality and behaviour

1.63

0.43

1.2

1.6

0.38

0.67

g/l

—

Other superficial injuries of ankle and foot

1.63

0.43

3.2

1.3

0.79

0.65

g/l

—

Atlantoaxial subluxation

1.63

0.43

1.0

1.5

0.52

0.74

g/l

—

Liposarcoma

1.63

0.43

1.0

2.3

0.59

1.21

g/l

—

Early lumbar disc prolapse operation

763

1.12

0.43

1.3

1.6

0.75

0.78

g/l

0.05

573

Migraine with aura, drug-induced

1.44

0.43

2.4

1.8

0.51

0.76

g/l

—

Toxic effect of ethanol

230

1.22

0.42

2.9

1.9

0.65

0.82

g/l

0.55

180

Type 1 diabetes, strict (exclude DM2)

734

1.12

0.42

1.5

1.8

0.65

0.76

g/l

0.42

576

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

793

1.11

0.42

1.3

1.6

0.51

0.79

g/l

2.60

604

Mandibular retrognathia

405

1.16

0.42

1.4

1.7

0.59

0.76

g/l

0.80

310

Benign neoplasm: Skin of other and unspecified parts of face

500

1.14

0.41

1.4

1.6

0.58

0.83

g/l

1.72

371

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.39

0.41

2.4

2.3

0.32

0.93

g/l

—

Non-seminoma of testis

1.53

0.41

1.4

1.5

0.37

0.91

g/l

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.41

0.0

1.3

—

1.32

—

Other abnormal products of conception

246

1542

1.06

0.41

1.5

0.52

0.59

g/l

0.85

187

1178

Conduct disorder

123

1.31

0.40

1.6

1.7

1.34

0.71

g/l

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.3

—

0.55

—

Other and unspecified injuries of forearm

1.48

0.40

1.0

2.3

0.26

1.04

g/l

—

Abnormal findings on antenatal screening of mother

508

0.86

0.40

1.6

0.60

0.65

g/l

0.14

390

Burn and corrosion of trunk

150

1.27

0.40

1.3

1.8

0.61

0.90

g/l

1.09

116

Pedal cyclist injured in transport accident

137

1482

0.92

0.40

1.6

0.75

0.78

g/l

0.07

106

1138

Xerosis cutis

1.32

0.39

1.5

1.7

0.54

0.76

g/l

—

Lesion of plantar nerve

306

1.18

0.39

1.8

1.6

0.68

0.78

g/l

0.26

228

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

102

0.68

0.39

1.3

1.6

0.62

1.10

g/l

—

Type 1 diabetes, strict definition

622

0.88

0.39

1.5

1.8

0.69

0.73

g/l

0.07

491

Thyrotoxicosis with toxic single thyroid nodule

1.44

0.39

1.8

1.3

0.85

0.55

g/l

—

Other abortion

1.44

0.39

1.2

1.5

0.39

0.59

g/l

—

Type 1 diabetes, definitions combined

738

1.11

0.39

1.5

1.8

0.65

0.76

g/l

0.41

580

Supervision of normal pregnancy

151

931

0.93

0.39

1.3

1.5

0.64

0.58

g/l

0.49

119

711

Myocardial infarction, unclassifiable

828

0.90

0.39

1.5

1.6

0.81

0.92

g/l

0.37

628

Medical treatment for female infertility

152

1409

1.08

0.39

1.5

0.55

0.60

g/l

0.48

123

1068

Contact with blunt object, undetermined intent

1.40

0.38

1.4

2.1

0.64

0.95

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

1.40

0.38

1.6

1.5

0.54

0.75

g/l

—

Nontraumatic intracranial haemmorrhage

102

932

1.10

0.38

1.7

1.6

0.74

0.80

g/l

0.29

692

Open wound of forearm

495

1.13

0.38

1.2

1.7

0.64

0.83

g/l

0.89

377

Benign mammary dysplasia

780

1.10

0.38

1.4

1.5

0.53

0.66

g/l

1.08

569

Other fall from one level to another

158

1473

1.07

0.37

1.5

1.6

0.87

0.78

g/l

0.32

118

1133

Congenital malformations of heart and great arteries

831

1.10

0.36

1.4

1.7

0.72

0.81

g/l

0.40

649

Basal cell carcinoma, including avohilmo

339

2548

1.05

0.36

1.7

1.5

0.66

0.84

g/l

2.64

261

1883

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

302

1977

1.05

0.36

1.7

1.6

0.66

0.84

g/l

2.23

232

1483

Spontaneous abortion

341

2214

1.05

0.36

1.3

1.5

0.58

0.60

g/l

0.17

257

1676

Twin gestation

574

1.12

0.35

1.5

1.6

0.58

0.64

g/l

0.33

428

Intermittent heterotropia

357

1.15

0.35

1.4

1.7

0.52

0.78

g/l

1.84

271

Combinations of oral blood glucose lowering drugs

176

1653

1.07

0.35

1.6

0.72

0.89

g/l

1.38

132

1233

Divergent concomitant strabismus

458

0.87

0.34

1.6

1.7

0.47

0.79

g/l

2.76

346

Other and unspecified injuries of head

292

1.17

0.34

1.4

1.7

0.91

0.80

g/l

0.22

222

Malignant neoplasm of stomach

181

1.22

0.34

1.3

1.6

0.72

0.94

g/l

0.48

137

Mental and behavioural disorders due to use of other stimulants, including caffeine

172

1.23

0.34

1.1

2.0

0.82

g/l

0.01

133

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.31

0.33

4.2

2.3

1.12

1.17

g/l

—

Other disorders of breast and lactation associated with childbirth

1.33

0.32

1.3

1.5

0.45

0.47

g/l

—

Other lesions of median nerve

101

1.29

0.31

1.2

1.8

0.38

0.86

g/l

—

Ectropion of eyelid

101

1.29

0.31

1.3

1.6

0.70

1.02

g/l

—

Previous suicide attempt

1.35

0.31

1.1

2.1

0.83

0.82

g/l

—

Postpartum haemorrhage due to anatomy

622

0.90

0.31

1.5

0.61

0.57

g/l

0.18

474

Parodontitis or/and operation codes

562

3235

1.03

0.31

1.5

0.66

0.72

g/l

0.82

433

2396

Otosclerosis

390

1.13

0.30

1.2

1.7

0.78

g/l

0.01

296

Generalized epilepsy, strict definition

120

1.25

0.30

1.3

1.6

0.46

0.77

g/l

—

Conotruncal defects

102

1.28

0.30

1.3

1.5

0.95

0.69

g/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

896

0.92

0.30

1.3

1.5

0.75

0.72

g/l

0.05

660

severe traumatic brain injury, does not include concussion

121

1130

1.07

0.30

1.4

1.6

0.75

0.88

g/l

0.89

859

Pedal cyclist injured in noncollision transport accidents

682

0.91

0.29

1.6

0.57

0.75

g/l

1.73

514

Burns and corrosions

890

1.08

0.29

1.7

1.6

0.67

0.80

g/l

0.74

676

Kela-code for severe mental illness

255

2666

0.96

0.29

1.3

1.6

0.63

0.75

g/l

1.57

187

1989

Peripheral retinal degeneration

139

1.23

0.29

1.4

1.6

0.42

0.86

g/l

—

103

Emergency coronary revascularization (for ACS)

321

2215

1.04

0.29

1.6

0.84

0.89

g/l

0.21

247

1646

Torsion of testis

130

1.24

0.29

1.6

1.8

2.59

0.87

g/l

0.47

102

Pre-eclampsia

143

1347

1.06

0.28

1.5

0.55

0.62

g/l

0.78

111

1007

Behavioural disorders

131

1.23

0.27

1.6

1.7

1.34

0.71

g/l

—

107

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.27

0.26

2.7

2.0

0.72

1.12

g/l

0.80

Postpartum hemorraghe, parous women as controls

158

1458

0.95

0.26

1.4

1.5

0.64

0.58

g/l

0.53

117

1115

LeFortI or BSSRO operation

235

0.85

0.25

1.4

1.7

0.54

0.76

g/l

0.77

176

Diabetic retinopathy

222

1340

1.05

0.25

1.4

1.6

0.75

g/l

0.01

143

995

Benign neoplasm: Larynx

123

1.22

0.25

1.8

1.7

0.61

1.00

g/l

—

Congenital malformations of aortic and mitral valves

235

1.15

0.25

1.6

1.7

0.88

0.86

g/l

0.02

183

Malignant neoplasm of colon

633

0.92

0.25

1.5

1.6

0.81

0.83

g/l

0.07

480

Bilateral sagittal split ramus osteotomy operation

191

0.84

0.24

1.4

1.8

0.56

0.80

g/l

0.65

142

Wide developmental disorders

217

1.15

0.24

1.2

1.6

0.43

0.70

g/l

2.15

172

Car occupant injured in noncollision transport accident

189

1.17

0.24

1.3

1.9

0.65

0.86

g/l

0.53

144

Focal brain injury

274

1.13

0.24

1.6

0.90

0.96

g/l

0.13

210

Generalized epilepsy

246

1.14

0.23

1.3

1.7

1.08

0.81

g/l

0.19

189

Complications following abortion and ectopic and molar pregnancy

171

1.17

0.23

1.4

1.6

0.55

0.65

g/l

0.26

127

Acquired absence of limb

1.32

0.23

1.6

1.9

0.73

0.97

g/l

—

Left ventricular outflow tract obstruction, narrow definition

294

1.12

0.23

1.6

1.7

0.84

g/l

0.00

229

Calcaneal spur

1.29

0.23

2.4

2.5

0.62

1.12

g/l

—

Benign neoplasm: Parathyroid gland

1.25

0.22

1.0

1.9

0.47

0.89

g/l

—

Contact with sharp glass

219

1.14

0.22

1.4

1.9

0.59

0.82

g/l

0.42

171

Marfan's syndrome

1.23

0.22

1.2

1.5

0.61

0.54

g/l

—

Malignant neoplasm of skin

383

2799

1.03

0.22

1.7

1.5

0.66

0.83

g/l

2.37

290

2080

Other and unspecified mononeuropathies of upper limb

144

1.18

0.22

1.4

1.7

0.59

0.82

g/l

0.54

108

Other perinatal haematological disorders

0.00

0.21

0.0

1.3

—

0.74

—

Pre-eclampsia or eclampsia

153

1461

1.05

0.21

1.5

0.56

0.62

g/l

0.68

121

1095

Malignant neoplasm of rectum

388

0.90

0.21

1.4

1.6

0.75

0.92

g/l

0.29

294

Accidental poisoning by and exposure to pesticides

0.00

0.21

0.0

1.8

—

0.50

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

1.6

—

0.68

—

Crowding of teeth, including avohilmo

499

1.08

0.20

1.4

1.7

0.58

0.82

g/l

2.06

382

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

861

0.94

0.20

1.5

1.6

0.97

0.87

g/l

0.20

650

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

403

1.09

0.20

1.1

1.6

0.53

0.67

g/l

0.75

303

Tibial collateral bursitis [Pellegrini-Stieda]

1.20

0.20

1.0

1.9

0.45

0.94

g/l

—

1.16

0.19

1.7

0.25

0.87

g/l

—

Other complications of labour and delivery, not elsewhere classified

680

1.06

0.18

1.3

1.6

0.61

0.64

g/l

0.10

512

Diabetic retinopathy, strict definition

114

954

1.05

0.18

1.5

1.7

0.91

0.78

g/l

0.20

704

Cellulitis of external ear

1.21

0.18

2.9

1.8

0.92

0.81

g/l

—

Parkinson's disease, excluding more controls

545

0.93

0.18

2.0

1.6

0.57

0.89

g/l

2.37

397

Erectile dysfunction

368

1.09

0.17

1.6

1.83

0.95

g/l

0.79

282

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

403

0.92

0.17

1.4

1.6

1.22

0.89

g/l

0.41

307

Congenital musculoskeletal deformities of head, face, spine and chest

1.22

0.17

1.6

1.9

1.33

0.80

g/l

—

Accidental poisoning by and exposure to alcohol

1.22

0.17

2.0

1.8

0.60

0.80

g/l

—

Hydatidiform mole

0.72

0.17

1.4

1.5

0.88

0.46

g/l

—

Puerperal sepsis

777

1.06

0.17

1.6

1.5

0.58

0.65

g/l

0.45

575

Congenital malformations of cardiac septa

422

1.08

0.16

1.4

1.7

0.69

0.78

g/l

0.34

344

Maternal care for other known or suspected fetal problems

175

1083

1.04

0.16

1.3

1.5

0.58

g/l

0.00

129

833

Acute and transient psychotic disorders

771

0.95

0.16

1.3

1.7

0.68

0.76

g/l

0.24

584

Gestational diabetes (for exclusion)

272

1874

1.03

0.15

1.3

1.5

0.57

0.59

g/l

0.14

218

1428

Male infertility

303

1.09

0.15

1.3

1.8

0.90

g/l

0.01

227

Respiratory and cardiovascular disorders specific to the perinatal period

181

0.88

0.15

1.7

1.6

0.53

0.75

g/l

0.87

157

Fracture of forearm

399

3659

1.02

0.15

1.5

0.80

0.73

g/l

0.38

304

2751

Respiratory distress of newborn

129

0.86

0.14

2.0

1.5

0.55

0.73

g/l

0.37

114

Maternal care for known or suspected abnormality of pelvic organs

178

1190

1.03

0.14

1.4

1.5

0.51

0.61

g/l

1.21

129

905

Benign neoplasm of breast

646

1.05

0.13

1.5

1.6

1.00

0.65

g/l

0.61

484

Obstructed labour due to malposition and malpresentation of fetus

151

1469

0.97

0.13

1.4

1.5

0.61

0.59

g/l

0.11

117

1117

Adenocarcinoma and papilloma adenocarcinoma of rectum

387

0.93

0.13

1.4

1.6

1.21

0.91

g/l

0.35

296

Use of disulfiram, acamprosate or naltrexone

561

0.94

0.13

1.3

1.7

0.75

0.86

g/l

0.34

430

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

221

0.90

0.12

1.4

1.8

0.34

0.92

g/l

4.34

172

Abnormalities of forces of labour

703

0.95

0.12

1.3

1.5

0.56

0.61

g/l

0.28

531

Overjet

168

0.89

0.12

1.5

1.6

0.76

0.64

g/l

—

140

Clear cell adenocarcinoma of kidney

189

0.90

0.12

1.6

1.7

1.58

0.91

g/l

0.48

145

Polycystic ovarian syndrome, broad definition

670

1.05

0.11

1.5

1.6

0.50

0.61

g/l

0.64

517

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

110

1137

0.97

0.11

1.2

1.6

0.80

0.87

g/l

0.25

859

Bicuspidal aortic valve syndrome

182

1.10

0.11

1.8

1.7

1.00

0.80

g/l

0.35

146

Malignant melanoma of skin

514

1.05

0.11

1.7

1.6

0.55

0.86

g/l

2.68

393

Antepartum haemorrhage, not elsewhere classified

573

1.05

0.10

1.3

1.6

0.47

0.64

g/l

1.31

431

Pedestrian injured in collision with pedal cycle

144

1.11

0.10

1.2

1.8

1.16

0.90

g/l

—

111

Contact with nonpowered hand tool

241

1.08

0.10

1.3

1.7

0.66

0.87

g/l

0.84

186

Thyrotoxicosis with toxic multinodular goitre

251

1.08

0.10

1.9

1.7

0.73

0.81

g/l

0.20

192

Benign neoplasm: Parathyroid gland

1.11

0.10

1.0

1.7

0.47

0.82

g/l

—

Tarsal tunnel syndrome

1.09

0.09

1.0

1.8

1.41

0.82

g/l

—

Birth asphyxia

1.07

0.09

1.0

1.5

0.38

0.68

g/l

—

Inflammatory disorders of breast

330

1.06

0.09

1.7

1.6

0.48

0.61

g/l

0.58

245

Pedal cyclist injured in collision with motor vehicle

145

1.10

0.09

2.1

1.8

0.70

0.86

g/l

0.49

114

Malignant neoplasm of brain

145

1.10

0.09

1.4

1.7

0.35

0.88

g/l

—

114

Multiple delivery

564

0.96

0.09

1.6

1.4

0.53

0.58

g/l

0.25

439

Atrial septal defect

231

1.08

0.09

1.2

1.7

0.63

0.79

g/l

0.41

192

Single delivery by caesarean section

148

835

1.03

0.09

1.5

0.60

0.59

g/l

0.06

110

655

Pedestrian injured in transport accident

360

1.06

0.09

1.3

1.7

0.93

0.81

g/l

0.19

275

Bacterial sepsis of newborn

1.13

0.09

1.5

1.7

1.09

0.59

g/l

—

Seminoma of testis

1.09

0.09

4.2

2.1

1.12

g/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.05

0.08

1.0

1.5

0.83

0.54

g/l

—

Manic episode

136

1.10

0.08

2.0

1.9

0.57

0.97

g/l

—

102

Hydrocephalus

308

0.94

0.08

1.8

1.6

0.73

0.89

g/l

0.49

239

Burns and corrosions of external body surface, specified by site

677

1.03

0.08

1.6

0.78

g/l

0.00

515

Parkinson's disease, strict definition, excluding more controls

490

0.96

0.07

2.1

1.6

0.58

0.89

g/l

1.99

357

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.05

0.07

2.5

1.9

0.44

0.88

g/l

—

Retained placenta and membranes, without haemorrhage

752

0.97

0.07

1.5

0.59

0.62

g/l

0.12

553

Sulfonylureas

181

1469

0.98

0.07

1.4

1.6

0.83

0.89

g/l

0.29

139

1082

Schizophrenia or delusion, excluding more controls

193

1945

0.98

0.06

1.4

1.6

0.68

0.79

g/l

0.76

132

1454

Malignant neoplasm of kidney, except renal pelvis

376

0.96

0.06

1.4

1.6

1.23

0.90

g/l

0.41

292

All dysplastic lesions of the cervix uteri

174

1709

1.02

0.06

1.4

1.5

0.51

0.60

g/l

0.96

124

1302

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

416

0.96

0.06

1.3

1.7

1.16

0.94

g/l

0.28

318

Distal bite

245

1.05

0.06

1.6

1.7

0.67

0.80

g/l

0.26

193

Benign neoplasm: Larynx

139

1.08

0.05

1.8

1.5

0.61

0.78

g/l

—

106

Retinal detachment with retinal break

627

0.97

0.05

1.8

1.6

0.99

0.84

g/l

0.25

484

Spermatocele

366

1.04

0.05

1.4

1.7

0.74

0.96

g/l

0.43

281

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

228

1.05

0.05

1.1

1.8

0.66

0.99

g/l

1.03

173

Inflammatory disease of cervix uteri

317

1.04

0.05

1.4

0.70

0.69

g/l

0.02

236

Unspecified mental disorder

305

3022

1.01

0.04

1.3

1.6

0.62

0.76

g/l

2.16

229

2274

Orchitis and epididymitis

484

0.97

0.04

1.6

1.7

0.65

0.98

g/l

2.51

375

Poor fetal growth

824

1.02

0.04

1.3

1.5

0.60

0.61

g/l

0.03

628

Other specified disorders of external ear

160

1.06

0.04

1.5

1.7

0.68

0.86

g/l

0.50

123

Pedestrian injured in collision with car, pick-up truck or van

111

1.08

0.04

1.4

1.6

0.81

0.73

g/l

—

Labour and delivery complicated by fetal stress [distress]

171

1128

1.01

0.03

1.4

1.5

0.59

0.58

g/l

0.05

131

856

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

129

0.93

0.03

1.6

1.8

2.08

1.03

g/l

0.48

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

462

0.97

0.03

1.6

1.8

0.74

0.93

g/l

0.72

351

Malignant neoplasm of corpus uteri

341

0.97

0.03

1.1

1.6

0.55

0.69

g/l

0.59

253

Antenatal screening

169

961

0.99

0.03

1.4

1.5

0.57

0.58

g/l

0.07

145

732

Acute appendicitis, with complications

122

1234

0.99

0.03

1.8

1.6

0.61

0.79

g/l

1.49

948

Type 1 diabetes, strict definition, subgroup 1

518

1.02

0.03

1.5

1.7

0.68

0.71

g/l

0.06

415

Polyhydramnios

259

0.96

0.02

1.6

0.82

0.66

g/l

0.30

189

Other obstructed labour

450

1.02

0.02

1.2

1.5

0.59

0.63

g/l

0.20

338

Injury of nerves at wrist and hand level

193

1.04

0.01

1.5

1.9

0.52

0.89

g/l

1.37

156

Maternal care for known or suspected fetal abnormality and damage

106

935

1.01

0.01

1.5

0.61

0.63

g/l

0.10

704

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

317

0.98

0.01

1.3

1.7

0.64

0.83

g/l

0.73

240

Failed induction of labour

323

1.02

0.01

1.6

0.41

0.59

g/l

1.38

241

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

176

0.97

0.00

1.6

1.8

1.58

1.04

g/l

0.37

141

Family history of certain disabilities and chronic diseases leading to disablement

246

0.98

0.00

1.3

1.7

0.61

0.76

g/l

0.46

191

Other and/or unspecified nontoxic goitre

406

0.99

0.00

2.8

1.6

0.94

0.76

g/l

0.57

301

Colon adenocarcinoma

456

0.99

0.00

1.6

0.74

0.87

g/l

0.44

348

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

845

0.99

0.00

1.5

1.6

1.00

0.82

g/l

0.53

632

Maternal care for known or suspected malpresentation of fetus

124

925

1.00

0.00

1.5

0.53

0.60

g/l

0.57

706

Coronary artery bypass grafting

132

1006

1.00

0.00

1.9

1.6

0.90

0.97

g/l

0.18

762

Uterine polyps

518

1.00

0.00

1.3

1.5

0.51

0.69

g/l

1.10

385

Non-small cell lung cancer, adenocarcinoma

235

1.02

0.00

1.1

1.6

0.66

0.93

g/l

0.79

179

Non-small cell lung cancer, adenocarcinoma, helper endpoint

235

1.02

0.00

1.1

1.6

0.66

0.93

g/l

0.79

179

Family history of malignant neoplasm

598

1.00

0.00

1.3

1.6

0.47

0.69

g/l

2.18

462

Subarachnoid haemorrhage

463

0.99

0.00

1.9

1.5

0.65

0.79

g/l

0.66

349

Benign neoplasm of breast

678

1.00

0.00

1.5

1.00

0.63

g/l

0.68

507

Septal defects

403

1.00

0.00

1.3

1.7

0.66

0.79

g/l

0.44

330

Malignant neoplasm of testis

1.04

0.00

3.1

2.1

0.81

1.05

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

314

0.99

0.00

1.3

1.8

0.64

0.91

g/l

1.17

246

Noise effects on inner ear

212

0.99

0.00

1.3

1.7

0.59

0.87

g/l

0.68

165

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

401

1.00

0.00

1.3

1.7

1.16

0.94

g/l

0.28

305

Pedal cyclist injured in other and unspecified transport accidents

651

1.00

0.00

1.4

1.6

1.00

0.77

g/l

0.27

494

Malignant neoplasm of urinary organs

404

0.99

0.00

1.4

1.6

1.16

0.90

g/l

0.36

316

Maternal care for cervical incompetence

185

1.03

0.00

1.4

1.6

0.69

0.70

g/l

0.03

140

Assault by unspecified chemical or noxious substance

0.00

0.0

1.5

—

0.53

—

Subclinical iodine-deficiency hypothyroidism

0.00

0.0

1.8

—

0.62

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.8

—

0.39

—

Birth injury to skeleton

0.00

0.0

1.5

—

0.79

—

Chondrosarcoma

0.00

0.0

2.0

—

0.51

—

Varus deformity, not elsewhere classified

0.91

0.00

2.0

1.9

0.79

0.71

g/l

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.3

—

0.56

—

Drowning and submersion in swimming-pool or bath

0.00

0.0

1.6

—

0.85

—

Other degenerative diseases of the basal ganglia

0.88

0.00

1.0

1.7

0.53

1.00

g/l

—

Lichen nitidus

0.00

0.0

1.2

—

0.59

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.7

—

0.46

—

Abuse of non-dependence-producing substances

0.00

0.0

1.4

—

1.18

—

Medullary carcinoma of thyroid gland

0.00

0.0

2.2

—

0.46

—

Carcinoma in situ of oral cavity

0.00

0.0

1.5

—

0.78

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.0

1.1

—

0.75

—

Liveborn infants according to place of birth

0.94

0.00

1.0

1.6

0.68

0.56

g/l

—

Alcoholic myopathy

0.00

0.0

1.5

—

0.72

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

0.91

0.00

1.0

1.6

1.12

1.15

g/l

—

General hospital and personal-use devices associated with adverse incidents

0.00

0.0

1.3

—

0.55

—

Flexion deformity

0.00

0.0

1.8

—

0.55

—

Exposure to noise

0.00

0.0

1.0

—

0.47

—

Other inherited muscular atrophy

0.00

0.0

1.3

—

0.56

—

Cutaneous autosensitization

0.00

0.0

1.4

—

0.81

—

Pemphigus foliaceus

0.00

0.0

1.8

—

0.55

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.2

—

0.82

—

Choroidal detachment

0.00

0.0

1.2

—

0.32

—

Use of pergolide

0.00

0.0

1.4

—

0.49

—

Degeneration of iris and ciliary body

0.00

0.0

1.6

—

0.33

—

Carcinoma in situ of lip

0.00

0.0

1.0

—

0.66

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

1.0

—

0.77

—

Other sudden death, cause unknown

0.00

0.0

1.3

—

0.64

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

1.2

—

0.42

—

Malignant neoplasm of rectosigmoid junction

1.02

0.00

1.2

1.8

2.74

0.91

g/l

—

Rhabdomyosarcoma

0.00

0.0

1.0

—

0.98

—

Delta-beta thalassaemia

0.00

0.0

1.2

—

0.61

—

Amputation of ankle

0.00

0.0

1.3

—

0.76

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 4 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS